Section 53

EurekaMag Full Text Articles Chapter 52,572


He, L.; Xu, J.-M.; He, T.; Liu, L.; Zhu, R. 2014: Dexmedetomidine pretreatment alleviates propofol injection pain. Upsala Journal of Medical Sciences 119(4): 338-342
Yang, Y.-c.; Meng, Q.-t.; Pan, X.; Xia, Z.-y.; Chen, X.-d. 2014: Dexmedetomidine produced analgesic effect via inhibition of HCN currents. European Journal of Pharmacology 740: 560-564
Yildiz, O.; Ulusoy, H.B.; Seyrek, M.; Gul, H.; Yildirim, V. 2007: Dexmedetomidine produces dual alpha2-adrenergic agonist and alpha1-adrenergic antagonist actions on human isolated internal mammary artery. Journal of Cardiothoracic and Vascular Anesthesia 21(5): 696-700
Agarwal, S.; Aggarwal, R.; Gupta, P. 2014: Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block. Journal of Anaesthesiology Clinical Pharmacology 30(1): 36-40
Dong, X.; Xing, Q.; Li, Y.; Han, X.; Sun, L. 2014: Dexmedetomidine protects against ischemia-reperfusion injury in rat skeletal muscle. Journal of Surgical Research 186(1): 240-245
Si, Y.-N.; Bao, H.-G.; Xu, L.; Wang, X.-L.; Shen, Y.; Wang, J.-S.; Yang, X.-B. 2014: Dexmedetomidine protects against ischemia/reperfusion injury in rat kidney. European Review for Medical and Pharmacological Sciences 18(13): 1843-1851
Rocha, J.ão.B.T.; Heinzmann Bulow, N.M.; Correa, E.F.M.; Scholze, C.; Nogueira, C.W.; Barbosa, N.B.V. 2011: Dexmedetomidine protects blood δ-aminolevulinate dehydratase from inactivation caused by hyperoxygenation in total intravenous anesthesia. Human and Experimental Toxicology 30(4): 289-295
Sanders, R.D.; Sun, P.; Patel, S.; Li, M.; Maze, M.; Ma, D. 2010: Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiologica Scandinavica 54(6): 710-716
Duan, X.; Li, Y.; Zhou, C.; Huang, L.; Dong, Z. 2014: Dexmedetomidine provides neuroprotection: impact on ketamine-induced neuroapoptosis in the developing rat brain. Acta Anaesthesiologica Scandinavica 58(9): 1121-1126
Xianbao, L.; Hong, Z.; Xu, Z.; Chunfang, Z.; Dunjin, C. 2013: Dexmedetomidine reduced cytokine release during postpartum bleeding-induced multiple organ dysfunction syndrome in rats. Mediators of Inflammation 2013: 627831
Wang, Z.X.; Huang, C.Y.; Hua, Y.P.; Huang, W.Q.; Deng, L.H.; Liu, K.X. 2014: Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial. British Journal of Anaesthesia 112(6): 1055-1064
Li, Y.; Zeng, M.; Chen, W.; Liu, C.; Wang, F.; Han, X.; Zuo, Z.; Peng, S. 2014: Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats. Plos one 9(4): E93639
Takamatsu, I.; Iwase, A.; Ozaki, M.; Kazama, T.; Wada, K.; Sekiguchi, M. 2008: Dexmedetomidine reduces long-term potentiation in mouse hippocampus. Anesthesiology 108(1): 94-102
Joo, J.; Baek, J.; Lee, J. 2014: Dexmedetomidine reduces pain associated with rocuronium injection without causing a decrease in BIS values: a dose-response study. Journal of Clinical Anesthesia 26(6): 475-479
Le Guen, M.; Liu, N.; Tounou, F.; Augé, M.; Tuil, O.; Chazot, T.; Dardelle, D.; Laloë, P.-A.; Bonnet, F.; Sessler, D.I.; Fischler, M. 2014: Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index-guided closed-loop anesthesia: a double-blind, placebo-controlled trial. Anesthesia and Analgesia 118(5): 946-955
He, L.; Xu, J.-M.; Dai, R.-P. 2012: Dexmedetomidine reduces the incidence of fentanyl-induced cough: a double-blind, randomized, and placebo-controlled study. Upsala Journal of Medical Sciences 117(1): 18-21
Yagmurdur, H.; Ozcan, N.; Dokumaci, F.; Kilinc, K.; Yilmaz, F.; Basar, H. 2008: Dexmedetomidine reduces the ischemia-reperfusion injury markers during upper extremity surgery with tourniquet. Journal of Hand Surgery 33(6): 941-947
Pasin, L.; Landoni, G.; Nardelli, P.; Belletti, A.; Di Prima, A.L.; Taddeo, D.; Isella, F.; Zangrillo, A. 2014: Dexmedetomidine reduces the risk of delirium, agitation and confusion in critically Ill patients: a meta-analysis of randomized controlled trials. Journal of Cardiothoracic and Vascular Anesthesia 28(6): 1459-1466
Chen, C.; Zhang, Z.; Chen, K.; Zhang, F.; Peng, M.; Wang, Y. 2014: Dexmedetomidine regulates inflammatory molecules contributing to ventilator-induced lung injury in dogs. Journal of Surgical Research 187(1): 211-218
Shah, A.N.; Koneru, J.; Nicoara, A.; Goldfeder, L.B.; Thomas, K.; Ehlert, F.A. 2007: Dexmedetomidine related cardiac arrest in a patient with permanent pacemaker; a cautionary tale. Pacing and Clinical Electrophysiology: Pace 30(9): 1158-1160
Phillips, W.J.; Gadiraju, S.; Dickey, S.; Galli, R.; Lerant, A.A. 2007: Dexmedetomidine relieves pain associated with acute sickle cell crisis. Journal of Pain and Symptom Management 34(4): 346-349
Xiong, B.; Shi, Q.-q.; Miao, C.-h. 2014: Dexmedetomidine renders a brain protection on hippocampal formation through inhibition of nNOS-NO signalling in endotoxin-induced shock rats. Brain Injury 28(7): 1003-1008
Hutchens, M.P.; Thorborg, P. 2009: Dexmedetomidine sedation (and cardiac perforation, pericardial tamponade, cardiac arrest, and cardiopulmonary resuscitation) leading to refractory cardiogenic shock. Anesthesia and Analgesia 108(1): 379-380
Ayoglu, H.; Altunkaya, H.; Ozer, Y.; Yapakci, O.; Ozkocak, I.; Oz, O.; Alpay, A.; Ugurbas, S.H. 2007: Dexmedetomidine sedation during cataract surgery under regional anaesthesia. British Journal of Anaesthesia 99(3): 448
Boyd, B.C.; Sutter, S.J. 2011: Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 69(6): 1608-1612
David, M.D.; De Marchi, L. 2010: Dexmedetomidine sedation for awake tracheotomy: case report and literature review. Journal of Clinical Anesthesia 22(5): 360-362
Sidorowicz, M.; Owczuk, R.ła.; Kwiecińska, B.; Wujtewicz, M.A.; Wojciechowski, J.; Wujtewicz, M. 2009: Dexmedetomidine sedation for carotid endarterectomy. Anestezjologia Intensywna Terapia 41(2): 78-83
Jense, R.J.; Souter, K.; Davies, J.; Romig, C.; Panneerselvam, A.; Maronian, N. 2008: Dexmedetomidine sedation for laryngeal framework surgery. Annals of Otology Rhinology and Laryngology 117(9): 659-664
Tokuhira, N.; Atagi, K.; Shimaoka, H.; Ujiro, A.; Otsuka, Y.; Ramsay, M. 2009: Dexmedetomidine sedation for pediatric post-Fontan procedure patients. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 10(2): 207-212
Girgin, N.K.; Iscimen, R.; Gurbet, A.; Kahveci, F.; Kutlay, O. 2007: Dexmedetomidine sedation for the treatment of tetanus in the intensive care unit. British Journal of Anaesthesia 99(4): 599-600
Jung, J.W.; Cheol Go, G.; Jeon, S.Y.; Bang, S.; Lee, K.H.; Kim, Y.H.; Kim, D.-K. 2013: Dexmedetomidine sedation for transesophageal echocardiography during percutaneous atrial septal defect closure in adult. Pakistan Journal of Medical Sciences 29(6): 1456-1458
Yu, S.-B. 2012: Dexmedetomidine sedation in ICU. Korean Journal of Anesthesiology 62(5): 405-411
Nafiu, O.O.; Srinivasan, A.; Ravanbakht, J.; Wu, B.; Lau, W.C. 2008: Dexmedetomidine sedation in a patient with superior vena cava syndrome and extreme needle phobia. Journal of Cardiothoracic and Vascular Anesthesia 22(4): 581-583
Hosokawa, K.; Shime, N.; Kato, Y.; Taniguchi, A.; Maeda, Y.; Miyazaki, T.; Hashimoto, S. 2010: Dexmedetomidine sedation in children after cardiac surgery. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 11(1): 39-43
Mansour, A.; Taha, S. 2012: Dexmedetomidine sedation in painful posterior segment surgery. Clinical Ophthalmology 6: 2075-2079
Smiley, M.K.; Prior, S.R. 2014: Dexmedetomidine sedation with and without midazolam for third molar surgery. Anesthesia Progress 61(1): 3-10
McMorrow, S.P.; Abramo, T.J. 2012: Dexmedetomidine sedation: uses in pediatric procedural sedation outside the operating room. Pediatric Emergency Care 28(3): 292-296
Abdelmalak, B.; Gutenberg, L.; Lorenz, R.R.; Smith, M.; Farag, E.; Doyle, D.John. 2009: Dexmedetomidine supplemented with local anesthesia for awake laryngoplasty. Journal of Clinical Anesthesia 21(6): 442-443
Tanabe, K.; Matsushima-Nishiwaki, R.; Kozawa, O.; Iida, H. 2014: Dexmedetomidine suppresses interleukin-1β-induced interleukin-6 synthesis in rat glial cells. International Journal of Molecular Medicine 34(4): 1032-1038
Kato, R.I.; Tachibana, K.; Hashimoto, T.; Takita, K.; Morimoto, Y. 2014: Dexmedetomidine suppresses long-term potentiation in the hippocampal CA1 field of anesthetized rats. Journal of Anesthesia 28(6): 828-832
Kawasaki, T.; Kawasaki, C.; Ueki, M.; Hamada, K.; Habe, K.; Sata, T. 2013: Dexmedetomidine suppresses proinflammatory mediator production in human whole blood in vitro. Journal of Trauma and Acute Care Surgery 74(5): 1370-1375
Kunisawa, T.; Nagata, O.; Nagashima, M.; Mitamura, S.; Ueno, M.; Suzuki, A.; Takahata, O.; Iwasaki, H. 2009: Dexmedetomidine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular response to tracheal intubation. Journal of Clinical Anesthesia 21(3): 194-199
Tobias, J.D. 2010: Dexmedetomidine to control agitation and delirium from toxic ingestions in adolescents. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 15(1): 43-48
Akingbola, O.A.; Singh, D. 2012: Dexmedetomidine to treat lisdexamfetamine overdose and serotonin toxidrome in a 6-year-old girl. American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 21(6): 456-459
Mundada, S.D.; Gosavi, K.S.; Upasani, C. 2014: Dexmedetomidine to wean patient of severe kyphoscoliosis with cerebral palsy in intensive care unit. Indian Journal of Anaesthesia 58(1): 89-90
Mizrak, A.; Erbagci, I.; Arici, T.; Avci, N.; Ganidagli, S.; Oner, U. 2011: Dexmedetomidine use during strabismus surgery in agitated children. Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 20(5): 427-432
Eremenko, A.A.; Chernova, E.V. 2013: Dexmedetomidine use for intravenous sedation and delirium treatment during early postoperative period in cardio-surgical patients. Anesteziologiia i Reanimatologiia 5: 4-8
Gur'ianov, V.A.; Nosenko, M.M.; Gadzhibekov, N.C.; Ialich, A.I.; Aliautdin, R.N.; Tolmachev, G.N. 2013: Dexmedetomidine use for postoperative adrenergic analgesia and sedation in abdominal surgery. Anesteziologiia i Reanimatologiia 6: 21-24
Chrysostomou, C.; Sanchez De Toledo, J.; Avolio, T.; Motoa, M.V.; Berry, D.; Morell, V.O.; Orr, R.; Munoz, R. 2009: Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery?. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 10(6): 654-660
Lam, S.W.; Alexander, E. 2008: Dexmedetomidine use in critical care. AACN Advanced Critical Care 19(2): 113-120
Mizrak, A.; Sanli, M.; Bozgeyik, S.; Gul, R.; Ganidagli, S.; Baysal, E.; Oner, U. 2012: Dexmedetomidine use in direct laryngoscopic biopsy under TIVA. Middle East Journal of Anaesthesiology 21(4): 605-612
Arcangeli, A.; D'Alò, C.; Gaspari, R. 2009: Dexmedetomidine use in general anaesthesia. Current Drug Targets 10(8): 687-695
Silver, A.L.; Yager, P.; Purohit, P.; Noviski, N.; Hartnick, C.J. 2011: Dexmedetomidine use in pediatric airway reconstruction. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 144(2): 262-267
Buck, M.L. 2010: Dexmedetomidine use in pediatric intensive care and procedural sedation. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 15(1): 17-29
Javed, F.; Benjo, A.Miguel.; Reddy, K.; Shoaib Akram, M.; Khan, S.Afsar.; Sabharwal, M.Singh.; Nadkarni, G.; Aziz, E.F.; Herzog, E. 2011: Dexmedetomidine use in the setting of cocaine-induced hypertensive emergency and aortic dissection: a novel indication. Case Reports in Medicine 2011: 174132
Nasreen, F.; Bano, S.; Khan, R.M.; Hasan, S.A. 2009: Dexmedetomidine used to provide hypotensive anesthesia during middle ear surgery. Indian Journal of Otolaryngology and Head and Neck Surgery: Official Publication of the Association of Otolaryngologists of India 61(3): 205-207
Moffett, B.S.; Mossad, E.B.; Tobias, J.D.; Cabrera, A.G. 2015: Dexmedetomidine utilisation and outcomes of children with trisomy 21 undergoing congenital heart disease surgery. Cardiology in the Young 25(5): 958-962
Reddy, S.V.; Balaji, D.; Ahmed, S.N. 2014: Dexmedetomidine versus esmolol to attenuate the hemodynamic response to laryngoscopy and tracheal intubation: a randomized double-blind clinical study. International Journal of Applied and Basic Medical Research 4(2): 95-100
Ali, A.R.; El Ghoneimy, M.N. 2010: Dexmedetomidine versus fentanyl as adjuvant to propofol: comparative study in children undergoing extracorporeal shock wave lithotripsy. European Journal of Anaesthesiology 27(12): 1058-1064
Wu, W.; Chen, Q.; Zhang, L.-C.; Chen, W.-H. 2014: Dexmedetomidine versus midazolam for sedation in upper gastrointestinal endoscopy. Journal of International Medical Research 42(2): 516-522
Huang, Z.; Chen, Y.-s.; Yang, Z.-l.; Liu, J.-y. 2012: Dexmedetomidine versus midazolam for the sedation of patients with non-invasive ventilation failure. Internal Medicine 51(17): 2299-2305
He, X.-Y.; Cao, J.-P.; Shi, X.-Y.; Zhang, H. 2013: Dexmedetomidine versus morphine or fentanyl in the management of children after tonsillectomy and adenoidectomy: a meta-analysis of randomized controlled trials. Annals of Otology Rhinology and Laryngology 122(2): 114-120
Ghali, A.; Mahfouz, A.K.; Ihanamäki, T.; El Btarny, A.M. 2011: Dexmedetomidine versus propofol for sedation in patients undergoing vitreoretinal surgery under sub-Tenon's anesthesia. Saudi Journal of Anaesthesia 5(1): 36-41
Ruokonen, E.; Parviainen, I.; Jakob, S.M.; Nunes, S.; Kaukonen, M.; Shepherd, S.T.; Sarapohja, T.; Bratty, J.R.; Takala, J.; Takala, J.; Ruokonen, E.; Jakob, S.M.; Brunello, A.; Haeberli, B.; Maier, K.; Rohner, J.ür.; Kaufmann, J.; Kaukonen, K.-M.; Salovaara-Hiltunen, M.; Ruokonen, E.; Parviainen, I.; Uusaro, A.; Metsävainio, K.; Bendel, S.; Kurola, J.; Toome, V.; Rahikainen, S.; Halonen, E.; Ahonen, H.; Laitinen, S.; Nunes, S.; Karlsson, S.; Arvola, P.; Suvela, M.; Tenhunen, J.; Halmela, R.; Korkala, A.-L.; Peltola, M.-L.; Kortelainen, S.; Shepherd, S.T.; Bratty, J.R.; Pohjanjousi, P.; Sarapohja, T.; Ahtola-Sätilä, T.; Kelloniemi, M.; Ruck, A. 2009: Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Medicine 35(2): 282-290
O'Mara, K.; Gal, P.; Wimmer, J.; Ransom, J.L.; Carlos, R.Q.; Dimaguila, M.A.V.T.; Davanzo, C.C.; Smith, M. 2012: Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 17(3): 252-262
Riker, R.R.; Shehabi, Y.; Bokesch, P.M.; Ceraso, D.; Wisemandle, W.; Koura, F.; Whitten, P.; Margolis, B.D.; Byrne, D.W.; Ely, E.W.; Rocha, M.G.; Torres Boden, M.; Ceraso, D.; Raimondi, A.; Gonzalez, M.; Shehabi, Y.; Turner, A.; Ernest, D.; Dobb, G.; Dias, F.; Rocha, M.; Baruzzi, A.; da Silva, I.; Rezende, E.; Margolin, G.; Feldman, J.; Tillinghast, J.; Geller, E.; Singla, N.; Dexter, J.; Jones, K.; Tang, J.; Cheng, E.; Douglas, I.; Fulda, G.; Herr, D.; Anderson, L.; Kett, D.; Basile, J.; Silverboard, H.; Cowen, J.; Margolis, B.; Whitten, P.; Simpson, S.; Bradley, J.; Koura, F.; Conrad, S.; Shanholtz, C.; Kahn, R.; Riker, R.; Bekemeyer, W.; Simonds, D.; Morrow, L.; Littman, J.; Shander, A.; Cuibotaru, R.; Dicpinigaitis, P.; George, L.; Grot 2009: Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301(5): 489-499
Jakob, S.M.; Ruokonen, E.; Grounds, R.M.; Sarapohja, T.; Garratt, C.; Pocock, S.J.; Bratty, J.R.; Takala, J.; Spapen, H.; Vincent, J.-L.; Colpaert, K.; Lambermont, B.; Kivistik, U.; Saar, A.; Toome, V.; Tamme, K.; Tenhunen, J.; Ala-Kokko, T.; Chiche, J.-D.; Montravers, P.; Mercat, A.; Mentec, H.; Timsit, J.-F.; Reignier, J.; Saulnier, F.; Dugard, A.; Boulain, T.; Robert, R.; Mercier, E.; Putensen, C.; Grundling, M.; Unertl, K.; Snellen, F.; Beishuizen, A.; Spronk, P.; van der Meer, B.; Koopman-Van Gemert, A.; Fennema, N.; Speelberg, B.; Foudraine, N.; Walter, S.; Helset, E.; Lovstad, R.; Stubhaug, A.; Guttormsen, A.; Jakob, S.; Haller, A.; Maggiorini, M.; Perkins, G.; Whitehouse, A.; MacNaughton, P.; Demeyer, I.; de Jongh, R.; Colpaert, K.; 2012: Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 307(11): 1151-1160
Chen, K.-Z.; Ye, M.; Hu, C.-B.; Shen, X. 2014: Dexmedetomidine vs remifentanil intravenous anaesthesia and spontaneous ventilation for airway foreign body removal in children. British Journal of Anaesthesia 112(5): 892-897
Reade, M.C.; O'Sullivan, K.; Bates, S.; Goldsmith, D.; Ainslie, W.R.S.T.J.; Bellomo, R. 2009: Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Critical Care 13(3): R75
Kunisawa, T.; Hanada, S.; Kurosawa, A.; Suzuki, A.; Takahata, O.; Iwasaki, H. 2010: Dexmedetomidine was safely used for sedation during spinal anesthesia in a very elderly patient. Journal of Anesthesia 24(6): 938-941
Ogawa, Y.; Iwasaki, K.-i.; Aoki, K.; Kojima, W.; Kato, J.; Ogawa, S. 2008: Dexmedetomidine weakens dynamic cerebral autoregulation as assessed by transfer function analysis and the thigh cuff method. Anesthesiology 109(4): 642-650
Chen, B.-S.; Peng, H.; Wu, S.-N. 2009: Dexmedetomidine, an alpha2-adrenergic agonist, inhibits neuronal delayed-rectifier potassium current and sodium current. British Journal of Anaesthesia 103(2): 244-254
Bell, M.T.; Puskas, F.; Bennett, D.T.; Herson, P.S.; Quillinan, N.; Fullerton, D.A.; Reece, T.B. 2014: Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion. Journal of Thoracic and Cardiovascular Surgery 147(1): 500-506
Gerlach, A.T.; Murphy, C.V. 2009: Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature. PharmacoTherapy 29(12): 1492
Turgut, N.; Turkmen, A.; Gökkaya, S.; Altan, A.; Hatiboglu, M.A. 2008: Dexmedetomidine-based versus fentanyl-based total intravenous anesthesia for lumbar laminectomy. Minerva Anestesiologica 74(9): 469-474
Takata, K.; Adachi, Y.U.; Suzuki, K.; Obata, Y.; Sato, S.; Nishiwaki, K. 2014: Dexmedetomidine-induced atrioventricular block followed by cardiac arrest during atrial pacing: a case report and review of the literature. Journal of Anesthesia 28(1): 116-120
Nakano, T.; Okamoto, H. 2009: Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats. Journal of Anesthesia 23(3): 378-384
Ok, S.-H.; Byon, H.-J.; Jin, H.; Kim, H.J.; Kim, W.; Nam, I.-K.; Eun, S.Y.; Sohn, J.-T. 2014: Dexmedetomidine-induced contraction involves c-Jun NH2 -terminal kinase phosphorylation through activation of the 5-lipoxygenase pathway in the isolated endothelium-denuded rat aorta. Clinical and Experimental Pharmacology and Physiology 41(12): 1014-1022
Baik, J.; Ok, S.-H.; Cho, H.; Yu, J.; Kim, W.; Nam, I.-K.; Choi, M.-J.; Lee, H.-K.; Sohn, J.-T. 2014: Dexmedetomidine-induced contraction involves phosphorylation of caldesmon by JNK in endothelium-denuded rat aortas. International Journal of Biological Sciences 10(10): 1108-1115
Ok, S.-H.; Bae, S.I.; Shim, H.S.; Sohn, J.-T. 2012: Dexmedetomidine-induced contraction of isolated rat aorta is dependent on extracellular calcium concentration. Korean Journal of Anesthesiology 63(3): 253-259
Garrity, A.G.; Botta, S.; Lazar, S.B.; Swor, E.; Vanini, G.; Baghdoyan, H.A.; Lydic, R. 2015: Dexmedetomidine-induced sedation does not mimic the neurobehavioral phenotypes of sleep in Sprague Dawley rat. Sleep 38(1): 73-84
Koruk, S.; Mizrak, A.; Gul, R.; Kilic, E.; Yendi, F.; Oner, U. 2010: Dexmedetomidine-ketamine and midazolam-ketamine combinations for sedation in pediatric patients undergoing extracorporeal shock wave lithotripsy: a randomized prospective study. Journal of Anesthesia 24(6): 858-863
Yang, C.-H.; Tsai, P.-S.; Wang, T.-Y.; Huang, C.-J. 2009: Dexmedetomidine-ketamine combination mitigates acute lung injury in haemorrhagic shock rats. Resuscitation 80(10): 1204-1210
Huang, S.-J.; Tsai, P.-S.; Huang, C.-J. 2010: Dexmedetomidine-ketamine combination mitigates pulmonary type-2 cationic amino acid transporter isozymes upregulation in hemorrhagic shock rats. Acta Anaesthesiologica Taiwanica: Official Journal of the Taiwan Society of Anesthesiologists 48(3): 110-116
Rozmiarek, A.; Corridore, M.; Tobias, J.D. 2011: Dexmedetomidine-ketamine sedation during bone marrow aspirate and biopsy in a patient with duchenne muscular dystrophy. Saudi Journal of Anaesthesia 5(2): 219-222
Raman, V.; Yacob, D.; Tobias, J.D. 2012: Dexmedetomidine-ketamine sedation during upper gastrointestinal endoscopy and biopsy in a patient with Duchenne muscular dystrophy and egg allergy. International Journal of Critical Illness and Injury Science 2(1): 40-43
Shepard, S.M.; Tejman-Yarden, S.; Khanna, S.; Davis, C.K.; Batra, A.S. 2011: Dexmedetomidine-related atrial standstill and loss of capture in a pediatric patient after congenital heart surgery. Critical Care Medicine 39(1): 187-189
Dhansura, T.S.; Bhorkar, N.; Gandhi, S.P. 2013: Dexmedetomidine-saves the day. Indian Journal of Anaesthesia 57(2): 212-213
Ihmsen, H.; Saari, T.I. 2012: Dexmedetomidine. Pharmacokinetics and pharmacodynamics. Der Anaesthesist 61(12): 1059-1066
Munro, H.M.; Felix, D.E.; Nykanen, D.G. 2009: Dexmedetomidine/ketamine for diagnostic cardiac catheterization in a child with idiopathic pulmonary hypertension. Journal of Clinical Anesthesia 21(6): 435-438
Nociti, Jé.Roberto.; Serzedo, P.Sérgio.Mateus.; Zuccolotto, E.Barbin.; Sebben, F.; Gonzales, R.F. 2003: Dexmedetomidine/propofol association for plastic surgery sedation during local anesthesia.. Revista Brasileira de Anestesiologia 53(2): 198-208
Halaszynski, T.M. 2012: Dexmedetomidine: a look at a promising new avenue of use. Saudi Journal of Anaesthesia 6(2): 104-106
Tobias, J.D. 2010: Dexmedetomidine: Are There Going to be Issues with Prolonged Administration?. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 15(1): 4-9
Grewal, A. 2011: Dexmedetomidine: new avenues. Journal of Anaesthesiology Clinical Pharmacology 27(3): 297-302
Myatra, S. 2014: Dexmedetomidine: Toward a paradigm shift in ICU sedation. Indian Journal of Critical Care Medicine: Peer-Reviewed Official Publication of Indian Society of Critical Care Medicine 18(5): 271-272
Keating, G.M.; Hoy, S.M.; Lyseng-Williamson, K.A. 2012: Dexmedetomidine: a guide to its use for sedation in the US. Clinical Drug Investigation 32(8): 561-567
O'Daniel, T.G.; Shanahan, P.T. 2006: Dexmedetomidine: a new alpha-agonist anesthetic agent for facial rejuvenation surgery. Aesthetic Surgery Journal 26(1): 35-40
Chrysostomou, C.; Beerman, L.; Shiderly, D.; Berry, D.; Morell, V.O.; Munoz, R. 2008: Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesthesia and Analgesia 107(5): 1514-1522
Zhang, X.; Zhao, X.; Wang, Y. 2015: Dexmedetomidine: a review of applications for cardiac surgery during perioperative period. Journal of Anesthesia 29(1): 102-111
Carollo, D.S.; Nossaman, B.D.; Ramadhyani, U. 2008: Dexmedetomidine: a review of clinical applications. Current Opinion in Anaesthesiology 21(4): 457-461
Hoy, S.M.; Keating, G.M. 2011: Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs 71(11): 1481-1501
Whalin, M.K.; Lopian, S.; Wyatt, K.; Sun, C.-H.J.; Nogueira, R.G.; Glenn, B.A.; Gershon, R.Y.; Gupta, R. 2014: Dexmedetomidine: a safe alternative to general anesthesia for endovascular stroke treatment. Journal of Neurointerventional Surgery 6(4): 270-275
Haselman, M.A. 2008: Dexmedetomidine: a useful adjunct to consider in some high-risk situations. Aana Journal 76(5): 335-339
Bajwa, S.; Kulshrestha, A. 2013: Dexmedetomidine: an adjuvant making large inroads into clinical practice. Annals of Medical and Health Sciences Research 3(4): 475-483
Turan, A.; Sen, H.üs.; Sizlan, A.; Yanarateş, O.; Ozkan, S.; Koyuncu, O.; Dağli, G.ün. 2011: Dexmedetomidine: an alternative for epidural anesthesia in tension-free vaginal-tape surgery. Journal of Anesthesia 25(3): 386-391
Tobias, J.D. 2010: Dexmedetomidine: are tolerance and withdrawal going to be an issue with long-term infusions?. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 11(1): 158-160
Ramadhyani, U.; Park, J.L.; Carollo, D.S.; Waterman, R.S.; Nossaman, B.D. 2010: Dexmedetomidine: clinical application as an adjunct for intravenous regional anesthesia. Anesthesiology Clinics 28(4): 709-722
Afonso, J.; Reis, F.áv. 2012: Dexmedetomidine: current role in anesthesia and intensive care. Revista Brasileira de Anestesiologia 62(1): 118-133
Tsifansky, M.D.; Schmitt, C.G.; Muñoz, R.A. 2007: Dexmedetomidine: do we know enough?. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 8(5): 492-493
Coyne, P.J.; Wozencraft, C.P.; Roberts, S.B.; Bobb, B.; Smith, T.J. 2010: Dexmedetomidine: exploring its potential role and dosing guideline for its use in intractable pain in the palliative care setting. Journal of Pain and Palliative Care PharmacoTherapy 24(4): 384-386
Sheen, M.J.; Ho, S.-T. 2008: Dexmedetomidine: more than a sedative and analgesic. Acta Anaesthesiologica Taiwanica: Official Journal of the Taiwan Society of Anesthesiologists 46(4): 149-150
Mantz, J.; Josserand, J.; Hamada, S. 2011: Dexmedetomidine: new insights. European Journal of Anaesthesiology 28(1): 3-6
Kulikov, A.S.; Lubnin, A.Y. 2013: Dexmedetomidine: new opportunities in anesthesiology. Anesteziologiia i Reanimatologiia 1: 37-41
Su, F.; Hammer, G.B. 2011: Dexmedetomidine: pediatric pharmacology, clinical uses and safety. Expert Opinion on Drug Safety 10(1): 55-66
Yuen, V.M.Y. 2010: Dexmedetomidine: perioperative applications in children. Paediatric Anaesthesia 20(3): 256-264
Bagatini, A.; Gomes, C.áu.R.; Masella, M.Z.; Rezer, G. 2002: Dexmedetomidine: pharmacology and clinical application. Revista Brasileira de Anestesiologia 52(5): 606-617
Chrysostomou, C.; Schmitt, C.G. 2008: Dexmedetomidine: sedation, analgesia and beyond. Expert Opinion on Drug Metabolism and Toxicology 4(5): 619-627
Chrysostomou, C. 2012: Dexmedetomidine: should it be standard after pediatric cardiac surgery?*. Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 13(6): 696-697
Chrysostomou, C.; Morell, V.O.; Wearden, P.; Sanchez-de-Toledo, J.; Jooste, E.H.; Beerman, L. 2013: Dexmedetomidine: therapeutic use for the termination of reentrant supraventricular tachycardia. Congenital Heart Disease 8(1): 48-56
Moen, M.D.; Keam, S.J. 2009: Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder. Cns Drugs 23(12): 1057-1083
Coury, D. 2009: Dexmethylphenidate for attention deficit hyperactivity disorder. Expert Opinion on PharmacoTherapy 10(16): 2679-2685
Liu, F.; Minami, H.; Silva, R.R. 2006: Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder. Neuropsychiatric Disease and Treatment 2(4): 467-473
Qin, Y.; Tang, Y.; Schally, A.; Beckman, B. 1995: Dexniguldipine hydrochloride inhibits growth of human ht-29 colon-carcinoma cells and expression of protein-kinase-C-delta and protein-kinase-C-zeta. International Journal of Oncology 7(5): 1073-1077
Proksch, E.; Nissen, H.P. 2002: Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation. Journal of Dermatological Treatment 13(4): 173-178
Heise, R.; Skazik, C.; Marquardt, Y.; Czaja, K.; Sebastian, K.; Kurschat, P.; Gan, L.; Denecke, B.; Ekanayake-Bohlig, S.; Wilhelm, K.-P.; Merk, H.F.; Baron, J.M. 2012: Dexpanthenol modulates gene expression in skin wound healing in vivo. Skin Pharmacology and Physiology 25(5): 241-248
Rudnicki, S.A.; Berry, J.D.; Ingersoll, E.; Archibald, D.; Cudkowicz, M.E.; Kerr, D.A.; Dong, Y. 2013: Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase Ii study: subgroup analysis of demographic and clinical characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14(1): 44-51
Cudkowicz, M.E.; van den Berg, L.H.; Shefner, J.M.; Mitsumoto, H.; Mora, J.S.; Ludolph, A.; Hardiman, O.; Bozik, M.E.; Ingersoll, E.W.; Archibald, D.; Meyers, A.L.; Dong, Y.; Farwell, W.R.; Kerr, D.A.; Henderson, R.; Kiernan, M.; Mathers, S.; Vucic, S.; De Bleecker, J.; Robberecht, W.; Briemberg, H.; Genge, A.; Korngut, L.; Matte, G.; Shoesmith, C.; Zinman, L.; Camu, W.; Desnuelle, C.; Destee, A.; Meininger, V.; Pouget, J.; Grehl, T.; Grosskreutz, J.; Ludolph, A.; Meyer, T.; Petri, S.; Hardiman, O.; de Visser, M.; Voermans, N.; van den Berg, L.; de Rivera, F.J.R.; Gamez, J.; Carbonell, J.G.; Pardina, J.S.M.; Povedano, M.; Persson, L.; Ronnevi, L.-O.; Al-Chalabi, A.; Morrison, K.; Shaw, P.; Talbot, K.; Williams, T.; Young, C.; Andrews, J.; A 2013: Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial. LANCET. Neurology 12(11): 1059-1067
Cheah, B.C.; Kiernan, M.C. 2010: Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis. Idrugs: the Investigational Drugs Journal 13(12): 911-920
Lau, K.-F.; Chan, W.-M.; Perkinton, M.S.; Tudor, E.L.; Chang, R.C.C.; Chan, H.-Y.E.; McLoughlin, D.M.; Miller, C.C.J. 2008: Dexras1 interacts with FE65 to regulate FE65-amyloid precursor protein-dependent transcription. Journal of Biological Chemistry 283(50): 34728-34737
Cha, J.Y.; Kim, H.J.; Yu, J.H.; Xu, J.; Kim, D.; Paul, B.D.; Choi, H.; Kim, S.; Lee, Y.J.; Ho, G.P.; Rao, F.; Snyder, S.H.; Kim, J.-W. 2013: Dexras1 mediates glucocorticoid-associated adipogenesis and diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 110(51): 20575-20580
Chen, Y.; Khan, R.S.; Cwanger, A.; Song, Y.; Steenstra, C.; Bang, S.; Cheah, J.H.; Dunaief, J.; Shindler, K.S.; Snyder, S.H.; Kim, S.F. 2013: Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 33(8): 3582-3587
Kane, R.C.; McGuinn, W.D.; Dagher, R.; Justice, R.; Pazdur, R. 2008: Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy. Oncologist 13(4): 445-450
Sepe, D.M.; Ginsberg, J.P.; Balis, F.M. 2010: Dexrazoxane as a cardioprotectant in children receiving anthracyclines. Oncologist 15(11): 1220-1226
Rabinovich, A.; Weiss, D.; Weissman, M.; Novack, V.; Levi, I. 2012: Dexrazoxane does not affect treatment outcome in non-Hodgkin's lymphoma patients. American Journal of Hematology 87(8): 830-832
Seif, A.E.; Walker, D.M.; Li, Y.; Huang, Y.-S.V.; Kavcic, M.; Torp, K.; Bagatell, R.; Fisher, B.T.; Aplenc, R. 2015: Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients. Pediatric Blood and Cancer 62(4): 704-709
Langer, S.W. 2007: Dexrazoxane for anthracycline extravasation. Expert Review of Anticancer Therapy 7(8): 1081-1088
Choi, H.Soo.; Park, E.Sil.; Kang, H.Jin.; Shin, H.Young.; Noh, C.Il.; Yun, Y.Soo.; Ahn, H.Seop.; Choi, J.Yun. 2010: Dexrazoxane for preventing anthracycline cardiotoxicity in children with solid tumors. Journal of Korean Medical Science 25(9): 1336-1342
Langer, S.W. 2014: Dexrazoxane for the treatment of chemotherapy-related side effects. Cancer Management and Research 6: 357-363
Goey, A.K.L.; Schellens, J.H.M.; Beijnen, J.H.; Huitema, A.D.R. 2010: Dexrazoxane in anthracycline induced cardiotoxicity and extravasation. Nederlands Tijdschrift Voor Geneeskunde 154: A1155
Deng, S.; Yan, T.; Jendrny, C.; Nemecek, A.; Vincetic, M.; Gödtel-Armbrust, U.; Wojnowski, L. 2014: Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms. Bmc Cancer 14: 842
Steiner, R.; Hellmann, K. 2013: Dexrazoxane prevention of anthracycline cardiomyopathy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31(10): 1379
Polanski, A-Katrin.; Ebner, A.; Ebner, B.; Hofmann, A.; Steinbronn, N.; Brandt, A.; Forkmann, M.; Tausche, A-Kathrin.; Morawietz, H.; Strasser, R.H.; Wunderlich, C. 2013: Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted mice. Journal of Cardiovascular Pharmacology 61(6): 545-552
Xiang, P.; Deng, H.Y.; Li, K.; Huang, G.-Y.; Chen, Y.; Tu, L.; Ng, P.C.; Pong, N.H.; Zhao, H.; Zhang, L.; Sung, R.Y.T. 2009: Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer ChemoTherapy and Pharmacology 63(2): 343-349
Ducroq, J.; Moha ou Maati, H.; Guilbot, S.; Dilly, S.; Laemmel, E.; Pons-Himbert, C.; Faivre, J.F.; Bois, P.; Stücker, O.; Le Grand, M. 2010: Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks). British Journal of Pharmacology 159(1): 93-101
Zatloukalová, L.še.; Filipský, T.áš; Mladěnka, P.ře.; Semecký, V.ír.; Macáková, K.ři.; Holečková, M.; Vávrová, J.; Palicka, V.; Hrdina, R.ír. 2012: Dexrazoxane provided moderate protection in a catecholamine model of severe cardiotoxicity. Canadian Journal of Physiology and Pharmacology 90(4): 473-484
Draenert, G.F.; Huetzen, D.O.; Kämmerer, P.W.; Palarie, V.; Nacu, V.; Wagner, W. 2012: Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery 40(8): E369-E374
Schulmeister, L. 2008: Dexrazoxane treatment for intrathoracic anthracycline extravasation. Onkologie 31(11): 634
Venable, R.O.; Saba, C.F.; Endicott, M.M.; Northrup, N.C. 2012: Dexrazoxane treatment of doxorubicin extravasation injury in four dogs. Journal of the American Veterinary Medical Association 240(3): 304-307
Walker, D.M.; Fisher, B.T.; Seif, A.E.; Huang, Y-Shung.V.; Torp, K.; Li, Y.; Aplenc, R. 2013: Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database. Pediatric Blood and Cancer 60(4): 616-620
Lipshultz, S.E.; Lipsitz, S.R.; Orav, E.John. 2007: Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 25(21): 3179; author reply 3180
Hellmann, K. 2007: Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without evidence. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 25(29): 4689-90; author reply 4690-1
Wu, V. 2015: Dexrazoxane: a cardioprotectant for pediatric cancer patients receiving anthracyclines. Journal of Pediatric Oncology Nursing: Official Journal of the Association of Pediatric Oncology Nurses 32(3): 178-184
Vidall, C.; Roe, H.; Dougherty, L.; Harrold, K. 2013: Dexrazoxane: a management option for anthracycline extravasations. British Journal of Nursing 22(17): S6-12
Anonymous 2008: Dexrazoxane: a second look. Prevention of anthracycline cardiotoxicity: useful for some patients. Prescrire international 17(97): 195
Anonymous 2009: Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide. Prescrire International 18(99): 6-8
Poirier, F. 1988: Dexterity as a valid measure of hand function. Occupational Therapy in Health Care 4(3-4): 69-83
Budini, F.; Lowery, M.M.; Hutchinson, M.; Bradley, D.; Conroy, L.; De Vito, G. 2014: Dexterity training improves manual precision in patients affected by essential tremor. Archives of Physical Medicine and Rehabilitation 95(4): 705-710
Poole, J.L.; Nakamoto, T.; McNulty, T.; Montoya, J.R.; Weill, D.; Dieruf, K.; Skipper, B. 2010: Dexterity, visual perception, and activities of daily living in persons with multiple sclerosis. Occupational Therapy in Health Care 24(2): 159-170
Cipriani, C.; Segil, J.L.; Birdwell, J.A.; ff Weir, R.F. 2014: Dexterous control of a prosthetic hand using fine-wire intramuscular electrodes in targeted extrinsic muscles. IEEE Transactions on Neural Systems and Rehabilitation Engineering: a Publication of the IEEE Engineering in Medicine and Biology Society 22(4): 828-836
Dayanidhi, S.; Valero-Cuevas, F.J. 2014: Dexterous manipulation is poorer at older ages and is dissociated from decline of hand strength. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 69(9): 1139-1145
Lehman, A.C.; Wood, N.A.; Farritor, S.; Goede, M.R.; Oleynikov, D. 2011: Dexterous miniature robot for advanced minimally invasive surgery. Surgical Endoscopy 25(1): 119-123
Chan, R.C.K.; Huang, J.; Di, X. 2009: Dexterous movement complexity and cerebellar activation: a meta-analysis. Brain Research Reviews 59(2): 316-323
Seah, S.A.; Drinkwater, B.W.; Carter, T.; Malkin, R.; Subramanian, S. 2014: Dexterous ultrasonic levitation of millimeter-sized objects in air. IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control 61(7): 1233-1236
Zhavoronkova, L.A. 2007: Dextrals and sinistrals (right-handers and left-handers): specificity of interhemispheric brain asymmetry and EEG coherence parameters. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 57(6): 645-662
Tario, J.D.; Chen, G.L.; Hahn, T.E.; Pan, D.; Furlage, R.L.; Zhang, Y.; Brix, L.; Halgreen, C.; Jacobsen, K.; McCarthy, P.L.; Wallace, P.K. 2015: Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samples. CYTOMETRY. Part B Clinical Cytometry 88(1): 6-20
Ljungström, K.-G.ös. 2007: Dextran 40 therapy made safer by pretreatment with dextran 1. Plastic and Reconstructive Surgery 120(1): 337-340
Shrivastava, P.K.; Shrivastava, A.; Sinha, S.K.; Shrivastava, S.K. 2013: Dextran Carrier Macromolecules for Colon-specific Delivery of 5-Aminosalicylic Acid. Indian Journal of Pharmaceutical Sciences 75(3): 277-283
Anonymous 1957: Dextran Sulfate as a Substitute for Heparin. Canadian Medical Association Journal 76(2): 139
Wang, T.; Nie, J.; Yang, D. 2012: Dextran and gelatin based photocrosslinkable tissue adhesive. Carbohydrate Polymers 90(4): 1428-1436
Mateo, J.; Paniagua, P.; Koller, T.; Moral, V.; Fontcuberta, J. 2011: Dextran and hydroxyethyl starch do not interfere with fibrinogen measurement if Clauss method with mechanical clot detection is used. Critical Care 15(5): 441
Yu, M.; Huang, S.; Yu, K.Jun.; Clyne, A.Morss. 2012: Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. International Journal of Molecular Sciences 13(5): 5554-5570
Delgado, D.; del Pozo-Rodríguez, A.; Solinís, M.Ángeles.; Avilés-Triqueros, M.; Weber, B.H.F.; Fernández, E.; Gascón, A.R. 2012: Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis. Human Gene Therapy 23(4): 345-355
Morimoto, J.; Sarkar, M.; Kenrick, S.; Kodadek, T. 2014: Dextran as a generally applicable multivalent scaffold for improving immunoglobulin-binding affinities of peptide and peptidomimetic ligands. Bioconjugate Chemistry 25(8): 1479-1491
Grubb, R. 1949: Dextran as a medium for the demonstration of incomplete anti-Rh-agglutinins; preliminary report. Journal of Clinical Pathology 2(3): 223
Li, C.; Li, K.; Yan, H.; Li, G.; Xia, J.; Wei, X. 2010: Dextran based pH-activated near-infrared fluorescence nanoprobe imaging the acidic compartments in cancer cells. Chemical Communications 46(8): 1326-1328
Liu, P.; Yue, C.; Shi, B.; Gao, G.; Li, M.; Wang, B.; Ma, Y.; Cai, L. 2013: Dextran based sensitive theranostic nanoparticles for near-infrared imaging and photothermal therapy in vitro. Chemical Communications 49(55): 6143-6145
Griffiths, S.M.; Singh, N.; Jenkins, G.J.S.; Williams, P.M.; Orbaek, A.W.; Barron, A.R.; Wright, C.J.; Doak, S.H. 2011: Dextran coated ultrafine superparamagnetic iron oxide nanoparticles: compatibility with common fluorometric and colorimetric dyes. Analytical Chemistry 83(10): 3778-3785
Usov, D.; Sukhorukov, G.B. 2010: Dextran coatings for aggregation control of layer-by-layer assembled polyelectrolyte microcapsules. Langmuir 26(15): 12575-12584
Agarwal, A.; Gupta, U.; Asthana, A.; Jain, N.K. 2009: Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials 30(21): 3588-3596
Varshosaz, J. 2012: Dextran conjugates in drug delivery. Expert Opinion on Drug Delivery 9(5): 509-523
Yuba, E.; Tajima, N.; Yoshizaki, Y.; Harada, A.; Hayashi, H.; Kono, K. 2014: Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy. Biomaterials 35(9): 3091-3101
Nguyen-Pouplin, J.; Pouplin, T.; Van, T.P.; The, T.D.; Thi, D.N.; Farrar, J.; Tinh, H.T.; Wills, B. 2011: Dextran fractional clearance studies in acute dengue infection. Plos Neglected Tropical Diseases 5(8): E1282
Yan, G.-P.; Xu, W.; Yang, L.; Li, L.; Liu, F.; Guo, Q.-Z. 2010: Dextran gadolinium complexes as contrast agents for magnetic resonance imaging to sentinel lymph nodes. Pharmaceutical Research 27(9): 1884-1892
Zhang, R.; Zhang, W.; Hu, T. 2011: Dextran glucosidase: a potential target of iminosugars in caries prevention. Medical Hypotheses 76(4): 574-575
Sun, G.; Zhang, X.; Shen, Y.-I.; Sebastian, R.; Dickinson, L.E.; Fox-Talbot, K.; Reinblatt, M.; Steenbergen, C.; Harmon, J.W.; Gerecht, S. 2011: Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proceedings of the National Academy of Sciences of the United States of America 108(52): 20976-20981
Richter, A.W.; Hedin, H.I. 1982: Dextran hypersensitivity. Immunology Today 3(5): 132-138
Obi, S.; Masuda, H.; Akimaru, H.; Shizuno, T.; Yamamoto, K.; Ando, J.; Asahara, T. 2014: Dextran induces differentiation of circulating endothelial progenitor cells. Physiological Reports 2(3): E00261
Mohaghegh, M.; Tafaghodi, M. 2011: Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit. Pharmaceutical Development and Technology 16(1): 36-43
Clay, J.G.; Zierold, D.; Grayson, K.; Battistella, F.D. 2009: Dextran polymer hemostatic dressing improves survival in liver injury model. Journal of Surgical Research 155(1): 89-93
Bhatt, A.P.; Neppalli, V.T.; Kelley, E.A.; Schlueter, A.J.; Thomas, C.P. 2011: Dextran removal by plasmapheresis in a kidney-pancreas transplant recipient with dextran 40-induced osmotic nephrosis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 57(4): 621-623
Luo, Q.; Cai, C.-q.; Xie, X.-h.; Chu, X.-w.; Wu, Q.-y.; Meng, X.-j.; Zou, F. 2010: Dextran sedimentation for study of neutrophil polarization. Nan Fang Yi Ke da Xue Xue Bao 30(7): 1514-1517
Laroui, H.; Ingersoll, S.A.; Liu, H.C.; Baker, M.T.; Ayyadurai, S.; Charania, M.A.; Laroui, F.; Yan, Y.; Sitaraman, S.V.; Merlin, D. 2012: Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. Plos one 7(3): E32084
Mukaiyama, H.; Giga-Hama, Y.; Tohda, H.; Takegawa, K. 2009: Dextran sodium sulfate enhances secretion of recombinant human transferrin in Schizosaccharomyces pombe. Applied Microbiology and Biotechnology 85(1): 155-164
Viennois, E.; Chen, F.; Laroui, H.; Baker, M.T.; Merlin, D. 2013: Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA. Bmc Research Notes 6: 360
Schneider, M. 2013: Dextran sodium sulfate-induced murine inflammatory colitis model. Methods in Molecular Biology 1031: 189-195
Perše, M.; Cerar, A. 2012: Dextran sodium sulphate colitis mouse model: traps and tricks. Journal of Biomedicine and Biotechnology 2012: 718617
Easo, S.Liza.; Mohanan, P.V. 2013: Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies. Carbohydrate Polymers 92(1): 726-732
Hayakawa, J.; Migita, M.; Ueda, T.; Fukazawa, R.; Adachi, K.; Ooue, Y.; Hayakawa, M.; Shimada, T.; Fukunaga, Y. 2009: Dextran sulfate and stromal cell derived factor-1 promote CXCR4 expression and improve bone marrow homing efficiency of infused hematopoietic stem cells. Journal of Nippon Medical School 76(4): 198-208
Gajanayake, T.; Sawitzki, B.; Matozan, K.; Korchagina, E.Y.; Lehmann, M.; Volk, H.-D.; Rieben, R. 2008: Dextran sulfate facilitates anti-CD4 mAb-induced long-term rat cardiac allograft survival after prolonged cold ischemia. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 8(6): 1151-1162
Banz, Y.; Gajanayake, T.; Matozan, K.; Yang, Z.; Rieben, R. 2009: Dextran sulfate modulates MAP kinase signaling and reduces endothelial injury in a rat aortic clamping model. Journal of Vascular Surgery 50(1): 161-170
Chassaing, B.; Aitken, J.D.; Malleshappa, M.; Vijay-Kumar, M. 2014: Dextran sulfate sodium (DSS)-induced colitis in mice. Current Protocols in Immunology 104: 15.25.1-15.25.14
Araki, Y.; Bamba, T.; Mukaisho, K.-i.; Kanauchi, O.; Ban, H.; Bamba, S.; Andoh, A.; Fujiyama, Y.; Hattori, T.; Sugihara, H. 2012: Dextran sulfate sodium administered orally is depolymerized in the stomach and induces cell cycle arrest plus apoptosis in the colon in early mouse colitis. Oncology Reports 28(5): 1597-1605
Lee, I.-A.; Bae, E.-A.; Hyun, Y.-J.; Kim, D.-H. 2010: Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. Journal of Inflammation 7: 7
Elsheikh, W.; Flannigan, K.L.; McKnight, W.; Ferraz, J.G.P.; Wallace, J.L. 2012: Dextran sulfate sodium induces pan-gastroenteritis in rodents: implications for studies of colitis. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 63(5): 463-469
Ye, Z.; Mishchuk, D.O.; Stephens, N.S.; Slupsky, C.M. 2011: Dextran sulfate sodium inhibits alanine synthesis in Caco-2 cells. International Journal of Molecular Sciences 12(4): 2325-2335
Jerkic, M.; Peter, M.; Ardelean, D.; Fine, M.; Konerding, M.A.; Letarte, M. 2010: Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in Endoglin heterozygous mice. Inflammatory Bowel Diseases 16(11): 1859-1870
Fritsch Fredin, M.; Elgbratt, K.; Svensson, D.; Jansson, L.; Melgar, S.; Hultgren Hörnquist, E. 2007: Dextran sulfate sodium-induced colitis generates a transient thymic involution--impact on thymocyte subsets. Scandinavian Journal of Immunology 65(5): 421-429
Trivedi, P.P.; Jena, G.B. 2012: Dextran sulfate sodium-induced ulcerative colitis leads to increased hematopoiesis and induces both local as well as systemic genotoxicity in mice. Mutation Research 744(2): 172-183
Parmar, A.R.; Trivedi, P.P.; Jena, G.B. 2014: Dextran sulfate sodium-induced ulcerative colitis leads to testicular toxicity in mice: Role of inflammation, oxidative stress and DNA damage. Reproductive Toxicology 49: 171-184
You, D.Gil.; Saravanakumar, G.; Son, S.; Han, H.Seung.; Heo, R.; Kim, K.; Kwon, I.Chan.; Lee, J.Young.; Park, J.Hyung. 2014: Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging. Carbohydrate Polymers 101: 1225-1233
Yamada, H.; Nagao, C.; Haredy, A.M.; Mori, Y.; Mizuguchi, K.; Yamanishi, K.; Okamoto, S. 2014: Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein. Antiviral Research 111: 69-77
Getz, T.M.; Manne, B.K.; Buitrago, L.; Mao, Y.; Kunapuli, S.P. 2013: Dextran sulphate induces fibrinogen receptor activation through a novel Syk-independent PI-3 kinase-mediated tyrosine kinase pathway in platelets. Thrombosis and Haemostasis 109(6): 1131-1140
Zhang, R.; Ito, S.; Nishio, N.; Cheng, Z.; Suzuki, H.; Isobe, K-I. 2011: Dextran sulphate sodium increases splenic Gr1(+)CD11b(+) cells which accelerate recovery from colitis following intravenous transplantation. Clinical and Experimental Immunology 164(3): 417-427
Lopez, A.; Monsan, P. 1980: Dextran synthesis by immobilized dextran sucrase. Biochimie 62(5-6): 323-329
Han, J.; Hang, F.; Guo, B.; Liu, Z.; You, C.; Wu, Z. 2014: Dextran synthesized by Leuconostoc mesenteroides BD1710 in tomato juice supplemented with sucrose. Carbohydrate Polymers 112: 556-562
Pramod, P.S.; Takamura, K.; Chaphekar, S.; Balasubramanian, N.; Jayakannan, M. 2012: Dextran vesicular carriers for dual encapsulation of hydrophilic and hydrophobic molecules and delivery into cells. Biomacromolecules 13(11): 3627-3640
Viudes De Castro, M.P.; Cortell, C.; Vicente, J.S. 2010: Dextran vitrification media prevents mucin coat and zona pellucida damage in rabbit embryo. Theriogenology 74(9): 1623-1628
Schuerholz, T.; Marx, G. 2007: Dextran-70 to modulate inflammatory response after cardiopulmonary bypass: potential for a novel approach?. Critical Care 11(5): 163
Hwang, J-Ho.; Choi, C.Woong.; Kim, H-Wook.; Kim, D.Hyung.; Kwak, T.Won.; Lee, H.Myeong.; Kim, C.Hyun.; Chung, C.Wook.; Jeong, Y-Ii.; Kang, D.Hwan. 2013: Dextran-b-poly(L-histidine) copolymer nanoparticles for ph-responsive drug delivery to tumor cells. International Journal of Nanomedicine 8: 3197-3207
Fülöp, Zán.; Nielsen, Tørn.T.; Larsen, K.L.; Loftsson, T. 2013: Dextran-based cyclodextrin polymers: their solubilizing effect and self-association. Carbohydrate Polymers 97(2): 635-642
Sagnella, S.M.; Duong, H.; MacMillan, A.; Boyer, C.; Whan, R.; McCarroll, J.A.; Davis, T.P.; Kavallaris, M. 2014: Dextran-based doxorubicin nanocarriers with improved tumor penetration. Biomacromolecules 15(1): 262-275
Dai, T.; Zhou, S.; Yin, C.; Li, S.; Cao, W.; Liu, W.; Sun, K.; Dou, H.; Cao, Y.; Zhou, G. 2014: Dextran-based fluorescent nanoprobes for sentinel lymph node mapping. Biomaterials 35(28): 8227-8235
Ribeiro, M.P.; Morgado, P.I.; Miguel, S.P.; Coutinho, P.; Correia, I.J. 2013: Dextran-based hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing. Materials Science and Engineering. C Materials for Biological Applications 33(5): 2958-2966
Casadei, M.A.; Cesa, S.; Pacelli, S.; Paolicelli, P.; Tita, B.; Vitali, F. 2014: Dextran-based hydrogel microspheres obtained in w/o emulsion: preparation, characterisation and in vivo studies. Journal of Microencapsulation 31(5): 440-447
Wei, Z.; Yang, J.H.; Du, X.J.; Xu, F.; Zrinyi, M.; Osada, Y.; Li, F.; Chen, Y.M. 2013: Dextran-based self-healing hydrogels formed by reversible diels-alder reaction under physiological conditions. Macromolecular Rapid Communications 34(18): 1464-1470
Nath, S.; Kaittanis, C.; Tinkham, A.; Perez, J.Manuel. 2008: Dextran-coated gold nanoparticles for the assessment of antimicrobial susceptibility. Analytical Chemistry 80(4): 1033-1038
Chiu, R.Y.T.; Nguyen, P.T.; Wang, J.; Jue, E.; Wu, B.M.; Kamei, D.T. 2014: Dextran-coated gold nanoprobes for the concentration and detection of protein biomarkers. Annals of Biomedical Engineering 42(11): 2322-2332
Tassa, C.; Shaw, S.Y.; Weissleder, R. 2011: Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Accounts of Chemical Research 44(10): 842-852
Santana, S.D.F.; Dhadge, V.L.; Roque, A.C.A. 2012: Dextran-coated magnetic supports modified with a biomimetic ligand for IgG purification. Acs Applied Materials and Interfaces 4(11): 5907-5914
Schulz, A.; Woolley, R.; Tabarin, T.; McDonagh, C. 2011: Dextran-coated silica nanoparticles for calcium-sensing. Analyst 136(8): 1722-1727
Kim, E.-M.; Jeong, H.-J.; Jeong, M.-H.; Lee, C.-M.; Cheong, S.-J.; Kim, D.W.; Lim, S.T.; Sohn, M.-H. 2012: Dextran-conjugated vascular endothelial growth factor receptor antibody for in vivo melanoma xenografted mouse imaging. Cancer BioTherapy and Radiopharmaceuticals 27(2): 141-148
Bisht, S.; Maitra, A. 2009: Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology 1(4): 415-425
Vyas, S.; Trivedi, P.; Chaturvedi, S.C. 2009: Dextran-etodolac conjugates: synthesis, in vitro and in vivo evaluation. Acta Poloniae Pharmaceutica 66(2): 201-206
Hehre, E.J. 1948: Dextran-forming streptococci from the blood in subacute endocarditis and from the throats of healthy persons. Bulletin of the new York Academy of Medicine 24(8): 543
Miranda-Vilela, A.Luisa.; Peixoto, R.Cândido.Apolinário.; Longo, Jāo.Paulo.Figueiró.; Silva e Cintra, Débora.de.Oliveira.; Portilho, Fávia.Arruda.; Miranda, K.Lopes.Caiado.; Sartoratto, Pícia.Pommé.Confessori.; Báo, Sônia.Nair.; de Azevedo, R.Bentes.; Lacava, Z.Guerrero.Marques. 2013: Dextran-functionalized magnetic fluid mediating magnetohyperthermia combined with preventive antioxidant pequi-oil supplementation: potential use against cancer. Journal of Biomedical Nanotechnology 9(7): 1261-1271
Miranda-Vilela, A.L.; Yamamoto, K.R.; Miranda, K.L.C.; Matos, B.N.; de Almeida, M.C.él.; Longo, J.ão.P.F.ó; de Souza Filho, J.é; Fernandes, J.M.S.; Sartoratto, P.íc.P.é C.; Lacava, Z.G.M. 2014: Dextran-functionalized magnetic fluid mediating magnetohyperthermia for treatment of Ehrlich-solid-tumor-bearing mice: toxicological and histopathological evaluations. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(4): 3391-3403
Thomas, J.J.; Rekha, M.R.; Sharma, C.P. 2010: Dextran-glycidyltrimethylammonium chloride conjugate/DNA nanoplex: a potential non-viral and haemocompatible gene delivery system. International Journal of Pharmaceutics 389(1-2): 195-206
Ochrimenko, S.; Vollrath, A.; Tauhardt, L.; Kempe, K.; Schubert, S.; Schubert, U.S.; Fischer, D. 2014: Dextran-graft-linear poly(ethylene imine)s for gene delivery: importance of the linking strategy. Carbohydrate Polymers 113: 597-606
Shi, Q.-H.; Jia, G.-D.; Sun, Y. 2010: Dextran-grafted cation exchanger based on superporous agarose gel: adsorption isotherms, uptake kinetics and dynamic protein adsorption performance. Journal of Chromatography. a 1217(31): 5084-5091
Kawano, H.; Nomura, K.; Kawahito, S.; Ohshita, N.; Tanaka, K.; Oshita, S. 2012: Dextran-induced anaphylactic shock during general anesthesia: a case report. Masui. Japanese Journal of Anesthesiology 61(11): 1265-1268
Herranz, S.; Marciello, M.; Olea, D.; Hernández, M.; Domingo, C.ón.; Vélez, M.; Gheber, L.A.; Guisán, J.M.; Moreno-Bondi, M.ía.C. 2013: Dextran-lipase conjugates as tools for low molecular weight ligand immobilization in microarray development. Analytical Chemistry 85(15): 7060-7068
Tang, Q.; Cao, B.; Lei, X.; Sun, B.; Zhang, Y.; Cheng, G. 2014: Dextran-peptide hybrid for efficient gene delivery. Langmuir 30(18): 5202-5208
Beloqui, A.; Solinís, Mía.Ángeles.; des Rieux, A.; Préat, Véronique.; Rodríguez-Gascón, A. 2014: Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs. International Journal of Pharmaceutics 468(1-2): 105-111
Thomas, J.J.; Rekha, M.R.; Sharma, C.P. 2010: Dextran-protamine polycation: an efficient nonviral and haemocompatible gene delivery system. Colloids and Surfaces. B Biointerfaces 81(1): 195-205
Delgado, D.; Gascón, A.Rodríguez.; Del Pozo-Rodríguez, A.; Echevarría, E.; Ruiz de Garibay, A.Pérez.; Rodríguez, J.Manuel.; Solinís, M.Ángeles. 2012: Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice. International Journal of Pharmaceutics 425(1-2): 35-43
Julius, U.; Parhofer, K.G.; Heibges, A.; Kurz, S.; Klingel, R.; Geiss, H.-C. 2007: Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALi and Lipidfiltration. Journal of Clinical Apheresis 22(4): 215-223
Lisman, A.; Butruk, B.; Wasiak, I.; Ciach, T. 2014: Dextran/Albumin hydrogel sealant for Dacron(R) vascular prosthesis. Journal of Biomaterials Applications 28(9): 1386-1396
Turner, F.P.; Butler, B.C. 1949: Dextran; an experimental plasma substitute. Surgery Gynecology and Obstetrics 88(5): 661-675
Bertrand, E.; Pierre, G.; Delattre, C.éd.; Gardarin, C.; Bridiau, N.; Maugard, T.; Štrancar, A.š; Michaud, P. 2014: Dextranase immobilization on epoxy CIM(®) disk for the production of isomaltooligosaccharides from dextran. Carbohydrate Polymers 111: 707-713
Zohra, R.R.; Aman, A.; Zohra, R.R.; Ansari, A.; Ghani, M.; Qader, S.A.U. 2013: Dextranase: hyper production of dextran degrading enzyme from newly isolated strain of Bacillus licheniformis. Carbohydrate Polymers 92(2): 2149-2153
Lin, C.; Song, Y.; Lou, B.; Zhao, P. 2014: Dextranation of bioreducible cationic polyamide for systemic gene delivery. Bio-Medical Materials and Engineering 24(1): 673-682
Tanikaze, S.; Osa, Y.; Tada, M.; Goya, N.; Asanuma, H.; Yamazaki, Y.; Shimada, K.; Sugita, Y.; Goto, T.; Yamaguchi, T. 2010: Dextranomer beads in stabilized non-animal sodium hyaluronate gel (NASHA/Dx gel) for vesicoureteral reflux: multi-center study in Japanease patients. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 101(5): 676-682
Martin, K.; Emil, S.; Bernard, C.; Gaied, F.; Blumenkrantz, M.; Laberge, J.-M.; Morinville, V.; Nguyen, V.-H. 2014: Dextranomer hyaluronic acid copolymer effects on gastroesophageal junction. Journal of Pediatric Gastroenterology and Nutrition 58(5): 593-597
Hoy, S.M. 2012: Dextranomer in stabilized sodium hyaluronate (Solesta®): in adults with faecal incontinence. Drugs 72(12): 1671-1678
DeCaro, J.J.; Kirsch, A.J. 2012: Dextranomer-hyaluronic acid implants misdiagnosed as bladder tumor on transvaginal ultrasonography. Obstetrics and Gynecology 119(2 Part 2): 476-478
Shapiro, E. 2007: Dextranomer/Hyaluronic Acid implantation for vesicoureteral reflux. Reviews in Urology 9(1): 43-44
Arena, S.; Fazzari, C.; Implatini, A.; Torre, S.; Villari, D.; Arena, F.; Di Benedetto, V. 2009: Dextranomer/hyaluronic Acid copolymer implant for vesicoureteral reflux: role of myofibroblast differentiation. Journal of Urology 181(6): 2695-2701
Nelson, C.P.; Chow, J.S. 2008: Dextranomer/hyaluronic acid copolymer (Deflux) implants mimicking distal ureteral calculi on CT. Pediatric Radiology 38(1): 104-106
Ernst, B.A. 2008: Dextranomer/hyaluronic acid copolymer for the treatment of vesicoureteral reflux. Urologic Nursing 28(4): 299-301
Clark, A.T.D.; Guerra, L.; Leonard, M. 2010: Dextranomer/hyaluronic acid copolymer implant calcification mimicking distal ureteral calculi on ultrasound. Urology 75(5): 1178-1179
Hunziker, M.; Mohanan, N.; Puri, P. 2013: Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems. Journal of Urology 189(5): 1876-1881
Routh, J.C.; Inman, B.A.; Reinberg, Y. 2010: Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics 125(5): 1010-1019
Bayne, A.P.; Roth, D.R. 2010: Dextranomer/hyaluronic injection for the management of vesicoureteric reflux in complete ureteral duplication: should age and gender be factors in decision making?. Journal of Endourology 24(6): 1013-1016
Robyt, J.F.; Yoon, S.-H.; Mukerjea, R. 2008: Dextransucrase and the mechanism for dextran biosynthesis. Carbohydrate Research 343(18): 3039-3048
Fang, Y.; Wu, J.; Xu, Z.-K. 2015: Dextransucrase-catalyzed elongation of polysaccharide brushes with immobilized mono-/di-saccharides as acceptors. Chemical Communications 51(1): 129-132
Gonçalves, C.; Torrado, Eídio.; Martins, T.; Pereira, P.; Pedrosa, J.; Gama, M. 2010: Dextrin nanoparticles: studies on the interaction with murine macrophages and blood clearance. Colloids and Surfaces. B Biointerfaces 75(2): 483-489
Ferguson, E.L.; Azzopardi, E.; Roberts, J.L.; Walsh, T.R.; Thomas, D.W. 2014: Dextrin-colistin conjugates as a model bioresponsive treatment for multidrug resistant bacterial infections. Molecular Pharmaceutics 11(12): 4437-4447
Luz, P.P.; Neri, C.áu.R.; Serra, O.A. 2008: Dextrin-microencapsulated porphyrin: luminescent properties. Annals of the new York Academy of Sciences 1130: 91-96
Ferguson, E.L.; Duncan, R. 2009: Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate. Biomacromolecules 10(6): 1358-1364
Hardwicke, J.; Ferguson, E.L.; Moseley, R.; Stephens, P.; Thomas, D.W.; Duncan, R. 2008: Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair. Journal of Controlled Release: Official Journal of the Controlled Release Society 130(3): 275-283
Treetharnmathurot, B.; Dieudonné, L.; Ferguson, E.L.; Schmaljohann, D.; Duncan, R.; Wiwattanapatapee, R. 2009: Dextrin-trypsin and ST-HPMA-trypsin conjugates: enzyme activity, autolysis and thermal stability. International Journal of Pharmaceutics 373(1-2): 68-76
Das, D.; Pal, S. 2015: Dextrin/poly (HEMA): pH responsive porous hydrogel for controlled release of ciprofloxacin. International Journal of Biological Macromolecules 72: 171-178
Anonymous 1949: Dextro-tubocurarine chloride: A provisional British standard. Bulletin of the World Health Organization 2(1): 65-68
Check, J.H.; DiAntonio, G.; Cohen, R. 2014: Dextroamphetamine sulfate, a very effective drug for pelvic pain relieved severe retroorbital stabbing pain in a woman with keratoconus who failed to respond to bilateral corneal implants. Clinical and Experimental Obstetrics and Gynecology 41(1): 80-82
Stein, M.D. 1974: Dextroamphetamine therapy in hyperactive children. Western Journal of Medicine 120(4): 327-328
Russakoff, A.H.; Katz, H.W. 1946: Dextrocardia and bronchiectasis, a review of the literature and a report of two cases. New England Journal of Medicine 235: 253-255
Tallroth, K.; Lohman, M.; Heliövaara, M.; Aromaa, A.; Knekt, P.; Standertskjöld-Nordenstam, C.-G. 2009: Dextrocardia and coronal alignment of thoracic curve: a population study. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 18(12): 1941-1945
Cordero García, C.; Nieto Castilla, A.és.; López Jiménez, E.; Amores García, I. 2009: Dextrocardia associated with left-sided Poland syndrome. American Journal of Physical Medicine and Rehabilitation 88(2): 168
Rennie, J.K. 1946: Dextrocardia from eventration of the diaphragm. British Heart Journal 8(4): 237
Stubenbord, W.D. 1946: Dextrocardia in association with a short P-R interval with prolongation of the QRS complex. United States Naval Medical Bulletin 46: 412-416
Torre, M.; Baban, A.; Buluggiu, A.; Costanzo, S.; Bricco, L.; Lerone, M.; Bianca, S.; Gatti, G.L.; Sénès, F.M.; Valle, M.; Calevo, M.G. 2010: Dextrocardia in patients with Poland syndrome: phenotypic characterization provides insight into the pathogenesis. Journal of Thoracic and Cardiovascular Surgery 139(5): 1177-1182
Pârvulescu, V.N.; Camen, D.; Ioncică, L.; Trăistaru, R.; Pârvulescu, G.; Stănescu, L.I.; Hriţcu, E.; Stoica, Z.; Popescu, M.; Petria, M. 2006: Dextrocardia of post right pneumonectomy. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 110(1): 73-76
Ellis, R.W. 1932: Dextrocardia with Patent Ductus Arteriosus and Transposition of Viscera. Proceedings of the Royal Society of Medicine 26(2): 149-151
Richman, S. 1947: Dextrocardia with complete situs inversus; case reports. American Journal of Roentgenology and Radium Therapy 57(5): 616-618
Gonçalves, L.F.áv.G.ão.; Souto, F.M.S.; Faro, F.N.; Mendonça, R.d.C.; Oliveira, J.L.M.; Sousa, A.ôn.C.S. 2013: Dextrocardia with situs inversus associated with non-compaction cardiomyopathy. Arquivos Brasileiros de Cardiologia 101(2): E33-E36
Hashmi, S.; Anis, M.; Darr, U. 2012: Dextrocardia with situs inversus totalis: coronary artery bypass grafting. Jpma. Journal of the Pakistan Medical Association 62(1): 69-70
Najm, H.K.; Jijeh, A.M.Z.; El Moazamy, Y.M.; Mufti, H.N.; Abu-Sulaiman, R.; Mutairi, M.Al. 2010: Dextrocardia, aortopulmonary window with transposition of the great arteries, case report. Journal of the Saudi Heart Association 22(2): 61-64
Pope, K.; Samanich, J.; Ramesh, K.H.; Cannizzaro, L.; Pan, Q.; Babcock, M. 2012: Dextrocardia, atrial septal defect, severe developmental delay, facial anomalies, and supernumerary ribs in a child with a complex unbalanced 8;22 translocation including partial 8p duplication. American Journal of Medical Genetics. Part a 158a (3): 641-647
Lloyd, J.J. 1932: Dextrocardia: A Report of Six Cases, Four Presenting Pulmonary Complications, Two of Which Present Marked Bronchiectasis. Transactions of the American Climatological and Clinical Association. American Climatological and Clinical Association 48: 138-146
Yusuf, S.W.; Durand, J.B.; Lenihan, D.J.; Swafford, J. 2009: Dextrocardia: an incidental finding. Texas Heart Institute Journal 36(4): 358-359
James, J.; Binns, C. 2017: Breastfeeding policy: the foundation for improving Australia's health. Breastfeeding Review: Professional Publication of the Nursing Mothers' Association of Australia 25(1): 7-8
Banken, J.A.; Foster, H. 2008: Dextromethorphan. Annals of the new York Academy of Sciences 1139: 402-411
Tomczak, E.; Wiergowski, M.; Jankowski, Z.; Wilmanowska, J.A. 2012: Dextromethorphan (DXM): new methods of intoxications among teenagers--a case description. Archiwum Medycyny Sadowej i Kryminologii 62(3): 197-202
Antoniou, T.; Juurlink, D.N. 2014: Dextromethorphan abuse. Cmaj: Canadian Medical Association Journal 186(16): E631
Forrester, M.B. 2011: Dextromethorphan abuse in Texas, 2000-2009. Journal of addictive diseases 30(3): 243-247
Müller, S.; Jaffan, L.; Kloiber, E.; Läer, S. 2014: Dextromethorphan abuse in adolescents: what can the pharmacists do?. Medizinische Monatsschrift für Pharmazeuten 37(3): 95-100
Cunningham, V. 2011: Dextromethorphan abuse in teens: beware acetaminophen poisoning!. Cjem 13(5): 298
Logan, B.K.; Yeakel, J.K.; Goldfogel, G.; Frost, M.P.; Sandstrom, G.; Wickham, D.J. 2012: Dextromethorphan abuse leading to assault, suicide, or homicide. Journal of Forensic Sciences 57(5): 1388-1394
Majlesi, N.; Lee, D.C.; Ali, S.S. 2011: Dextromethorphan abuse masquerading as a recurrent seizure disorder. Pediatric Emergency Care 27(3): 210-211
Romanelli, F.; Smith, K.M. 2009: Dextromethorphan abuse: clinical effects and management. Journal of the American Pharmacists Association: Japha 49(2): E20
Akerele, E.; Bisaga, A.; Sullivan, M.A.; Garawi, F.; Comer, S.D.; Thomas, A.A.; Nunes, E.V.; Kleber, H.D. 2008: Dextromethorphan and quinidine combination for heroin detoxification. American Journal on Addictions 17(3): 176-180
Messias, E.; Everett, B. 2012: Dextromethorphan and quinidine combination in emotional lability associated with depression: a case report. Primary Care Companion for Cns Disorders 14(5)
Werling, L.L.; Lauterbach, E.C.; Calef, U. 2007: Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. Neurologist 13(5): 272-293
Lauterbach, E.C. 2011: Dextromethorphan as a potential rapid-acting antidepressant. Medical Hypotheses 76(5): 717-719
Li, M-Han.; Luo, Y-Hsia.; Lin, C-Feng.; Chang, Y-Tzu.; Lu, S-Ling.; Kuo, C-Feng.; Hong, J-Shyong.; Lin, Y-Shin. 2011: Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group a streptococcal sepsis. Antimicrobial Agents and ChemoTherapy 55(3): 967-973
Harada, M.; Kuwahara, R.; Yoshida, H.; Hashimoto, O.; Sakamoto, M.; Koga, Y.; Kano, T.; Sata, M. 2001: Dextromethorphan for neuropathic pain with Churg-Strauss syndrome. Modern Rheumatology 11(1): 80-82
Kane, D.L.; Glassnap, A. 1998: Dextromethorphan hydrobromide and opioid tolerance: a compounding opportunity for pharmacists with chronic pain patients. International Journal of Pharmaceutical Compounding 2(2): 118-119
Liu, H.; Xie, Y.; Huang, Y.-H. 2008: Dextromethorphan hydrobromide poisoning in one child. Zhongguo Dang Dai Er Ke Za Zhi 10(3): 421-422
Fierens, C.; Corthout, J. 2009: Dextromethorphan hydrobromide preparations on the Belgian market--a comparative study. Journal de Pharmacie de Belgique 1: 15-17
Cochems, A.; Harding, P.; Liddicoat, L. 2007: Dextromethorphan in Wisconsin drivers. Journal of Analytical Toxicology 31(4): 227-232
Chien, Y.-H.; Lin, M.-I.; Weng, W.-C.; Du, J.-C.; Lee, W.-T. 2012: Dextromethorphan in the treatment of early myoclonic encephalopathy evolving into migrating partial seizures in infancy. Journal of the Formosan Medical Association 111(5): 290-294
Song, J.-H.; Yeh, J.Z. 2012: Dextromethorphan inhibition of voltage-gated proton currents in BV2 microglial cells. Neuroscience Letters 516(1): 94-98
Wu, K.; Lin, T.-H.; Liou, H.-C.; Lu, D.-H.; Chen, Y.-R.; Fu, W.-M.; Yang, R.-S. 2013: Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 24(8): 2201-2214
Ohi, Y.; Tsunekawa, S.; Haji, A. 2011: Dextromethorphan inhibits the glutamatergic synaptic transmission in the nucleus tractus solitarius of guinea pigs. Journal of Pharmacological Sciences 116(1): 54-62
Upadhyaya, J.D.; Singh, N.; Sikarwar, A.S.; Chakraborty, R.; Pydi, S.P.; Bhullar, R.P.; Dakshinamurti, S.; Chelikani, P. 2014: Dextromethorphan mediated bitter taste receptor activation in the pulmonary circuit causes vasoconstriction. Plos one 9(10): E110373
Pioro, E.P.; Brooks, B.R.; Cummings, J.; Schiffer, R.; Thisted, R.A.; Wynn, D.; Hepner, A.; Kaye, R.; Armon, C.; Bedlack, R.; Boylan, K.; Bravver, E.; Corse, A.; Cudkowicz, M.E.; Dietrich, D.; Donofrio, P.; Ginsburg, D.; Glass, J.; Graves, M.; Gutmann, L.; Weinstock-Guttman, B.; Hayat, G.; Heitzman, D.; Lomen-Hoerth, C.; Jackson, C.E.; Kasarskis, E.; Kellogg, J.; Licht, J.; Little, A.; Lou, J.-S.; Madison, C.; McCluskey, L.; McVey, A.; Mitsumoto, H.; Mozaffar, T.; Nash, S.; Newman, D.; Ni, O.; Pattee, G.; Heiman-Patterson, T.; Pioro, E.; Rollins, Y.; Shi, J.; Simpson, E.; Sivak, M.; Sivakumar, K.; Steingo, B.; Sufit, R.; Tandan, R.; Vasquez, A.; Verma, A.; Weissman, J.; Williams, B.; Wymer, J.; Wynn, D.; Alfici, A.F.R.; Callegaro, D.; Carr 2010: Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Annals of Neurology 68(5): 693-702
Liu, S.-L.; Li, Y.-H.; Shi, G.-Y.; Tang, S.-H.; Jiang, S.-J.; Huang, C.-W.; Liu, P.-Y.; Hong, J.-S.; Wu, H.-L. 2009: Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice. Cardiovascular Research 82(1): 161-169
Miller, S.C. 2011: Dextromethorphan to dextrorphan: a pathway towards abuse liability. Human psychopharmacology 26(1): 89-90; author reply 91
Mutschler, J.; Koopmann, A.; Grosshans, M.; Hermann, D.; Mann, K.; Kiefer, F. 2010: Dextromethorphan withdrawal and dependence syndrome. Deutsches Arzteblatt International 107(30): 537-540
Mishkan, E.S. 2005: Dextromethorphan, an NMDA Receptor Antagonist, as a Treatment for Pain. International Journal of Pharmaceutical Compounding 9(5): 339-346
Monte, A.A.; Chuang, R.; Bodmer, M. 2010: Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review. British Journal of Clinical Pharmacology 70(6): 794-798
Matin, N.; Kurani, A.; Kennedy, C.A.; Liu, Q.-Y. 2007: Dextromethorphan-induced near-fatal suicide attempt in a slow metabolizer at cytochrome P450 2D6. American Journal of Geriatric PharmacoTherapy 5(2): 162-165
Nam, Y.; Shin, E.-J.; Yang, B.-K.; Bach, J.-H.; Jeong, J.H.; Chung, Y.H.; Park, E.S.; Li, Z.; Kim, K.-W.; Kwon, Y.-B.; Nabeshima, T.; Kim, H.-C. 2012: Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors. Neurochemistry International 61(6): 913-922
Schwartz, A.R.; Pizon, A.F.; Brooks, D.E. 2008: Dextromethorphan-induced serotonin syndrome. Clinical Toxicology 46(8): 771-773
Bortolotti, F.; Bertaso, A.; Gottardo, R.; Musile, G.; Tagliaro, F. 2013: Dextromethorphan/levomethorphan issues in a case of opiate overdose. Drug Testing and Analysis 5(9-10): 781-784
Anonymous 2011: Dextromethorphan/quinidine (Nuedexta) for pseudobulbar affect. Medical Letter on Drugs and Therapeutics 53(1366): 46-47
Ondo, W.G. 2012: Dextromethorphan/quinidine for chorea: an open-label assessment. Clinical Neuropharmacology 35(1): 53-54
Patatanian, E.; Casselman, J. 2014: Dextromethorphan/quinidine for the treatment of pseudobulbar affect. Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 29(4): 264-269
Rosen, H. 2008: Dextromethorphan/quinidine sulfate for pseudobulbar affect. Drugs of Today 44(9): 661-668
Yang, L.P.H.; Deeks, E.D. 2015: Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect. Drugs 75(1): 83-90
Garnock-Jones, K.P. 2011: Dextromethorphan/quinidine: in pseudobulbar affect. Cns Drugs 25(5): 435-445
Siu, A.; Drachtman, R. 2007: Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain. Cns Drug Reviews 13(1): 96-106
Ghosh, A.K.; Peh, L.H. 2011: Dextromethorphan: abusing the overused. Singapore Medical Journal 52(2): 134-135
Bozok, S.; Kestelli, M.; Akyüz, M. 2014: Dextroposition of the aorta in tetralogy of Fallot. Cardiology in the young 24(1): 186
Balhara, Y.P.S. 2014: Dextropropoxyphene ban in India: Is there a case for reconsideration?. Journal of Pharmacology and Pharmacotherapeutics 5(1): 8-11
Gaubert, S.; Vié, M.; Damase-Michel, C.; Pathak, A.; Montastruc, J-Louis. 2009: Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption. Fundamental and Clinical Pharmacology 23(2): 247-252
Anonymous 2008: Dextropropoxyphene: welcome withdrawal from a French hospital's formulary. Prescrire International 17(95): 112
Anonymous 2009: Dextropropoxyphene: withdrawal from the US market requested: harmful drug. Prescrire International 18(102): 166-167
Anonymous 2009: Dextropropoxyphene: withdrawn in the EU. Withdrawn from pharmacies in France. Prescrire International 18(102): 166
Bikker, F.J.; Kaman, W.E.; Veerman, E.C.I. 2013: Dextrorotary protease substrates could be suitable for oral microbiological diagnostics. Nederlands Tijdschrift Voor Tandheelkunde 120(3): 164-167
Kiefer, M.V.; Gene Hern, H.; Alter, H.J.; Barger, J.B. 2014: Dextrose 10% in the treatment of out-of-hospital hypoglycemia. Prehospital and Disaster Medicine 29(2): 190-194
Tsui, B.C.H. 2009: Dextrose 5% in water as an alternative medium to gel for performing ultrasound-guided peripheral nerve blocks. Regional Anesthesia and Pain Medicine 34(5): 525-527
Katsinelos, P.; Kountouras, J.; Chatzimavroudis, G.; Paroutoglou, G.; Zavos, C. 2008: Dextrose 50 % solution as a submucosal fluid cushion in the resection of sessile colorectal polyps. Endoscopy 40(8): 705
Tang, K.Y.; Chan, C.K.; Lau, F.L. 2010: Dextrose 50% as a better substitute for saturated salt solution in mothball float test. Clinical Toxicology 48(7): 750-751
Mosalli, R. 2014: Dextrose Gel is Superior to Feeding Alone in Neonatal Hypoglycemia. Journal of Clinical Neonatology 3(1): 10-11
Rabago, D.; Patterson, J.J.; Mundt, M.; Zgierska, A.; Fortney, L.; Grettie, J.; Kijowski, R. 2014: Dextrose and morrhuate sodium injections (prolotherapy) for knee osteoarthritis: a prospective open-label trial. Journal of Alternative and Complementary Medicine 20(5): 383-391
Kutamba, E.; Lubega, S.; Mugalu, J.; Ouma, J.; Mupere, E. 2014: Dextrose boluses versus burette dextrose infusions in prevention of hypoglycemia among preterms admitted at Mulago Hospital: an open label randomized clinical trial. African Health Sciences 14(3): 502-509
Harris, D.L.; Weston, P.J.; Signal, M.; Chase, J.G.; Harding, J.E. 2013: Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial. Lancet 382(9910): 2077-2083
Feldman-Billard, S.; Joubert, M.; Reznik, Y. 2013: Dextrose infusion and glucose disorders in people without diabetes hospitalized in general wards. Diabetes Research and Clinical Practice 102(2): E35-E37
Khan, S.A.; Kumar, A.; Varshney, M.K.; Trikha, V.; Yadav, C.S. 2008: Dextrose prolotherapy for recalcitrant coccygodynia. Journal of Orthopaedic Surgery 16(1): 27-29
Gordon, G.H. 2013: Dextrose saline compared with normal saline rehydration of hyperemesis gravidarum: a randomized controlled trial. Obstetrics and Gynecology 121(6): 1360
Stokes, W.R.; Stoner, H.W. 1909: Dextrose vs Lactose for Determining Colon Bacilli. American Journal of Public Hygiene 19(2): 312-313
Oh, S.; Ettema, A.M.; Zhao, C.; Zobitz, M.E.; Wold, L.E.; An, K.-N.; Amadio, P.C. 2008: Dextrose-induced subsynovial connective tissue fibrosis in the rabbit carpal tunnel: a potential model to study carpal tunnel syndrome?. Hand 3(1): 34-40
Bartlett, P.; Gaebler, O.H. 1947: Dextrose: nitrogen ratios in pyridoxine deficiency. Federation Proceedings 6(1 Part 2): 236
Finsterer, J.; Stöllberger, C. 2014: Dextroversion and noncompaction. Arquivos Brasileiros de Cardiologia 102(3): 307-308
S, O. 1880: Deyer's Astronomical Record. Science 1(7): 77
He, L.; Ding, Y.; Chen, H.; Qian, Y.; Li, Z. 2015: Dezocine pretreatment prevents myoclonus induced by etomidate: a randomized, double-blinded controlled trial. Journal of Anesthesia 29(1): 143-145
Sun, Q.; Zhou, W.; Wu, B.; Ji, M-Huo.; Peng, Y.G. 2012: Dezocine: a novel drug to prevent fentanyl-induced cough during general anesthesia induction?. Journal of Anesthesia 26(3): 470
Agarwal, V.; Penzel, S.; Szekely, K.; Cadalbert, R.; Testori, E.; Oss, A.; Past, J.; Samoson, A.; Ernst, M.; Böckmann, A.; Meier, B.H. 2014: De novo 3D structure determination from sub-milligram protein samples by solid-state 100 kHz MAS NMR spectroscopy. Angewandte Chemie 53(45): 12253-12256
Wheeler, T.J.; Clements, J.; Eddy, S.R.; Hubley, R.; Jones, T.A.; Jurka, J.; Smit, A.F.A.; Finn, R.D. 2013: Dfam: a database of repetitive DNA based on profile hidden Markov models. Nucleic Acids Research 41(Database Issue): D70-D82
Stolz, A.; Schweizer, R.S.; Schäfer, A.; Wolf, D.H. 2010: Dfm1 forms distinct complexes with Cdc48 and the ER ubiquitin ligases and is required for ERAD. Traffic 11(10): 1363-1369
Reschen, R.F.; Colombie, N.; Wheatley, L.; Dobbelaere, J.; St Johnston, D.; Ohkura, H.; Raff, J.W. 2012: Dgp71WD is required for the assembly of the acentrosomal Meiosis i spindle, and is not a general targeting factor for the γ-TuRC. Biology Open 1(5): 422-429
Calderón-Torres, M.; Castro, D.E.; Montero, P.; Peña, A. 2011: DhARO4 induction and tyrosine nitration in response to reactive radicals generated by salt stress in Debaryomyces hansenii. Yeast 28(10): 733-746
Huang, L.; Li, P.; Wang, G.; Guan, S.; Sun, X.; Wang, L. 2013: DhHP-6 extends lifespan of Caenorhabditis elegans by enhancing nuclear translocation and transcriptional activity of DAF-16. Free Radical Research 47(4): 316-324
Wand, A.; Kaur, R. 2014: Dharan or Nabhi Sarakna: a cultural syndrome presenting with unexplained medical symptoms. Psychosomatics 55(2): 207-209
Khalsa, D.Singh.; Gustafson, C. 2014: Dharma Singh Khalsa, MD: The pillars of Alzheimer's prevention. Advances in Mind-Body Medicine 28(3): 26-32
Seetharam, S. 2013: Dharma and medical ethics. Indian Journal of Medical Ethics 10(4): 226-231
Matus, T. 2013: Dharma, yoga, tantra. Substance use and Misuse 48(12): 1180-1186
Singh, G.; Avasthi, A.; Pravin, D. 2001: Dhat syndrome in a female- a case report. Indian Journal of Psychiatry 43(4): 345-348
Singh, G. 1985: Dhat syndrome revisited. Indian Journal of Psychiatry 27(2): 119-122
Mehta, V.; De, A.; Balachandran, C. 2009: Dhat syndrome: a reappraisal. Indian Journal of Dermatology 54(1): 89-90
Deb, K.Sinha.; Balhara, Y.Pal.Singh. 2013: Dhat syndrome: a review of the world literature. Indian Journal of Psychological Medicine 35(4): 326-331
Rajkumar, R.P.; Bharadwaj, B. 2014: Dhat syndrome: evidence for a depressive spectrum subtype. Asian Journal of Psychiatry 9: 57-60
Udina, M.; Foulon, H.; Córcoles, D.; Martín-Santos, Río. 2012: Dhat syndrome: report of six cases. Medicina Clinica 138(7): 320
Behere, P.B.; Natraj, G.S. 1984: Dhat syndrome: the phenomenology of a culture bound sex neurosis of the orient. Indian Journal of Psychiatry 26(1): 76-78
Rao, S.D. 1994: Dhatwagni vyapara in carcinogenesis. Ancient Science of Life 14(1-2): 61-67
Ye, M.; Zhang, J.-J.; Fang, X.; Lawlis, G.B.; Troxell, B.; Zhou, Y.; Gomelsky, M.; Lou, Y.; Yang, X.F. 2014: DhhP, a cyclic di-AMP phosphodiesterase of Borrelia burgdorferi, is essential for cell growth and virulence. Infection and Immunity 82(5): 1840-1849
De Silva, E.D.; Williams, D.E.; Jayanetti, D.R.; Centko, R.M.; Patrick, B.O.; Wijesundera, R.L.C.; Andersen, R.J. 2011: Dhilirolides A-D, meroterpenoids produced in culture by the fruit-infecting fungus Penicillium purpurogenum collected in Sri Lanka. Organic Letters 13(5): 1174-1177
Centko, R.M.; Williams, D.E.; Patrick, B.O.; Akhtar, Y.; Garcia Chavez, M.A.; Wang, Y.A.; Isman, M.B.; de Silva, E.D.; Andersen, R.J. 2014: Dhilirolides E-N, meroterpenoids produced in culture by the fungus Penicillium purpurogenum collected in Sri Lanka: structure elucidation, stable isotope feeding studies, and insecticidal activity. Journal of Organic Chemistry 79(8): 3327-3335
Kam, R.K.T.; Shi, W.; Chan, S.O.; Chen, Y.; Xu, G.; Lau, C.B.-S.; Fung, K.P.; Chan, W.Y.; Zhao, H. 2013: Dhrs3 protein attenuates retinoic acid signaling and is required for early embryonic patterning. Journal of Biological Chemistry 288(44): 31477-31487
Feng, L.; Hernandez, R.E.; Waxman, J.S.; Yelon, D.; Moens, C.B. 2010: Dhrs3a regulates retinoic acid biosynthesis through a feedback inhibition mechanism. Developmental Biology 338(1): 1-14
Wang, W.; Craig, Z.R.; Basavarajappa, M.S.; Gupta, R.K.; Flaws, J.A. 2012: Di (2-ethylhexyl) phthalate inhibits growth of mouse ovarian antral follicles through an oxidative stress pathway. Toxicology and Applied Pharmacology 258(2): 288-295
Xiao-feng, Z.; Nai-qiang, Q.; Jing, Z.; Zi, L.; Yang, Z. 2009: Di (n-butyl) phthalate inhibits testosterone synthesis through a glucocorticoid-mediated pathway in rats. International Journal of Toxicology 28(5): 448-456
Bhat, F.A.; Ramajayam, G.; Parameswari, S.; Vignesh, R.C.; Karthikeyan, S.; Senthilkumar, K.; Karthikeyan, G.D.; Balasubramanian, K.; Arunakaran, J.; Srinivasan, N. 2013: Di 2-ethyl hexyl phthalate affects differentiation and matrix mineralization of rat calvarial osteoblasts--in vitro. Toxicology in Vitro: An International Journal Published in Association with Bibra 27(1): 250-256
Zhang, Y-hui. 2008: Di Dang Tang in the treatment of insulin resistance in type 2 diabetes--report of 37 cases. Zhongguo Zhong Xi Yi Jie he Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 28(2): 161-162
Vera de Pedro, E.; Salado Marín, C.; Botella Astorqui, M.P.; Rodríguez Estévez, A.; Díez López, I.; Gamarra Cabrerizo, A. 2007: Di George syndrome associated with hemimelia. Anales de Pediatria 66(6): 628-630
Bertola, G.; Giambona, S.; Bianchi, R.; Girola, A.; Berra, S.A. 2013: Di George syndrome: not always a pediatric diagnosis. Recenti Progressi in Medicina 104(2): 69
Kumar, M.; Bhasker, S.Kumar.; Singh, R.; Kohli, N.; Kumar, R. 2012: Di Sala syndrome. BMJ Case Reports
Manwaring, W.H. 1931: Di Sodium Tetra Iodo Ortho Sulpho Benzo Ate. California and Western Medicine 34(2): 127
Wang, D.-N.; Jang, F.; Zhang, X.-W. 2012: The opportunities and challenges of Chinese medicine and pharmacy in intervening HIV drug resistance. Zhongguo Zhong Xi Yi Jie he Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 32(6): 828-830
Huff, J. 1982: Di(2-ethylhexyl) adipate: Condensation of the Carcinogenesis Bioassay Technical Report. Environmental Health Perspectives 45: 205-207
Liu, X.; He, D-Wei.; Zhang, D-Ying.; Lin, T.; Wei, G-Hui. 2008: Di(2-ethylhexyl) phthalate (DEHP) increases transforming growth factor-beta1 expression in fetal mouse genital tubercles. Journal of Toxicology and Environmental Health. Part a 71(19): 1289-1294
Takahashi, Y.; Shibata, T.; Sasaki, Y.; Fujii, H.; Bito, Y.; Suehiro, S. 2008: Di(2-ethylhexyl) phthalate exposure during cardiopulmonary bypass. Asian Cardiovascular and Thoracic Annals 16(1): 4-6
DeKeyser, J.G.; Stagliano, M.C.; Auerbach, S.S.; Prabhu, K.S.; Jones, A.D.; Omiecinski, C.J. 2009: Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant CAR2. Molecular Pharmacology 75(5): 1005-1013
Solymos, E.; Guddat, S.; Geyer, H.; Thomas, A.; Thevis, M.; Schänzer, W. 2011: Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: intra-individual variability of urinary concentrations. Drug Testing and Analysis 3(11-12): 892-895
Sun, X.; Lin, Y.; Huang, Q.; Shi, J.; Qiu, L.; Kang, M.; Chen, Y.; Fang, C.; Ye, T.; Dong, S. 2015: Di(2-ethylhexyl) phthalate-induced apoptosis in rat INS-1 cells is dependent on activation of endoplasmic reticulum stress and suppression of antioxidant protection. Journal of Cellular and Molecular Medicine 19(3): 581-594
Strauss, A.A. 2004: Di(2-ethylhexyl)phthalate (DEHP). Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 9(2): 89-95
Cirillo, T.; Fasano, E.; Esposito, F.; Montuori, P.; Amodio Cocchieri, R. 2013: Di(2-ethylhexyl)phthalate (DEHP) and di-n-butylphthalate (DBP) exposure through diet in hospital patients. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 51: 434-438
Takatori, S.; Akutsu, K.; Kondo, F.; Ishii, R.; Nakazawa, H.; Makino, T. 2012: Di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in media for in vitro fertilization. Chemosphere 86(5): 454-459
Rajesh, P.; Balasubramanian, K. 2014: Di(2-ethylhexyl)phthalate exposure impairs insulin receptor and glucose transporter 4 gene expression in L6 myotubes. Human and Experimental Toxicology 33(7): 685-700
Erkekoglu, P.ın.; Giray, B.K.; Kızilgün, M.; Rachidi, W.; Hininger-Favier, I.; Roussel, A.-M.; Favier, A.; Hincal, F. 2012: Di(2-ethylhexyl)phthalate-induced renal oxidative stress in rats and protective effect of selenium. Toxicology Mechanisms and Methods 22(6): 415-423
Niittymäki, T.; Virta, P.; Ketomäki, K.; Lönnberg, H. 2007: Di(azacrown) conjugates of 2'-O-methyl oligoribonucleotides as sequence-selective artificial ribonucleases. Bioconjugate Chemistry 18(5): 1583-1592
Silva, J.P.; Machado, V.A.; Calhelha, R.C.; Queiroz, M.R.; Coutinho, O.P. 2010: Di(hetero)arylamines in the benzo[b]thiophene series as novel potent antioxidants. Drug Discoveries and Therapeutics 4(4): 246-256
Barbul, I.; Varga, R.A.; Molloy, K.C.; Silvestru, C. 2013: Di(imino)aryltin(IV) dichlorides as tectons for heterometallic coordination compounds. Dalton Transactions 42(43): 15427-15436
Wu, J.; Ni, B.; Headley, A.D. 2009: Di(methylimidazole)prolinol silyl ether catalyzed highly Michael addition of aldehydes to nitroolefins in water. Organic Letters 11(15): 3354-3356
Filipiak, E.; Walczak-Jędrzejowska, R.; Krupiński, M.; Oszukowska, E.żb.; Marchlewska, K.; Długoński, J.; Kula, K.; Słowikowska-Hilczer, J. 2011: Di(n-butyl) phthalate has no effect on the rat prepubertal testis despite its estrogenic activity in vitro. Folia Histochemica et Cytobiologica 49(4): 685-689
Alam, M.S.; Ohsako, S.; Tay, T.W.; Tsunekawa, N.; Kanai, Y.; Kurohmaru, M. 2010: Di(n-butyl) phthalate induces vimentin filaments disruption in rat sertoli cells: a possible relation with spermatogenic cell apoptosis. Anatomia Histologia Embryologia 39(3): 186-193
Zelaya, C.A.; Stevens, E.D.; Dowd, M.K. 2013: Di(phenylpropylamino)gossypol: a derivative of the dimeric natural product gossypol. Acta Crystallographica. Section C Crystal Structure Communications 69(Part 4): 439-443
Pierrat, P.; Réthoré, C.él.; Muller, T.; Bräse, S. 2009: Di- and dodeca-Mitsunobu reactions on C60 derivatives: post-functionalization of fullerene mono- and hexakis-adducts. Chemistry 15(43): 11458-11460
Yilmaz, V.T.; Gocmen, E.; Icsel, C.; Cengiz, M.; Susluer, S.Y.; Buyukgungor, O. 2014: Di- and polynuclear silver(I) saccharinate complexes of tertiary diphosphane ligands: synthesis, structures, in vitro DNA binding, and antibacterial and anticancer properties. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 19(1): 29-44
Gouveia, V.; Seca, A.M.L.; Barreto, M.C.; Pinto, D.C.G.A. 2013: Di- and sesquiterpenoids from Cystoseira genus: structure, intra-molecular transformations and biological activity. Mini Reviews in Medicinal Chemistry 13(8): 1150-1159
Olguín, J.; Kalisz, M.; Clérac, R.; Brooker, S. 2012: Di- and tetra-nuclear copper(II), nickel(II), and cobalt(II) complexes of four bis-tetradentate triazole-based ligands: synthesis, structure, and magnetic properties. Inorganic Chemistry 51(9): 5058-5069
Zhu, G.; Geletii, Y.V.; Song, J.; Zhao, C.; Glass, E.N.; Bacsa, J.; Hill, C.L. 2013: Di- and tri-cobalt silicotungstates: synthesis, characterization, and stability studies. Inorganic Chemistry 52(2): 1018-1024
Olšinová, M.; Jurkiewicz, P.; Pozník, M.; Šachl, R.; Prausová, T.; Hof, M.; Kozmík, V.ác.; Teplý, F.; Svoboda, J.ří; Cebecauer, M. 2014: Di- and tri-oxalkyl derivatives of a boron dipyrromethene (BODIPY) rotor dye in lipid bilayers. Physical Chemistry Chemical Physics: Pccp 16(22): 10688-10697
Kember, M.R.; White, A.J.P.; Williams, C.K. 2009: Di- and tri-zinc catalysts for the low-pressure copolymerization of CO2 and cyclohexene oxide. Inorganic Chemistry 48(19): 9535-9542
Chen, X.; Tan, Y.; Berionni, G.; Ofial, A.R.; Mayr, H. 2014: Di- and triarylmethylium ions as probes for the ambident reactivities of carbanions derived from 5-benzylated Meldrum's acid. Chemistry 20(35): 11069-11077
Lee, S.H.; Mok, H.; Park, T.G. 2011: Di- and triblock siRNA-PEG copolymers: PEG density effect of polyelectrolyte complexes on cellular uptake and gene silencing efficiency. Macromolecular Bioscience 11(3): 410-418
Dhiman, S.; Ramasastry, S.S.V. 2013: Di- and triheteroarylalkanes via self-condensation and intramolecular Friedel-Crafts type reaction of heteroaryl alcohols. Organic and Biomolecular Chemistry 11(46): 8030-8035
Fellah, F.Z.C.; Costes, J.-P.; Dahan, F.ço.; Duhayon, C.; Novitchi, G.; Tuchagues, J.-P.; Vendier, L. 2008: Di- and triheteronuclear Cu-Gd and Cu-Gd-Cu complexes with dissymmetric double bridge. Inorganic Chemistry 47(14): 6444-6451
Matsuo, Y.; Tahara, K.; Fujita, T.; Nakamura, E. 2009: Di- and trinuclear [70]fullerene complexes: syntheses and metal-metal electronic interactions. Angewandte Chemie 48(34): 6239-6241
Bestgen, S.; Gamer, M.T.; Lebedkin, S.; Kappes, M.M.; Roesky, P.W. 2015: Di- and trinuclear gold complexes of diphenylphosphinoethyl-functionalised imidazolium salts and their N-heterocyclic carbenes: synthesis and photophysical properties. Chemistry 21(2): 601-614
Bender, R.; Okio, C.; Welter, R.; Braunstein, P. 2009: Di- and trinuclear phosphido-bridged platinum complexes. Crystal structures of [Pt{CH(2)=CHC(O)OMe}(PPh(3))(2)], trans-[Pt(2)(micro-PPh(2))(2)I(2)(PPh(3))(2)] and cis,cis,cis-[Pt(3)(mu-I)(2)(mu-PPh(2))(2)Cl(0.5)I(1.5)(PPh(3))(2). Dalton Transactions 2009(25): 4901-4907
Zhang, B.; Wee, A.G.H. 2010: Di- and trisubstituted γ-lactams via Rh(II)-carbenoid reaction of N-Cα-branched, N-bis(trimethylsilyl)methyl α-diazoamides. Synthesis of (±)-α-allokainic acid. Organic Letters 12(23): 5386-5389
Vo, T.T.B.; Jung, E.-M.; Dang, V.H.; Yoo, Y.-M.; Choi, K.-C.; Yu, F.H.; Jeung, E.-B. 2009: Di-(2 ethylhexyl) phthalate and flutamide alter gene expression in the testis of immature male rats. Reproductive Biology and Endocrinology: Rb&e 7: 104
Li, N.; Liu, T.; Zhou, L.; He, J.; Ye, L. 2012: Di-(2-ethylhcxyl) phthalate reduces progesterone levels and induces apoptosis of ovarian granulosa cell in adult female ICR mice. Environmental Toxicology and Pharmacology 34(3): 869-875
Cao, X.-L.; Zhao, W.; Churchill, R.; Dabeka, R. 2013: Di-(2-ethylhexyl) adipate in selected total diet food composite samples. Journal of Food Protection 76(11): 1985-1988
Zhao, J.-F.; Hsiao, S.-H.; Hsu, M.-H.; Pao, K.-C.; Kou, Y.R.; Shyue, S.-K.; Lee, T.-S. 2016: Di-(2-ethylhexyl) phthalate accelerates atherosclerosis in apolipoprotein E-deficient mice. Archives of Toxicology 90(1): 181-190
Wu, W.-G.; Tang, Y.-J.; Sun, Z.-L. 2013: Di-(2-ethylhexyl) phthalate activates the apoptosis Caspase pathway in rat Leydig cells in vitro. Zhonghua Nan Ke Xue 19(8): 683-688
Han, Y.; Wang, X.; Chen, G.; Xu, G.; Liu, X.; Zhu, W.; Hu, P.; Zhang, Y.; Zhu, C.; Miao, J. 2014: Di-(2-ethylhexyl) phthalate adjuvantly induces imbalanced humoral immunity in ovalbumin-sensitized BALB/c mice ascribing to T follicular helper cells hyperfunction. Toxicology 324: 88-97
Testa, C.; Nuti, F.; Hayek, J.; De Felice, C.; Chelli, M.; Rovero, P.; Latini, G.; Papini, A.M. 2012: Di-(2-ethylhexyl) phthalate and autism spectrum disorders. Asn Neuro 4(4): 223-229
Zhang, T.; Li, L.; Qin, X.-S.; Zhou, Y.; Zhang, X.-F.; Wang, L.-Q.; De Felici, M.; Chen, H.; Qin, G.-Q.; Shen, W. 2014: Di-(2-ethylhexyl) phthalate and bisphenol a exposure impairs mouse primordial follicle assembly in vitro. Environmental and Molecular Mutagenesis 55(4): 343-353
Gupta, R.K.; Singh, J.M.; Leslie, T.C.; Meachum, S.; Flaws, J.A.; Yao, H.H-C. 2010: Di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro. Toxicology and Applied Pharmacology 242(2): 224-230
Matsuda, T.; Kurohane, K.; Imai, Y. 2010: Di-(2-ethylhexyl) phthalate enhances skin sensitization to isocyanate haptens in mice. Toxicology Letters 192(2): 97-100
Park, S.; Cheong, J.H.; Cho, S.-C.; Kim, J.-W.; Shin, M.-S.; Yoo, H.J.; Han, D.H.; Kim, B.-N. 2015: Di-(2-ethylhexyl) phthalate exposure is negatively correlated with trait anxiety in girls but not with trait anxiety in boys or anxiety-like behavior in male mice. Journal of Child Neurology 30(1): 48-52
Wu, S.-d.; Zhu, J.; Li, Y.-s.; Gan, L.-q.; Yuan, X.-g.; Xu, M.-d.; Wei, G.-h. 2009: Di-(2-ethylhexyl) phthalate increases the DNA methylation level of genomes in the mouse testis. Zhonghua Nan Ke Xue 15(10): 876-881
Nishioka, J.; Iwahara, C.; Kawasaki, M.; Yoshizaki, F.; Nakayama, H.; Takamori, K.; Ogawa, H.; Iwabuchi, K. 2012: Di-(2-ethylhexyl) phthalate induces production of inflammatory molecules in human macrophages. Inflammation Research: Official Journal of the European Histamine Research Society . 61(1): 69-78
Liu, X.; Zhang, D.-Y.; Li, Y.-S.; Xiong, J.; He, D.-W.; Lin, T.; Li, X.-L.; Wei, G.-H. 2009: Di-(2-ethylhexyl) phthalate upregulates ATF3 expression and suppresses apoptosis in mouse genital tubercle. Journal of Occupational Health 51(1): 57-63
Eveillard, A.; Mselli-Lakhal, L.ïl.; Mogha, A.; Lasserre, F.éd.ér.; Polizzi, A.; Pascussi, J.-M.; Guillou, H.é; Martin, P.G.P.; Pineau, T. 2009: Di-(2-ethylhexyl)-phthalate (DEHP) activates the constitutive androstane receptor (CAR): a novel signalling pathway sensitive to phthalates. Biochemical Pharmacology 77(11): 1735-1746
Ferri, M.; Marcella, F.; Chiellini, F.; Federica, C.; Pili, G.; Giorgio, P.; Grimaldi, L.; Luca, G.; Florio, E.Tiziana.; Pili, S.; Stefania, P.; Cucci, F.; Francesco, C.; Latini, G.; Giuseppe, L. 2012: Di-(2-ethylhexyl)-phthalate migration from irradiated poly(vinyl chloride) blood bags for graft-vs-host disease prevention. International Journal of Pharmaceutics 430(1-2): 86-88
Chen, S.-S.; Hung, H.-T.; Chen, T.-J.; Hung, H.-S.; Wang, D.-C. 2013: Di-(2-ethylhexyl)-phthalate reduces MyoD and myogenin expression and inhibits myogenic differentiation in C2C12 cells. Journal of Toxicological Sciences 38(5): 783-791
Latini, G.; De Felice, C.; Del Vecchio, A.; Barducci, A.; Ferri, M.; Chiellini, F. 2009: Di-(2-ethylhexyl)phthalate leakage and color changes in endotracheal tubes after application in high-risk newborns. Neonatology 95(4): 317-323
Zuo, H.X.; Li, J.Q.; Han, B.; Ke, C.J.; Liu, X.D.; Zhang, Y.C.; Li, L.; Yang, X. 2014: Di-(n-butyl)-phthalate-induced oxidative stress and depression-like behavior in mice with or without ovalbumin immunization. Biomedical and Environmental Sciences: Bes 27(4): 268-280
Grummitt, O. 1950: Di-(p-chlorophenyl)methylcarbinol, a new Miticide. Science 111(2884): 361-362
Lan, Y.; Novitchi, G.; Clérac, R.; Tang, J.-K.; Madhu, N.T.; Hewitt, I.J.; Anson, C.E.; Brooker, S.; Powell, A.K. 2009: Di-, tetra- and hexanuclear iron(III), manganese(II/III) and copper(II) complexes of Schiff-base ligands derived from 6-substituted-2-formylphenols. Dalton Transactions 10: 1721-1727
Ganesamoorthy, C.; Balakrishna, M.S.; Mague, J.T. 2009: Di-, tetra- and polynuclear RhI complexes containing phenylene-1,4-diaminotetra (phosphonite), p-C6H4[N{P(OC6H4OMe-o)2}2]2 and their catalytic investigation towards transfer hydrogenation reactions. Dalton Transactions 2009(11): 1984-1990
Sahoo, D.; Suriyanarayanan, R.; Chandrasekhar, V. 2014: Di-, tri- and tetranuclear molecular vanadium phosphonates: a chloride encapsulated tetranuclear bowl. Dalton Transactions 43(28): 10898-10909
Giese, M.; Albrecht, M.; Steike, S.; Ackermann, A.; Valkonen, A.; Rissanen, K. 2013: Di-, tri-, and tetra(pentafluorophenyl) derivatives for oligotopic anion-π interactions. Inorganic Chemistry 52(13): 7666-7672
Liu, B.; Pan, S.; Liu, B.; Chen, W. 2014: Di-, tri-, and tetranuclear copper(I) complexes of phenanthroline-linked dicarbene ligands. Inorganic Chemistry 53(19): 10485-10497
Das, L.K.; Biswas, A.; Kinyon, J.S.; Dalal, N.S.; Zhou, H.; Ghosh, A. 2013: Di-, tri-, and tetranuclear nickel(II) complexes with oximato bridges: magnetism and catecholase-like activity of two tetranuclear complexes possessing rhombic topology. Inorganic Chemistry 52(20): 11744-11757
Murugavel, R.; Kuppuswamy, S.; Maity, A.N.; Singh, M.P. 2009: Di-, tri-, tetra-, and hexanuclear copper(II) mono-organophosphates: structure and nuclearity dependence on the choice of phosphorus substituents and auxiliary N-donor ligands. Inorganic Chemistry 48(1): 183-192
Foss, O. 1947: Di-0-alkylmonothiophosphates and Di-0-alkylmonoselenophosphates and the corresponding pseudohalogens. Acta Chemica Scandinavica 1(1): 8-31
Ma, H.; Li, J.; Yang, J.-J.; Tian, W.-C.; Liu, H.; Zhou, Y.-Z.; Zhang, W.-T.; Zhao, P. 2012: Di-2-ethylhexyl phthalate and its metabolite single-ethylhexyl phthalate affect TGF-beta 1 expression and telomerase activity in the testis of young male rats. Zhonghua Nan Ke Xue 18(9): 783-788
Zhang, C.; Yuan, L.; Liu, J.-Y.; Xu, W. 2009: Di-2-pyridyl disulfide-succinic acid (1/1). Acta Crystallographica. Section e Structure Reports Online 65(Part 6): O1213
Ordoñez, M.S.; de Torres, A.G.; Pavon, J.M. 1985: Di-2-pyridyl ketone 2-furoylhydrazone as a reagent for the fluorimetric determination of low concentrations of aluminium. Talanta 32(9): 887-891
Afrati, T.; Zaleski, C.M.; Dendrinou-Samara, C.; Mezei, G.; Kampf, J.W.; Pecoraro, V.L.; Kessissoglou, D.P. 2007: Di-2-pyridyl ketone oxime in copper chemistry: di-, tri-, penta- and hexanuclear complexes. Dalton Transactions 25: 2658-2668
Stamatatos, T.C.; Tangoulis, V.; Raptopoulou, C.P.; Terzis, A.; Papaefstathiou, G.S.; Perlepes, S.P. 2008: Di-2-pyridyl ketone/benzoate/azide combination as a source of copper(II) clusters and coordination polymers: dependence of the product identity on the solvent. Inorganic Chemistry 47(18): 7969-7971
Liu, N.; Tengstrand, E.A.; Chourb, L.; Hsieh, F.Y. 2014: Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment. Toxicology and Applied Pharmacology 279(3): 467-476
Wang, D.-J.; Zhao, J.-M.; Zhang, J.; Lin, J.-L. 2009: Di-4-pyridyl disulfide-isophthalic acid (1/1). Acta Crystallographica. Section e Structure Reports Online 65(Part 5): O1055
Qin, J.-H.; Li, X.-D.; Wang, J.-G. 2008: Di-4-pyridyl sulfide-isophthalic acid (1/1). Acta Crystallographica. Section e Structure Reports Online 64(Part 12): O2279
Knapp, W.R.; Laduca, R.L. 2008: Di-4-pyridylmethane-diol. Acta Crystallographica. Section E Structure Reports Online 64(Part 7): O1347
Robinson, D.; Besley, N.A.; O'Shea, P.; Hirst, J.D. 2011: Di-8-ANEPPS emission spectra in phospholipid/cholesterol membranes: a theoretical study. Journal of Physical Chemistry. B 115(14): 4160-4167
Tucker, M.J.; Abdo, M.; Courter, J.R.; Chen, J.; Smith, A.B.; Hochstrasser, R.M. 2012: Di-Cysteine S,S-Tetrazine: A Potential Ultra-fast Photochemical Trigger to Explore the Early Events of Peptide/Protein Folding. Journal of Photochemistry and Photobiology. A Chemistry 234: 156-163
Arribas, B.én.; Suárez-Pereira, E.; Ortiz Mellet, C.; García Fernández, J.é M.; Buttersack, C.; Rodríguez-Cabezas, M.E.; Garrido-Mesa, N.; Bailon, E.; Guerra-Hernández, E.; Zarzuelo, A.; Gálvez, J. 2010: Di-D-fructose dianhydride-enriched caramels: effect on colon microbiota, inflammation, and tissue damage in trinitrobenzenesulfonic acid-induced colitic rats. Journal of Agricultural and Food Chemistry 58(10): 6476-6484
Lee, Y.S.; Kim, Y.-J.; Choi, S.H.; Shin, K.H.; Jang, W.S.; Lee, I.H.; Chung, J.W. 2010: Di-K19Hc, an antimicrobial peptide as new ototopical agent for treatment of otitis media. Acta Oto-Laryngologica 130(8): 897-903
Al-Mutairi, N.F.; Al-Omran, Y.A.; Parameaswari, P.J. 2017: Breastfeeding practice and knowledge among women attending primary health-care centers in Riyadh 2016. Journal of Family Medicine and Primary Care 6(2): 392-398
Zhang, X.; Dong, C.; Wu, Q.J.; Balch, W.E.; Wu, G. 2011: Di-acidic motifs in the membrane-distal C termini modulate the transport of angiotensin Ii receptors from the endoplasmic reticulum to the cell surface. Journal of Biological Chemistry 286(23): 20525-20535
Monds, R.D.; Newell, P.D.; Wagner, J.C.; Schwartzman, J.A.; Lu, W.; Rabinowitz, J.D.; O'Toole, G.A. 2010: Di-adenosine tetraphosphate (Ap4A) metabolism impacts biofilm formation by Pseudomonas fluorescens via modulation of c-di-GMP-dependent pathways. Journal of Bacteriology 192(12): 3011-3023
Messina, M.J. 2011: Di-ag-KNOW-sis. Hda now 2011: 28-29
Ben Haj Hassen, L.; Ezzayani, K.; Rousselin, Y.; Nasri, H. 2014: Di-aqua-[5,10,15,20-tetra-kis-(4-chloro-phen-yl)porphyrinato-κ(4) N]iron(III) tri-fluoro-methane-sulfonate-4-hy-droxy-3-meth-oxy-benzaldehyde-water (1/1/2). Acta Crystallographica. Section E Structure Reports Online 70(Part 8): M296-M297
Purdy, A.P.; Butcher, R.J. 2014: Di-aqua-bis-(2-ethyl-5-methyl-imidazole-4-sulfonato-κ(2) N (3),O)nickel(II) dihydrate. Acta Crystallographica. Section E Structure Reports Online 70(Part 1): M18-M19
Bozkurt, N.; Dilek, N.; Caylak Delibaş, N.; Necefoğlu, H.; Hökelek, T. 2013: Di-aqua-bis-(3-chloro-benzoato-κO)bis-(nicotinamide-κN (1))cobalt(II). Acta Crystallographica. Section E Structure Reports Online 69(Part 6): M349-M350
Chooset, S.; Cunningham, B.; Kantacha, A.; Zeller, M.; Wongnawa, S. 2014: Di-aqua-bis-(cinnamato-κ(2) O,O')cadmium. Acta Crystallographica. Section E Structure Reports Online 70(Part 3): M106-M107
Direm, A.; Falek, W.; Pilet, G.; Benali-Cherif, N. 2014: Di-aqua-bis-(ethyl-enedi-amine-κ(2) N,N')copper(II) bis-(sulfamerazinate). Acta Crystallographica. Section E Structure Reports Online 70(Part 6): M222-M223
Pandey, D.; Narvi, S.S.; Mehrotra, G.K.; Butcher, R.J. 2014: Di-aqua-bis-(nicotinamide-κN (1))bis-(thio-cyanato-κN)nickel(II). Acta Crystallographica. Section E Structure Reports Online 70(Part 5): M183
Pandey, D.; Narvi, S.S.; Chaudhuri, S. 2014: Di-aqua-bis-(nicotinamide-κN (1))bis-(thiocyanato-κS)cobalt(II). Acta Crystallographica. Section E Structure Reports Online 70(Part 6): M236
Croitor, L.; Chisca, D.; Coropceanu, E.B.; Fonari, M.S. 2013: Di-aqua-bis-(pyridine-2-carboxyl-ato-κ(2) N,O)zinc di-methyl-formamide hemisolvate. Acta Crystallographica. Section E Structure Reports Online 69(Part 8): M454
Zeghouan, O.; Guenifa, F.; Hadjadj, N.; Bendjeddou, L.; Merazig, H. 2013: Di-aqua-bis-[2-(2-hy-droxy-eth-yl)pyridine-κ(2) N,O]cobalt(II) dichloride. Acta Crystallographica. Section E Structure Reports Online 69(Part 8): M439-M440
Bensegueni, M.A.; Cherouana, A.; Dahaoui, S.; Boudraa, I. 2014: Di-aqua-bis-[5-(2-pyrazin-2-yl)tetra-zolato]copper(II)-pyrazine-2-carbo-nitrile (1/2). Acta Crystallographica. Section e Structure Reports Online 70(Part 3): M80-M81
Wang, Y.-N.; Dong, W.-W. 2014: Di-aqua-bis-[5-(pyrazin-2-yl-κN (1))-3-(pyridin-3-yl)-1,2,4-triazolido-κN (1)]zinc. Acta Crystallographica. Section e Structure Reports Online 70(Part 4): M116
Kovalchukova, O.; Bostanabad, A.S.; Stash, A.; Strashnova, S.; Zyuzin, I. 2014: Di-aqua-bis-[N-(2-fluoro-benz-yl)-N-nitroso-hydroxy-laminato-κ(2) O,O']nickel(II). Acta Crystallographica. Section e Structure Reports Online 70(Part 3): M98-M99
Kannan, P.S.; Ganeshraja, A.S.; Anbalagan, K.; Govindan, E.; Subbiahpandi, A. 2013: Di-aqua-dichlorido-bis-(pyridine-κN)cobalt(II). Acta Crystallographica. Section E Structure Reports Online 69(Part 9): M508-M509
Seredyuk, M.; Pavlenko, V.A.; Znovjyak, K.O.; Gumienna-Kontecka, E.; Iskenderov, T.S. 2013: Di-aqua-sesqui(nitrato-κO)hemi(perchlorato-κO)copper(II)]-μ-{bis-[5-methyl-3-(pyridin-2-yl)-1H-pyrazol-4-yl] selenide}-[tri-aqua-(perchlorato-κO)copper(II)] nitrate monohydrate. Acta Crystallographica. Section E Structure Reports Online 69(Pt 6): M314-M315
Kayalvizhi, M.; Vasuki, G.; Kaabi, K.; Ben Nasr, C. 2013: Di-aqua-tetra-kis-(1H-imidazole-κN (3))magnesium dichloride. Acta Crystallographica. Section E Structure Reports Online 69(Part 9): M481
Datta, A.; Machura, B.; Huang, J-Hsien.; Sheu, S-Cherng. 2013: Di-aqua-{2,2'-dimeth-oxy-6,6'-[(1E,1'E)-propane-1,3-diylbis(aza-nylyl-idene)bis-(methanylyl-idene)]diphenolato}nickel(II). Acta Crystallographica. Section E Structure Reports Online 69(Pt 7): M399
Nimthong, R.; Thepsena, N.; Puetpaiboon, W.; Wattanakanjana, Y. 2014: Di-aqua-{μ2-N,N'-bis-[(cyclo-hexa-nyl-idene)amino]-oxamide}-bis-(tri-phenyl-phosphane)silver(I) dinitrate. Acta Crystallographica. Section E Structure Reports Online 70(Pt 2): M30-M31
Ercan, E.; Chung, S.-H.; Bhardwaj, R.; Seedorf, M. 2012: Di-arginine signals and the K-rich domain retain the Ca²⁺ sensor STIM1 in the endoplasmic reticulum. Traffic 13(7): 992-1003
Liu, B.-C.; Jin, Y.-L.; Liu, F.-Q. 2013: Di-bromido-bis-(2-methyl-1H-benzimidazole-κN (3))cadmium. Acta Crystallographica. Section e Structure Reports Online 69(Part 10): M536
Kostka, G.; Urbanek-Olejnik, K.; Wiadrowska, B. 2010: Di-butyl phthalate-induced hypomethylation of the c-myc gene in rat liver. Toxicology and Industrial Health 26(7): 407-416
Schorer, M.; Debache, K.; Barna, F.; Monney, T.; Müller, J.; Boykin, D.W.; Stephens, C.E.; Hemphill, A. 2012: Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice. International Journal for Parasitology. Drugs and Drug Resistance 2: 109-120
Gutiérrez-Márquez, R.A.; Crisóstomo-Lucas, C.; Reyes-Martínez, R.; Hernández-Ortega, S.ón.; Morales-Morales, D. 2014: Di-chlorido-(4,4'-di-tert-butyl-2,2'-bi-pyridine-κ(2) N,N')palladium(II) dimethyl sulfoxide monosolvate monohydrate. Acta Crystallographica. Section e Structure Reports Online 70(Part 6): M200-M201
Faizi, M.Serajul.Haque.; Sen, P. 2014: Di-chlorido-(4-{[(quinolin-2-yl)methyl-idene]amino}phenol-κ(2) N,N')mercury(II). Acta Crystallographica. Section E Structure Reports Online 70(Pt 5): M173
Soury, R.; Belkhiria, M.S.; Giorgi, M.; Nasri, H. 2014: Di-chlorido-(5,10,15,20-tetra-phenyl-porphyrinato-κ(4) N)anti-mony(V) hexa-chlorido-anti-monate(V). Acta Crystallographica. Section e Structure Reports Online 70(Part 7): M256-M257
Faizi, M.Serajul.Haque.; Hussain, S. 2014: Di-chlorido-(N,N-diethyl-4-{[(quinolin-2-yl)methyl-idene]amino-κ(2) N,N'}aniline)mercury(II). Acta Crystallographica. Section E Structure Reports Online 70(Pt 6): M197
Oda, K.; Funahashi, Y.; Masuda, H. 2013: Di-chlorido-[6,8,22,24,34,36-hexa-methyl-33,35-diaza-3,11,19,27-tetra-azonia-penta-cyclo[,9).1(13,17).1(21,25)]hexa-triaconta-1(33),5,7,9(34),13,15,17(35),21,23,25(36),29,31-dodeca-ene-κ(6) N (3),N (11),N (19),N (27),N (33),N (35)]dipalladium(II) bis(per-chlor-ate) N,N-di-methyl-formamide disolvate methanol disolvate. Acta Crystallographica. Section E Structure Reports Online 69(Part 9): M520-M521
Bolotin, D.S.; Bokach, N.A.; Haukka, M. 2014: Di-chlorido-[N-(N,N-di-methyl-carbamimido-yl)-N',N',4-tri-methyl-benzohydrazonamide]-platinum(II) nitro-methane hemisolvate. Acta Crystallographica. Section E Structure Reports Online 70(Part 4): M131-M132
Zhang, Y.; Lin, Z. 2013: Di-chlorido-bis-[1-(2,4,6-tri-methyl-phen-yl)-1H-imidazole-κN (3)]copper(II). Acta Crystallographica. Section E Structure Reports Online 69(Part 11): M621
Sow, Y.; Diop, L.; Fernandes, M.A.; Stoeckli-Evans, H. 2014: Di-chlorido-dimethyl-bis-(thio-urea-κS)tin(IV). Acta Crystallographica. Section E Structure Reports Online 70(Part 3): M83
Sow, Y.; Diop, L.; Molloy, K.C.; Kociok-Köhn, G. 2013: Di-chlorido-diphenyl-bis-(thio-urea-κS)tin(IV). Acta Crystallographica. Section E Structure Reports Online 69(Part 10): M539-M540
Aiswarya, N.; Sithambaresan, M.; Kurup, M.R.Prathapachandra.; Ng, S.Weng. 2013: Di-chlorido-{2-[(E)-phen-yl(pyridin-2-yl-κN)methyl-idene]-N-phenyl-hydra-zine-carboxamide-κ(2) N (2),O}copper(II). Acta Crystallographica. Section E Structure Reports Online 69(Pt 11): M588-M589
Al-Sudani, A-Razak.H. 2014: Di-chlorido-{8-[2-(di-methyl-amino)-ethyl-amino]-quinoline-κ(3) N,N',N''}zinc. Acta Crystallographica. Section E Structure Reports Online 70(Pt 1): M1
Nguyen, M.N.; Ma, J.; Fogel, G.B.; Rajapakse, J.C. 2009: Di-codon usage for classification of genes. Bio Systems 98(1): 1-6
Held, P. 2014: Di-ethyl-ammonium di-hydrogen orthophosphate. Acta Crystallographica. Section E Structure Reports Online 70(Part 2): O129
Sims, J.N.; Graham, B.; Pacurari, M.; Leggett, S.S.; Tchounwou, P.B.; Ndebele, K. 2014: Di-ethylhexylphthalate (DEHP) modulates cell invasion, migration and anchorage independent growth through targeting S100P in LN-229 glioblastoma cells. International Journal of Environmental Research and Public Health 11(5): 5006-5019
Joshi, T.; Patra, M.; Spiccia, L.; Gasser, G. 2013: Di-heterometalation of thiol-functionalized peptide nucleic acids. Artificial Dna Pna and Xna 4(1): 11-18
Mireille Ninon, M.O.; Fahim, M.; Lachkar, M.; Marco Contelles, J.é L.; Perles, J.; El Bali, B. 2013: Di-hydro-cyclam dimaleate [H2(cyclam)(maleate)2. Acta Crystallographica. Section e Structure Reports Online 69(Part 10): O1574-O1575
Zhang, D.; Cao, X.; Purkiss, D.W.; Bartsch, R.A. 2007: Di-ionizable p-tert-butylcalix[4]arene-1,2-crown-3 ligands in cone and 1,2-alternate conformations: synthesis and metal ion extraction. Organic and Biomolecular Chemistry 5(8): 1251-1259
Justino, M.C.; Baptista, J.M.; Saraiva, L.íg.M. 2009: Di-iron proteins of the Ric family are involved in iron-sulfur cluster repair. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 22(1): 99-108
Quilliam, J.P. 1947: Di-iso propylfluorophosphonate (DFP) its pharmacology and its therapeutic uses in glaucoma and myasthenia gravis. Postgraduate Medical Journal 23(260): 280-282
Leopold, I.H.; McDONALD, P.R. 1948: Di-isopropyl fluorophosphate in treatment of glaucoma; further observations. Archives of Ophthalmology 40(2): 176-188
Himwich, H.E.; Freedman, A.M. 1948: Di-isopropyl fluorophosphate; site of injection and variation in response. Federation Proceedings 7(1 Pt 1): 55
Mendel, B.; Hawkins, R.D. 1947: Di-isopropyl fluorophosphonate as a selective inhibitor of pseudocholinesterase. Biochemical Journal 41(2): Xxii
Arneil, G.C.; Douglas, A.S. 1949: Di-isopropyl fluorophosphonate as an intestinal carminative. Lancet 2(6578): 556
Freedman, A.M.; Himwich, H.E. 1949: Di-isopropyl flurophosphate; site of injection and variation in response. American Journal of Physiology 156(1): 125-128
Sugiura, K.; Sugiura, M. 2009: Di-isostearyl malate and macademia nut oil in lipstick caused cheilitis. Journal of the European Academy of Dermatology and Venereology: Jeadv 23(5): 606-607
Noronha, J.; Gyulassy, M.; Torrieri, G. 2009: Di-jet conical correlations associated with heavy quark jets in anti-de sitter space/conformal field theory correspondence. Physical Review Letters 102(10): 102301
Yang, T.; Zhao, X.; Nagase, S. 2011: Di-lanthanide encapsulated into large fullerene C100: a DFT survey. Physical Chemistry Chemical Physics: Pccp 13(11): 5034-5037
Benelli, C.; Borgogelli, E.; Formica, M.; Fusi, V.; Giorgi, L.; Macedi, E.; Micheloni, M.; Paoli, P.; Rossi, P. 2013: Di-maltol-polyamine ligands to form heterotrinuclear metal complexes: solid state, aqueous solution and magnetic characterization. Dalton Transactions 42(16): 5848-5859
Greeson, N.T.; Sengupta, R.; Arida, A.R.; Jenuwein, T.; Sanders, S.L. 2008: Di-methyl H4 lysine 20 targets the checkpoint protein Crb2 to sites of DNA damage. Journal of Biological Chemistry 283(48): 33168-33174
Held, P. 2014: Di-methyl-ammonium tetra-aqua-(hydrogen-sulfato)-sulfato-cuprate(II). Acta Crystallographica. Section E Structure Reports Online 70(Part 4): M119
Sahin, Z.S.; Içbudak, H.; Işik, S. 2009: Di-mu-acesulfamato-kappa3N,O:O;kappa3O:N,O-bis[(acesulfamato-kappa2N,O)bis(3-methylpyridine)cadmium(II). Acta Crystallographica. Section C Crystal Structure Communications 65(Part 12): M463-M465
Li, R.; Zhao, P.; Tang, G.; Tang, X. 2008: Di-mu-chlorido-bis({2-[1-(2-pyridylethylimino)ethyl]pyrrolato-kappa3N,N',N''}copper(II)). Acta Crystallographica. Section C Crystal Structure Communications 64(Pt 10): M339-M341
Chen, Y.L.; Li, B.Z.; Yang, P.; Wu, J.Z. 2009: Di-mu-chlorido-bis[chlorido(4'-p-tolyl-2,2':6',2''-terpyridine-kappa3N,N',N'')nickel(II)]: a supramolecular system constructed by C-H...Cl interactions. Acta Crystallographica. Section C Crystal Structure Communications 65(Part 7): M238-M240
García, A.María.; Manzur, J.; Vega, Aés. 2007: Di-mu-hydroxido-bis{[bis(6-methyl-2-pyridylmethyl)(2-phenylethyl)amine-kappa(3)N',N'',N''']copper(II)} bis(perchlorate). Acta Crystallographica. Section C Crystal Structure Communications 63(Pt 7): M335-M337
Nielsen, A.; McKenzie, C.J.; Bond, A.D. 2009: Di-mu-oxido-bis{bis[N,N'-bis(2-pyridylmethyl)ethane-1,2-diamine]manganese(III,IV)} tris(perchlorate) hexahydrate: clarification of an order-disorder phase transition. Acta Crystallographica. Section C Crystal Structure Communications 65(Pt 11): M447-M450
Gielen, M.; Ma, H.; Bouhdid, A.; Dalil, H.; Biesemans, M.; Willem, R. 1997: Di-n-Butyl-, Tri-n-Butyl- and Triphenyltin dl-Terebates: Synthesis, Characterization and in Vitro Antitumour Activity. Metal-Based Drugs 4(4): 193-197
Wang, L.-J.; Hu, S.-Q.; Guo, Q.-L.; Yang, G.-L.; Chen, X.-G. 2011: Di-n-amyl L-tartrate-boric acid complex chiral selector in situ synthesis and its application in chiral nonaqueous capillary electrophoresis. Journal of Chromatography. a 1218(9): 1300-1309
Qiao, Y.; Wang, F. 2013: Di-n-but-yl[4-hy-droxy-N'-(3-meth-oxy-2-oxido-benzyl-idene-κO (2))benzo-hydrazidato-κ(2) N,O]tin(IV). Acta Crystallographica. Section E Structure Reports Online 69(Part 12): M675
Affan, M.Abu.; Chee, D.N.A.Chee.; Assim, Z.; Ng, S.Weng. 2010: Di-n-but-yl{1-[1-(2-hydroxy-phen-yl)ethyl-idene]-5-[1-(2-oxidophen-yl)ethyl-idene]thio-carbazonato-κO,N,S}tin(IV). Acta Crystallographica. Section E Structure Reports Online 66(Pt 6): M618-M619
Affan, M.Abu.; Sam, N.; Ahmad, F.; Ng, S.Weng. 2010: Di-n-but-yl{4-hydr-oxy-N'-[(2-oxido-1-naphthyl-κO)methyl-ene]benzo-hydrazidato-κO,N'}tin(IV). Acta Crystallographica. Section E Structure Reports Online 66(Pt 5): M572
Rivera, A.; Quiroga, D.; Ríos-Motta, J.; Fejfarová, K.; Dušek, M. 2011: Di-n-butyl 4,4'-dihy-droxy-3,3'-{[(3aRS,7aRS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-1,3-benzimidazole-1,3-di-yl]bis-(methyl-ene)}dibenzoate. Acta Crystallographica. Section E Structure Reports Online 67(Pt 9): O2297
Zhou, T.; Zhou, R.-J.; An, Z. 2009: Di-n-butyl 5-amino-isophthalate. Acta Crystallographica. Section e Structure Reports Online 65(Part 8): O1754
Perricos, D.C.; Tsolis, A.K.; Belkas, E.P. 1970: Di-n-butyl carbamoylphosphonate as an extradant of inorganic ions from hydrochloric acid solutions. Talanta 17(6): 551-553
Zhou, D.; Wang, H.; Zhang, J.; Gao, X.; Zhao, W.; Zheng, Y. 2010: Di-n-butyl phthalate (DBP) exposure induces oxidative damage in testes of adult rats. Systems Biology in Reproductive Medicine 56(6): 413-419
Zhou, D.; Wang, H.; Zhang, J. 2011: Di-n-butyl phthalate (DBP) exposure induces oxidative stress in epididymis of adult rats. Toxicology and Industrial Health 27(1): 65-71
Bhatia, H.; Kumar, A.; Ogino, Y.; Gregg, A.; Chapman, J.; McLaughlin, M.J.; Iguchi, T. 2014: Di-n-butyl phthalate causes estrogenic effects in adult male Murray rainbowfish (Melanotaenia fluviatilis). Aquatic Toxicology 149: 103-115
Mansor, S.; Yehye, W.A.; Ariffin, A.; Rahman, N.A.; Ng, S.W. 2008: Di-n-butyl-ammonium 2-(3,5-di-tert-butyl-4-hydroxy-benzyl-sulfan-yl)nicotinate. Acta Crystallographica. Section e Structure Reports Online 64(Part 9): O1799
Alhadi, A.A.; Khaledi, H.; Mohd Ali, H.; Olmstead, M.M. 2010: Di-n-butyl-ammonium 2-[(3,5-di-tert-butyl-4-hy-droxy-benz-yl)sulfan-yl]benzoate. Acta Crystallographica. Section E Structure Reports Online 66(Part 9): O2454
Baba, I.; Dzulkefli, N.N.; Ng, S.W. 2009: Di-n-butyl-bis(N-n-butyl-N-ethyl-dithio-carbamato-κS)tin(IV). Acta Crystallographica. Section e Structure Reports Online 65(Part 5): M594
Awang, N.; Baba, I.; Yamin, B.M.; Ng, S.W. 2010: Di-n-butyl-bis-(N-cyclo-hexyl-N-ethyl-dithio-carbamato-κS,S')tin(IV). Acta Crystallographica. Section e Structure Reports Online 66(Part 8): M938
Kamaludin, N.F.; Baba, I.; Awang, N.; Mohamed Tahir, M.I.; Tiekink, E.R.T. 2012: Di-n-butyl-bis-(N-ethyl-N-phenyl-dithio-carbamato-κS)tin(IV). Acta Crystallographica. Section e Structure Reports Online 68(Part 1): M79-M80
Najafi, E.; Amini, M.M.; Ng, S.W. 2011: Di-n-butyl-bis-(thio-cyanato-κN)(1,10-phenanthroline-κN,N')tin(IV). Acta Crystallographica. Section e Structure Reports Online 67(Part 2): M210
Joshi, A.; Verma, S.; Gaurb, R.B.; Sharma, R.R. 2005: Di-n-butyltin(IV) complexes derived from heterocyclic beta-diketones and N-phthaloyl amino acids: preparation, biological evaluation, structural elucidation based upon spectral [IR, NMR (1H, 13C, 19F and 119Sn)] studies. Bioinorganic Chemistry and Applications 2005: 201-215
Rivera, A.; Quiroga, D.; Ríos-Motta, J.; Fejfarová, K.; Dušek, M. 2011: Di-n-propyl 4,4'-dihy-droxy-3,3'-{[(3aRS,7aRS)-2,3,3a,4,5,6,7,7a-octa-hydro-1H-benzimidazole-1,3-di-yl]bis-(methyl-ene)}dibenzoate. Acta Crystallographica. Section E Structure Reports Online 67(Pt 10): O2627-O2628
Jayanthiny, P.; Tennekoon, K.H.; Karunanayake, E.H.; Kumarasiri, J.M.; Wijesundera, A.P.D.S. 2011: Di-nucleotide repeat polymorphisms of the insulin-like growth factor-1 gene and their association with IGF-1, insulin-like growth factor-binding protein-1 and birth size in a Sri-Lankan cohort. Neonatology 100(1): 37-43
Efrat, M.; Rosenblat, M.; Mahmood, S.; Vaya, J.; Aviram, M. 2009: Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies. Atherosclerosis 202(2): 461-469
Cicek, F.A.; Amber, C.F.; Tokcaer-Keskin, Z.; Zeynep, T.-K.; Ozcinar, E.; Evren, O.; Bozkus, Y.; Yusuf, B.; Akcali, K.C.; Can, A.K.; Turan, B.; Belma, T. 2014: Di-peptidyl peptidase-4 inhibitor sitagliptin protects vascular function in metabolic syndrome: possible role of epigenetic regulation. Molecular Biology Reports 41(8): 4853-4863
Mendoza, C.; Benet-Buchholz, J.; Pericás, M.A.; Vilar, R.ón. 2009: Di-platinum complexes containing thiolato-urea ligands: structural and anion binding studies. Dalton Transactions 16: 2974-2985
Jiang, L.; Shen, C.; Dai, J.; Meng, Q. 2013: Di-rhamnolipids improve effect of trehalose on both hypothermic preservation and cryopreservation of rat hepatocytes. Applied Microbiology and Biotechnology 97(10): 4553-4561
Malamas, M.S.; Barnes, K.; Johnson, M.; Hui, Y.; Zhou, P.; Turner, J.; Hu, Y.; Wagner, E.; Fan, K.; Chopra, R.; Olland, A.; Bard, J.; Pangalos, M.; Reinhart, P.; Robichaud, A.J. 2010: Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitors. Bioorganic and Medicinal Chemistry 18(2): 630-639
Kompanje, E.J.O. 2009: Di-symmetric cephalopagus conjoined twins described by Hovorakova et al.: some additions and corrections. Reproductive Toxicology 27(2): 203-5; Author Reply 206-7
Ali, Q.; Anis, I.; Raza Shah, M.; Ng, S.W. 2011: Di-tert-Butyl 2,2'-[2,2'-methyl-enebis(naphthalene-2,1-diyldi-oxy)]diacetate. Acta Crystallographica. Section e Structure Reports Online 67(Part 2): O533
Mustafa, A.; Shah, M.R.; Khatoon, M.; Ng, S.W. 2009: Di-tert-butyl (1,1'-binaphthyl-2,2'-di-oxy)diacetate. Acta Crystallographica. Section e Structure Reports Online 65(Part 4): O912
Hixson, J.L.; Taylor, D.K.; Ng, S.Weng.; Tiekink, E.R.T. 2012: Di-tert-butyl (2R,3R)-2-{[(2E)-3-(4-acet-yloxy-3-meth-oxy-phen-yl)prop-2-eno-yl]-oxy}-3-hy-droxy-butane-dioate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 3): O568-O569
Bai, X.-G.; Yang, X.-Y.; Wang, J.-X. 2014: Di-tert-butyl 1-[2-hy-droxy-3-(methyl-sulfan-yl)prop-yl]hydrazine-1,2-di-carboxyl-ate. Acta Crystallographica. Section e Structure Reports Online 70(Part 8): O843
Ali, Q.; Ibad, F.; Shah, M.R.; Vanderveer, D. 2008: Di-tert-butyl 2,2'-(biphenyl-2,2'-diyl-dioxy)diacetate. Acta Crystallographica. Section e Structure Reports Online 64(Part 8): O1408
Yang, Y.; Zhu, L.; Zhang, H. 2009: Di-tert-butyl 2,2'-[(2-hydroxy-ethyl)aza-nedi-yl]diacetate. Acta Crystallographica. Section E Structure Reports Online 65(Part 12): O3167
Ali, Q.; Yousuf, S.; Raza Shah, M.; Ng, S.W. 2010: Di-tert-butyl 2,2'-[(biphenyl-4,4'-diyl)-dioxy]diacetate. Acta Crystallographica. Section e Structure Reports Online 66(Part 7): O1739
Afrakssou, Z.; Rodi, Y.K.; Saffon, N.; Essassi, E.M.; Ng, S.W. 2011: Di-tert-butyl 2,6,11-trioxo-2,3-dihydro-1H-anthra[1,2-d]imidazole-1,3-diacetate. Acta Crystallographica. Section e Structure Reports Online 67(Part 7): O1730
Didierjean, C.; Brosse, N.; Bodiguel, J.; Jamart-Grégoire, B. 2007: Di-tert-butyl 2-benzoyl-hydrazine-1,1-dicarboxyl-ate. Acta Crystallographica. Section E Structure Reports Online 64(Part 1): O205
Wang, K.; Li, Y.-J.; Zhang, T.-T.; Liang, H.-Z. 2009: Di-tert-butyl 3,3'-(2,2'-bi-1H-imidazole-1,1'-di-yl)dipropanoate. Acta Crystallographica. Section e Structure Reports Online 65(Part 7): O1577
Zhang, Z.-P.; Wu, W.-N. 2012: Di-tert-butyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxyl-ate. Acta Crystallographica. Section e Structure Reports Online 68(Part 7): O2133
Kendhale, A.M.; Gonnade, R.G.; Sanjayan, G.J. 2008: Di-tert-butyl N,N'-(octa-hydro-penta-lene-2,5-di-yl)dicarbamate. Acta Crystallographica. Section E Structure Reports Online 64(Part 6): O1149
Capuano, B.; Crosby, I.T.; Forsyth, C.M.; Khakham, Y.; Manallack, D.T. 2009: Di-tert-butyl N-[2,6-bis-(methoxy-meth-oxy)phen-yl]imino-diacetate. Acta Crystallographica. Section E Structure Reports Online 65(Part 4): O819
François, A.; Marty, L.; Picard, C.; Mallet-Ladeira, S.; Benoist, E. 2012: Di-tert-butyl N-{[1-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl]methyl}iminodiacetate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 11): O3162
Ali, S.N.; Winnik, M.A.; Begum, S.; Lough, A.J. 2009: Di-tert-butyl cyclo-hex-2-ene-1,4-diyl dicarbonate. Acta Crystallographica. Section e Structure Reports Online 65(Part 11): O2690
Peng, H.; Yu, J.-T.; Jiang, Y.; Yang, H.; Cheng, J. 2014: Di-tert-butyl peroxide-promoted α-alkylation of α-amino carbonyl compounds by simple alkanes. Journal of Organic Chemistry 79(20): 9847-9853
Muthalib, A.F.; Baba, I.; Samsudin, M.W.; Ng, S.W. 2010: Di-tert-butyl-bis(N-isopropyl-N-methyl-dithio-carbamato-κS,S')tin(IV). Acta Crystallographica. Section e Structure Reports Online 66(Part 4): M356
Abdul Muthalib, A.F.; Baba, I.; Mohamed Tahir, M.I.; Tiekink, E.R.T. 2011: Di-tert-butyl-chlorido(N,N-dibenzyl-dithio-carbamato)tin(IV). Acta Crystallographica. Section e Structure Reports Online 67(Part 3): M386
Li, F.; Li, Y.; Harrison, W.T.A.; Wang, W.; Feng, Y. 2007: Di-tert-butyl-chlorido(pyrrolidine-1-dithio-carboxyl-ato-κS,S')tin(IV). Acta Crystallographica. Section E Structure Reports Online 64(Part 1): M87
Liang, H.; Hu, L.; Corey, E.J. 2011: Di-tert-butylisobutylsilyl, another useful protecting group. Organic Letters 13(15): 4120-4123
Sato, T.; Imamura, A.; Ando, H.; Ishida, H.; Kiso, M. 2009: Di-tert-butylsilylene-directed alpha-selective synthesis of p-nitrophenyl T-antigen analogues. Glycoconjugate Journal 26(1): 83-98
Sitkiewicz, E.; Olędzki, J.; Poznański, Jław.; Dadlez, Mł. 2014: Di-tyrosine cross-link decreases the collisional cross-section of aβ peptide dimers and trimers in the gas phase: an ion mobility study. Plos one 9(6): E100200
Kubono, K.; Tani, K.; Yokoi, K.; Shinmyozu, T.; Goto, K. 2013: Di-μ 2-acetato-1:2κ (2) O:O';2:3κ (2) O:O'-bis-{μ 2-4,4'-di-chloro-2,2'-[2,2-di-methyl-propane-1,3-diylbis(nitrilo-methanylyl-idene)]diphenolato}-1:2κ (6) O,N,N',O':O,O';2:3κ (6) O,O':O,N,N',O'-tri-cadmium. Acta Crystallographica. Section E Structure Reports Online 69(Pt 12): M629-M630
Li, H-Bing. 2010: Di-μ(1,1)-azido-bis-[(2-{1-[2-(isopropyl-amino)ethyl-imino]eth-yl}phenolato)copper(II). Acta Crystallographica. Section E Structure Reports Online 66(Pt 6): M651-M652
Hou, J. 2008: Di-μ(1,1)-azido-bis-[azido-(5,5'-dimethyl-2,2'-bipyridine)nickel(II). Acta Crystallographica. Section E Structure Reports Online 64(Part 12): M1571
Kubono, K.; Tani, K.; Yokoi, K. 2012: Di-μ(2)-acetato-1:2κ(2)O:O';2:3κ(2)O:O'-bis-{μ(2)-4,4'-dichloro-2,2'-[2,2-dimethyl-propane-1,3-diylbis(nitrilo-methanylyl-idene)]diphenolato}-1:2κ(6)O,N,N',O':O,O';2:3κ(6)O,O':O,N,N',O'-tricopper(II). Acta Crystallographica. Section E Structure Reports Online 68(Pt 11): M1430-M1431
Tatar Yıldırım, L.; Atakol, O. 2008: Di-μ(2)-acetato-1:2κO:O';2:3κO:O'-bis-(N,N'-dimethyl-formamide)-1κO,3κO-bis-{μ(2)-2,2'-[propane-1,3-diylbis(imino-methyl-ene)]diphenolato-1κO,N,N',O':2κO,O';2κO,O':3κO,N,N',O'-1,3-dinickel(II)-2-cadmium(II). Acta Crystallographica. Section E Structure Reports Online 64(Pt 2): M291-M292
Tan, S-Yong.; Chang, F.; Gao, Y-Peng. 2012: Di-μ(2)-acetato-di-μ(2)-azido-di-μ(3)-methanol-tetra-kis-{μ-2-[(2-methyl-1-oxidopropan-2-yl)imino-meth-yl]-6-meth-oxy-phenolato}tetra-nickel(II) methanol disolvate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 2): M150-M151
Assey, G.E.; Butcher, R.J.; Gultneh, Y. 2011: Di-μ(2)-acetato-diacetato-bis-{μ(2)-3,3',5,5'-tetra-meth-oxy-2,2-[ethane-1,2-diylbis(nitrilo-methyl-idyne)]diphenolato}tricobalt(II,III) dichloro-methane disolvate. Acta Crystallographica. Section E Structure Reports Online 67(Pt 3): M303-M304
Espinosa-Jalapa, N.; Hernández-Ortega, S.ón.; Le Lagadec, R.; Morales-Morales, D. 2009: Di-μ(2)-bromido-bis-[bromido(η-1,2,4,5-tetra-methyl-benzene)ruthenium(II). Acta Crystallographica. Section e Structure Reports Online 65(Part 12): M1684
Han, K.-F.; Wu, H.-Y.; Wang, Z.-M.; Guo, H.-Y. 2008: Di-μ(2)-chlorido-bis-[aqua-(2,2'-bipyridine-4,4'-dicarboxylic acid-κN,N')(nitrato-κO)copper(II). Acta Crystallographica. Section e Structure Reports Online 64(Part 12): M1607-M1608
González-Torres, Y.; Espinosa-Jalapa, N.; Hernández-Ortega, S.ón.; Le Lagadec, R.; Morales-Morales, D. 2009: Di-μ(2)-chlorido-bis-[chlorido(η-hexa-methyl-benzene)ruthenium(II). Acta Crystallographica. Section e Structure Reports Online 65(Part 11): M1369
Rodríguez, N.ás.; Brandão, P.F.B.; Okio, C.K.Y.A. 2012: Di-μ(2)-chlorido-dichloridoocta-methyldi-μ(3)-oxido-tetra-tin(IV) bis[chloridodimeth-yl(pyrrolidine-1-carbodithio-ato-κ(2)S,S')tin(IV). Acta Crystallographica. Section e Structure Reports Online 68(Part 5): M672
Wang, S.; He, W.; Ding, X.; Huang, W. 2010: Di-μ(2)-cyanido-dicyanidobis{2,2'-[ethane-1,2-diylbis(nitrilo-methyl-idyne)]diphenolato}(1,4,8,11-tetra-azacyclo-tetra-deca-ne)dichromium(III)nickel(II) methanol disolvate. Acta Crystallographica. Section E Structure Reports Online 66(Pt 6): M661-M662
Najafi, E.; Amini, M.M.; Ng, S.W. 2011: Di-μ(2)-methano-lato-bis-(μ-4-methyl-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazolido-κN:N)di-μ(3)-oxido-tetra-kis-[dibutyltin(IV). Acta Crystallographica. Section e Structure Reports Online 67(Part 2): M243
Najafi, E.; Amini, M.M.; Ng, S.W. 2011: Di-μ(2)-methano-lato-bis-(μ-4-methyl-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazolido-κN:N)di-μ(3)-oxido-tetra-kis-[dimethyl-tin(IV). Acta Crystallographica. Section e Structure Reports Online 67(Part 2): M242
Lim, Z.; Forsyth, C.M.; Graham, B. 2011: Di-μ(2)-methoxo-bis-{[μ-3,10,18,25-tetra-aza-penta-cyclo-[]triconta-1(31),2,4(9),5,7,10,12,14,16(32),17,19(24),20,22,25,27,29-hexa-deca-ene-31,32-diolato]dizinc(II)} bis-(perchlorate) N,N-dimethyl-formamide disolvate. Acta Crystallographica. Section E Structure Reports Online 67(Pt 3): M368
Zhu, R.-Q. 2011: Di-μ(3)-chlorido-tetra-μ(2)-chlorido-dichloridobis(dimethyl-formamide-κO)hexa-kis-(1H-imidazole-κN)tetra-cadmium. Acta Crystallographica. Section e Structure Reports Online 67(Part 10): M1416
Xie, H.-Y.; Zhang, L.; Shi, W.-J. 2007: Di-μ(3)-iodido-diiodidobis(μ(2)-4'-phenyl-2,2':6',2''-terpyridine)tetra-copper(I). Acta Crystallographica. Section e Structure Reports Online 64(Part 1): M42-M43
Wang, H.; Yin, H. 2007: Di-μ(3)-oxido-bis-(μ(2)-quinaldato-κO:O)-bis-(quinaldato-κN,O)tetra-kis[di-n-butyl-tin(IV). Acta Crystallographica. Section E Structure Reports Online 64(Part 1): M197-M198
Ahmed, T.J.; Zakharov, L.N.; Tyler, D.R. 2008: Di-μ(3)-oxido-di-μ(2)-oxido-tetra-oxido-bis-(1,1,2,2-tetra-methyl-ethylenedicyclo-penta-dien-yl)-dimolyb-denum(IV)-dimolybdenum(VI) hexa-hydrate. Acta Crystallographica. Section E Structure Reports Online 64(Part 11): M1370-M1371
Kitiphaisalnont, P.; Siripaisarnpipat, S.; Chaichit, N. 2009: Di-μ(4)-succinato-tetra-kis[aqua-phenanthrolinecopper(II)] tetra-nitrate tetra-hydrate. Acta Crystallographica. Section E Structure Reports Online 65(Part 11): M1284
Ou, G.-C.; Ng, S.W. 2011: Di-μ-acetato-1:2κO:O';2:3κO:O,O'-bis-(5,5,7,12,12,14-hexa-methyl-1,4,8,11-tetra-aza-cyclo-tetra-deca-ne)-1κN,3κN-bis-(perchlorato-2κO,O')-2-sodium-1,3-dizinc perchlorate. Acta Crystallographica. Section e Structure Reports Online 67(Part 12): M1664
Tigyer, B.R.; Zeller, M.; Zaleski, C.M. 2011: Di-μ-acetato-bis-(dimethyl-formamide)-penta-kis-(μ-N,2-dioxidobenzene-1-car-boximidato)tetra-kis-(1-ethyl-imidazole)-penta-manganese(III)-manganese(II)-diethyl ether-dimethyl-foramide-methanol-water (1/1/1/1/0.12). Acta Crystallographica. Section E Structure Reports Online 67(Part 8): M1041-M1042
Perec, M.; Baggio, R. 2010: Di-μ-acetato-bis-[(acetato-κO,O')bis-(iso-nicotinamide-κN)copper(II). Acta Crystallographica. Section E Structure Reports Online 66(Part 3): M275-M276
Wannarit, N.; Pakawatchai, C.; Youngme, S. 2013: Di-μ-acetato-κ(4) O:O'-bis-[(1,10-phenanthroline-κ(2) N,N')(tri-fluoro-methane-sulfonato-κO)copper(II). Acta Crystallographica. Section E Structure Reports Online 69(Part 11): M591-M592
Ido, Y.; Fujihara, T.; Nagasawa, A. 2013: Di-μ-acetato-κ(4) O:O'-μ-oxido-κ(2) O:O'-bis-[cis-(2,2'-bipyridine-κ(2) N,N')-trans-(pyridine-κN)ruthenium(III)] bis-(hexa-fluoridophosphate). Acta Crystallographica. Section E Structure Reports Online 69(Part 3): M145-M146
Wang, X-Qin. 2012: Di-μ-acetato-κ(4)O:O-bis-({2-[(piperidin-2-ylmeth-yl)imino-meth-yl]phenolato-κ(3)N,N',O}copper(II)) monohydrate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 6): M833
Vineetha, M.C.; Sithambaresan, M.; Jacob, J.Mary.; Kurup, M.R.Prathapachandra. 2012: Di-μ-acetato-κ(4)O:O-bis-({N'-[(E)-phen-yl-(pyridin-2-yl-κN)methyl-idene]benzo-hydrazidato-κ(2)N',O}copper(II)). Acta Crystallographica. Section E Structure Reports Online 68(Pt 8): M1086-M1087
Cui, F.; Zhang, S. 2011: Di-μ-acetato-κO,O':O';κO:O,O'-bis-[(acetato-κO,O')bis-(5-nitro-1,10-phenanthroline-κN,N')cadmium. Acta Crystallographica. Section E Structure Reports Online 67(Part 9): M1247
Harvey, M.A.; Baggio, S.; Garland, M.ía.T.; Baggio, R. 2008: Di-μ-acetato-κO,O':O;κO:O,O'-bis-[(acetato-κO,O')(1,10-phenan-throline-κN,N')cadmium(II). Acta Crystallographica. Section e Structure Reports Online 64(Part 11): M1450
Dinçer, M.; Ozdemir, Nık.; Günay, M.Emin.; Cetinkaya, B. 2008: Di-μ-acetato-κO:O'-bis-{[2-(2-pyrid-yl)phenyl-κC,N]palladium(II)}. Acta Crystallographica. Section E Structure Reports Online 64(Pt 2): M381
Guo, J-Hua. 2011: Di-μ-acetato-κO:O-bis-{(acetato-κO,O')bis-[3-(1H-imidazol-1-yl-κN)-1-phenyl-propan-1-one]cadmium} tetra-hydrate. Acta Crystallographica. Section E Structure Reports Online 67(Pt 12): M1884
Zimmermann, I.; Keene, T.D.; Neels, A.; Decurtins, S. 2008: Di-μ-acetato-μ-aqua-bis-[acetatobis(1H-benzimidazole)cobalt(II). Acta Crystallographica. Section E Structure Reports Online 64(Part 6): M845-M846
Xu, W.; Qi, J-Li. 2012: Di-μ-adipato-κ⁴O¹:O⁶-bis-{aqua-[5,6-di-phenyl-3-(pyridin-2-yl)-1,2,4-triazine-κ²N²,N³]copper(II)}. Acta Crystallographica. Section E Structure Reports Online 68(Pt 7): M906
Starosta, W.; Leciejewicz, J. 2009: Di-μ-aqua-bis-(μ-pyridazine-4-carboxyl-ato-κN:N')bis-[triaqua-(pyridazine-4-carboxyl-ato-κO,O')lead(II)] dihydrate. Acta Crystallographica. Section E Structure Reports Online 65(Part 11): M1291
Starosta, W.; Leciejewicz, J. 2013: Di-μ-aqua-bis-[aqua-(5-carboxyl-ato-1H-1,2,3-triazole-4-carb-oxy-lic acid-κ(2) N (3),O (4))lithium. Acta Crystallographica. Section E Structure Reports Online 69(Part 9): M515-M516
Li, X.; Zuo, Y. 2008: Di-μ-aqua-bis-[diaqua-bis(thio-cyanato-κN)iron(II)] 4-(4-chloro-phen-yl)-1,2,4-triazole hexa-solvate. Acta Crystallographica. Section E Structure Reports Online 64(Part 8): M996-M997
Zhang, M.; Sun, F-Yu.; Zhao, G-Zhe.; Liu, Y-Qing. 2012: Di-μ-aqua-bis-{diaqua-[μ-4-({4-[bis-(2-hy-droxy-eth-yl)amino]-6-chloro-1,3,5-triazin-2-yl}amino)-benzene-sulfonato]-sodium(I)}. Acta Crystallographica. Section E Structure Reports Online 68(Pt 6): M847-M848
Dai, J.; Chen, X-Yuan. 2010: Di-μ-aqua-bis-{triaqua-[5-(1-oxopyridin-4-yl)tetra-zol-1-ido]sodium}. Acta Crystallographica. Section E Structure Reports Online 67(Pt 1): M111
Datta, A.; Das, K.; Jhou, Y-Ming.; Huang, J-Hsien.; Lee, H.Man. 2010: Di-μ-azido-bis-({N'-[1-(2-pyrid-yl-κN)ethyl-idene]acetohydrazidato-κN',O}dicopper(II)). Acta Crystallographica. Section E Structure Reports Online 66(Pt 10): M1271
Toumi, H.; Amiri, N.; Belkhiria, M.S.; Daran, J.-C.; Nasri, H. 2012: Di-μ-azido-bis-(μ-1,4,7,10,13,16-hexa-oxacyclo-octa-deca-ne)bis-(5,10,15,20-tetra-phenyl-porphyrinato)dicadmium-disodium. Acta Crystallographica. Section e Structure Reports Online 68(Part 12): M1557-M1558
Liu, C.; Abboud, K.A. 2013: Di-μ-azido-di-azidodi-μ-oxalato-di-histamine-tetra-copper(II) 0.9-hydrate. Acta Crystallographica. Section E Structure Reports Online 69(Part 6): M337-M338
Kunnath, R.J.; Prathapachandra Kurup, M.R.; Ng, S.Weng. 2012: Di-μ-azido-κ(4)N(1):N(1')-bis-({1-[(E)-phen-yl(pyridin-2-yl-κN)methyl-idene]thio-semi-carbazidato-κ(2)N(1),S}copper(II)). Acta Crystallographica. Section E Structure Reports Online 68(Pt 9): M1195
Ghaemi, A.; Rayati, S.; Fayyazi, K.; Ng, S.Weng.; Tiekink, E.R.T. 2012: Di-μ-azido-κ(4)N:N-bis-({2-[(3-amino-2,2-dimethyl-prop-yl)imino-meth-yl]-6-meth-oxy-phenolato-1κ(3)N,N',O(1)}copper(II)). Acta Crystallographica. Section E Structure Reports Online 68(Pt 7): M993-M994
Mohammadnezhad, G.; Ghanbarpour, A.R.; Amini, M.M.; Ng, S.W. 2010: Di-μ-azido-κN:N-bis-[(1,10-phen-anthroline-κN,N')(thio-cyanato-κN)lead(II). Acta Crystallographica. Section e Structure Reports Online 66(Part 9): M1120
Luo, Y-Yuan. 2011: Di-μ-azido-κN:N-bis-{aqua-[bis-(1H-benzimidazol-2-ylmeth-yl)amine]-copper(II)} dinitrate. Acta Crystallographica. Section E Structure Reports Online 67(Pt 12): M1703-M1704
Cheng, Y.; Yan, F.; Shi, W.; Zhang, L. 2012: Di-μ-benzoato-κ(3)O,O':O;κ(3)O:O,O'-bis-[aqua-(nitrato-κO)(1,10-phenanthroline-κ(2)N,N')lead(II). Acta Crystallographica. Section E Structure Reports Online 68(Part 4): M528-M529
Li, H.-J.; Gao, Z.-Q.; Gu, J.-Z. 2011: Di-μ-benzoato-κO,O':O';κO:O,O'-bis-[(benzoato-κO,O')(1,10-phenanthroline-κN,N')cadmium. Acta Crystallographica. Section e Structure Reports Online 67(Part 7): M919
Wang, Z.; Zhou, X. 2011: Di-μ-benzoato-κO,O':O';κO:O,O'-bis[aqua-bis-(benzoato-κO,O')(dimethylformamide-κO)europium(III). Acta Crystallographica. Section E Structure Reports Online 67(Part 11): M1579-M1580
Gao, J.; Xuan, X. 2009: Di-μ-benzoato-κO,O':O;κO:O,O'-bis-[(acetato-κO)(1,10-phenanthroline-κN,N')lead(II)] dihydrate. Acta Crystallographica. Section E Structure Reports Online 65(Part 8): M900
Li, H.-J.; Gao, Z.-Q.; Gu, J.-Z. 2011: Di-μ-benzoato-κO,O':O;κO:O,O'-bis-[(benzoato-κO,O')(1,10-phenanthroline-κN,N')lead(II). Acta Crystallographica. Section e Structure Reports Online 67(Part 6): M778
Nimthong, R.; Pakawatchai, C.; Wattanakanjana, Y. 2012: Di-μ-bromido-bis-({2-[(4,6-dimethyl-pyrimidin-2-yl)disulfan-yl]-4,6-dimethyl-pyrimidine-κ(2)N(1),S(2)}copper(I)). Acta Crystallographica. Section E Structure Reports Online 68(Pt 5): M645
Butcher, R.J.; Gultneh, Y.; Yisgedu, T.B.; Tesema, Y.T. 2008: Di-μ-bromido-bis-({bis-[2-(2-pyrid-yl)eth-yl]amine}copper(II)) bis-(perchlorate). Acta Crystallographica. Section E Structure Reports Online 64(Pt 2): M323
Seven, O.; Bolte, M.; Lerner, H.-W. 2013: Di-μ-bromido-bis-[(diethyl ether-κO)(2,4,6-tri-methyl-phen-yl)magnesium]: the mesityl Grignard reagent. Acta Crystallographica. Section e Structure Reports Online 69(Part 7): M424
Nesbit, M.A.; Gray, D.L.; Girolami, G.S. 2012: Di-μ-bromido-bis-[benz-yl(diethyl ether)magnesium. Acta Crystallographica. Section E Structure Reports Online 68(Part 7): M942
Kalateh, K.; Ebadi, A.; Ahmadi, R.; Amani, V.; Khavasi, H.R. 2008: Di-μ-bromido-bis-[bromido(4,4'-dimethyl-2,2'-bipyridine-κN,N')mercury(II). Acta Crystallographica. Section e Structure Reports Online 64(Part 11): M1397-M1398
Shirvan, S.A.; Haydari Dezfuli, S.; Khazali, F.; Aghajeri, M.; Borsalani, A. 2012: Di-μ-bromido-bis-[bromido(4,7-diphenyl-1,10-phenanthroline-κ(2) N,N')cadmium. Acta Crystallographica. Section E Structure Reports Online 68(Part 12): M1471
Westcott, B.L.; Kopp-Vaughn, K.M.; Daniels, L.M.; Zeller, M. 2008: Di-μ-bromido-bis-[bromido(di-2-pyridylmethane-diol-κN,N')copper(II)] dihydrate. Acta Crystallographica. Section E Structure Reports Online 64(Part 9): M1122-M1123
Goh, C.; Remillard, Z.D.; Martinez, A.P.; Keeley, A.C.; Jasinski, J.P. 2012: Di-μ-bromido-bis-{[N,N-dimethyl-N'-(thio-phen-2-yl-methyl-idene)ethane-1,2-diamine]-copper(I)]}. Acta Crystallographica. Section E Structure Reports Online 68(Pt 5): M691-M692
Gao, W.; Zhou, Y.; Zhang, H. 2009: Di-μ-bromido-tris-(triphenyl-phosphine)-1κP,2κP-disilver(I) tetra-hydro-furan 0.85-solvate. Acta Crystallographica. Section E Structure Reports Online 65(Part 4): M441
Atria, A.M.ía.; Astete, A.; Garland, M.T.; Baggio, R. 2011: Di-μ-but-2-enoato-bis-[diaqua-bis(but-2-enoato)neodymium(III)] 2,6-diamino-purine disolvate. Acta Crystallographica. Section e Structure Reports Online 67(Part 9): M1191-M1192
Gueorguieva, P.G.; Laneman, S.A.; Stanley, G.G.; Fronczek, F.R.; Watkins, S.F. 2012: Di-μ-carbonyl-bis-[bis-(triphenyl-phos-phane)rhodium(0)](Rh-Rh) acetone disolvate. Acta Crystallographica. Section E Structure Reports Online 68(Part 11): M1408-M1409
Akkurt, M.; Khandar, A.Akbar.; Tahir, M.Nawaz.; Afkhami, F.Akbari.; Yazdi, S.Abolfazl.Hosseini. 2014: Di-μ-chlorido-bis-(chlorido-{N'-[phen-yl(pyridin-2-yl-κN)methyl-idene]pyridine-2-carbohydrazide-κ(2) N',O}cadmium). Acta Crystallographica. Section E Structure Reports Online 70(Pt 6): M213-M214
Qi, Z-Peng.; Wang, A-Dong.; Zhang, H.; Wang, X-Xi. 2009: Di-μ-chlorido-bis-(chlorido{2,2'-[3-(1H-imidazol-4-ylmeth-yl)-3-aza-pentane-1,5-di-yl]diphthalimide}copper(II)). Acta Crystallographica. Section E Structure Reports Online 65(Pt 12): M1507-M1508
Dehghanpour, S.; Mahmoudi, A.; Khalaj, M.; Abbasi, S.; Mojahed, F. 2011: Di-μ-chlorido-bis-(chlorido{2-[(4-ethyl-phen-yl)imino-meth-yl]pyridine-κN,N'}copper(II)). Acta Crystallographica. Section E Structure Reports Online 67(Pt 9): M1296
Mahmoudi, A.; Dehghanpour, S.; Khalaj, M.; Pakravan, S. 2009: Di-μ-chlorido-bis-({2-[(4-bromo-phen-yl)-imino-meth-yl]pyridine-κN,N'}-chloridomercury(II)). Acta Crystallographica. Section E Structure Reports Online 65(Pt 8): M889
Davis, W.L.; Muller, A. 2012: Di-μ-chlorido-bis-({8-[bis-(naphthalen-1-yl)phosphan-yl]naphthalen-1-yl-κ(2) C (1),P}palladium(II)) dichloro-methane disolvate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 12): M1565-M1566
Zhou, J.; Wang, Q.; Sun, H. 2008: Di-μ-chlorido-bis-({9-[(2,6-diisopropyl-phen-yl)imino-meth-yl]anthracen-1-yl}palladium(II)). Acta Crystallographica. Section E Structure Reports Online 64(Pt 5): M688
Shahverdizadeh, G.H.; Ng, S.W.; Tiekink, E.R.T.; Mirtamizdoust, B. 2012: Di-μ-chlorido-bis-[(1,10-phenanthroline-κN,N')(trichloro-acetato-κO)copper(II). Acta Crystallographica. Section e Structure Reports Online 68(Part 3): M242-M243
Zhang, W.; Li, W.-J. 2009: Di-μ-chlorido-bis-[(2'-carb-oxybiphen-yl-2-carboxyl-ato-κO)(2,2':6',2''-terpyridine-κN,N',N'')cadmium(II)] hemihydrate. Acta Crystallographica. Section e Structure Reports Online 65(Part 11): M1409-M1410
Liu, G. 2008: Di-μ-chlorido-bis-[(2,2'-bibenzimidazole)chloridocadmium(II). Acta Crystallographica. Section E Structure Reports Online 65(Part 1): M37
Oien, S.; Wragg, D.S.; Lillerud, K.P.; Tilset, M. 2013: Di-μ-chlorido-bis-[(2,2'-bipyridine-5,5'-dicarb-oxy-lic acid-κ(2)N,N')chloridocopper(II)] dimethyl-formamide tetra-solvate. Acta Crystallographica. Section e Structure Reports Online 69(Part 2): M73-M74
Tadjarodi, A.; Bijanzad, K.; Notash, B. 2012: Di-μ-chlorido-bis-[(2-amino-4-methyl-pyridine-κN)-chloridomercury(II). Acta Crystallographica. Section E Structure Reports Online 68(Part 10): M1300-M1301
Damous, M.; Dénès, G.; Bouacida, S.; Hamlaoui, M.; Merazig, H.; Daran, J.-C. 2013: Di-μ-chlorido-bis-[(2-amino-benzamide-κ(2) N (2),O)chlorido-copper(II). Acta Crystallographica. Section e Structure Reports Online 69(Part 9): M488
Li, Y. 2011: Di-μ-chlorido-bis-[(2-{(E)-[(2,3-dihy-droxy-prop-yl)imino]-meth-yl}phenolato)copper(II)] methanol monosolvate. Acta Crystallographica. Section E Structure Reports Online 67(Pt 11): M1539
Zhu, L.-L.; Sun, Y.; Zhang, H.-H.; Wang, Y.; Sun, B.-W. 2009: Di-μ-chlorido-bis-[aqua-(2,2'-bipyridine-κN,N')chloridocobalt(II). Acta Crystallographica. Section e Structure Reports Online 65(Part 8): M991
Amini, M.M.; Ng, S.W. 2012: Di-μ-chlorido-bis-[aqua-chloridodimethyl-tin(IV)]-1,4,7,10,13-penta-oxacyclo-penta-decane (1/1). Acta Crystallographica. Section e Structure Reports Online 68(Part 4): M354
Näther, C.; Jess, I. 2009: Di-μ-chlorido-bis-[bis-(ethyl-enediamine-κN,N')cadmium(II)] dichloride. Acta Crystallographica. Section E Structure Reports Online 66(Part 1): M98
Yamagata, T.; Nakajima, K.; Arimitsu, K.; Iseki, A.; Tani, K. 2008: Di-μ-chlorido-bis-[bis-(η-cyclo-octene)iridium(I). Acta Crystallographica. Section E Structure Reports Online 64(Part 4): M579-M580
Yang, X.-M.; Leng, Q.-B.; Chen, Y.; He, Y.-G.; Luo, S.-W. 2009: Di-μ-chlorido-bis-[chlorido(1,10-phenanthroline-κN,N')zinc(II). Acta Crystallographica. Section e Structure Reports Online 65(Part 5): M567
Bortoluzzi, A.J.; Neves, A.; Peralta, R.A.; Camargo, T.P.; Weiss, V.C. 2009: Di-μ-chlorido-bis-[chlorido(1,4,6-trimethyl-6-nitro-1,4-diazepine)copper(II). Acta Crystallographica. Section E Structure Reports Online 65(Part 2): M144-M145
Liu, Y.-F.; Rong, D.-F.; Xia, H.-T.; Wang, D.-Q. 2009: Di-μ-chlorido-bis-[chlorido(N,N'-dibenzyl-propane-1,2-diamine-κN,N')copper(II). Acta Crystallographica. Section e Structure Reports Online 65(Part 11): M1492
Yu, M.-M.; Shi, Q.-Z.; Zhang, Y.-N.; Li, Z.-X. 2009: Di-μ-chlorido-bis-[chlorido(N,N-di-methyl-ethylenediamine-κN,N')zinc(II). Acta Crystallographica. Section e Structure Reports Online 65(Part 7): M744-M745
Slawin, A.M.Z.; Waddell, P.G.; Woollins, J.D. 2010: Di-μ-chlorido-bis-[chlorido(dimethoxy-phenyl-phosphine)palladium(II). Acta Crystallographica. Section e Structure Reports Online 66(Part 5): M499
Takao, K.; Ikeda, Y. 2007: Di-μ-chlorido-bis-[chloridobis(dimethyl sulfoxide)dioxidouranium(VI). Acta Crystallographica. Section E Structure Reports Online 64(Part 1): M107
Dastych, D.; Rotter, P.; Demo, G.; Dastychová, L. 2011: Di-μ-chlorido-bis-[diacetonitrile-chlorido-oxidovanadium(IV). Acta Crystallographica. Section E Structure Reports Online 67(Part 10): M1398
Kurawa, M.A.; Adams, C.J.; Orpen, A.G. 2008: Di-μ-chlorido-bis-[dichlorido(3,3',5,5'-tetra-methyl-4,4'-bipyrazol-1-ium-κN)copper(II)] dihydrate. Acta Crystallographica. Section e Structure Reports Online 64(Part 8): M1053-M1054
Straessler, N.A.; Caudle, M.T.; Groy, T.L. 2007: Di-μ-chlorido-bis-[dichlorido(N,N-diethyl-acetamidinato)(N,N-diethyl-acetamidine)titanium(IV)] acetonitrile disolvate. Acta Crystallographica. Section e Structure Reports Online 64(Part 1): M20
Gao, J-Sheng.; Yu, Y-Hui.; Liu, Y.; Hou, G-Feng. 2011: Di-μ-chlorido-bis-{[1,2-bis-(pyridin-2-ylmeth-oxy)benzene-κN,O,O',N']chloridocadmium}. Acta Crystallographica. Section E Structure Reports Online 67(Pt 10): M1415
Du, Z-Xiang.; Qin, J-Hua.; Wang, J-Ge. 2008: Di-μ-chlorido-bis-{[2-(2-pyridylmethyl-amino)ethanesulfonato-κN,N',O]copper(II)}. Acta Crystallographica. Section E Structure Reports Online 64(Pt 2): M341
Wang, Z-Hong.; Fan, J.; Zhang, W-Guang.; Wang, J. 2008: Di-μ-chlorido-bis-{[2-(8-quinol-yloxy)-acetato-κN,O,O]copper(II)}. Acta Crystallographica. Section E Structure Reports Online 64(Pt 11): M1446
Kim, Y-Inn.; Song, Y-Kwang.; Yun, S-Jae.; Kim, I-Chan.; Kang, S.Kwon. 2010: Di-μ-chlorido-bis-{[2-(benzyl-imino-meth-yl)pyridine-κN,N']chloridomercury(II)} dichloridomercury(II). Acta Crystallographica. Section E Structure Reports Online 67(Pt 1): M52-M53
Holzapfel, C.W.; Omondi, B. 2013: Di-μ-chlorido-bis-{[2-(di-tert-butyl-phosphan-yl)biphenyl-3-yl-κ(2)C(3),P]palladium(II)} dichloro-methane disolvate. Acta Crystallographica. Section E Structure Reports Online 69(Pt 2): M86
Copolovici, D.; Silvestru, C.; Isaia, F.; Varga, R.A. 2008: Di-μ-chlorido-bis-{[2-(morpholinometh-yl)phenyl-κC,N]palladium(II)}. Acta Crystallographica. Section E Structure Reports Online 64(Pt 8): M1057-M1058
Coelho, S.E.; Terra, G.G.; Bortoluzzi, A.J. 2010: Di-μ-chlorido-bis-{[2-({[2-(2-pyrid-yl)eth-yl](2-pyridylmeth-yl)amino}meth-yl)phenol]zinc(II)} bis-(perchlorate) dihydrate. Acta Crystallographica. Section E Structure Reports Online 66(Pt 2): M229-M230
Guo, J.; Tang, M.; Chen, J.; Li, C-Peng. 2011: Di-μ-chlorido-bis-{[4-amino-3,5-bis-(2-pyrid-yl)-4H-1,2,4-triazole-κN]chloridomercury(II)}. Acta Crystallographica. Section E Structure Reports Online 67(Pt 9): M1180
Sang, Y.; Hong, Q.; Qiu, W.; Liu, Q.; Yang, F. 2010: Di-μ-chlorido-bis-{[4-chloro-2-(dimethyl-amino-meth-yl)phenyl-κC,N]palladium(II)}. Acta Crystallographica. Section E Structure Reports Online 66(Pt 3): M252
Cheng, J. 2011: Di-μ-chlorido-bis-{[N,N'-dicyclo-hexyl-N'',N''-bis-(trimethyl-sil-yl)guanidinato-κN,N'](tetra-hydro-furan-κO)magnesium(II)}. Acta Crystallographica. Section E Structure Reports Online 67(Pt 7): M987
Schnetz, T.; Rominger, F.; Hofmann, P. 2010: Di-μ-chlorido-bis-{[μ-1,8-bis-(diisopropyl-phosphan-yl)-9,10-dihydro-9,10-ethano-anthracene-κP:P']-μ-chlorido-μ-methyl-idene-dipalladium(II)} tetra-hydro-furan penta-solvate. Acta Crystallographica. Section E Structure Reports Online 66(Pt 4): M453-M454
Seidel, Rüdiger.W.; Oppel, I.M. 2009: Di-μ-chlorido-bis-{aqua-chlorido[2,2'-thio-bis(pyridine N-oxide)-κO]copper(II)}. Acta Crystallographica. Section E Structure Reports Online 65(Pt 4): M460
Wang, Z.; Gong, I.; Liu, C.; Zhang, X. 2009: Di-μ-chlorido-bis-{aqua-chlorido[3-ethyl-4-phenyl-5-(2-pyrid-yl)-4H-1,2,4-triazole-κN,N]manganese(II)}. Acta Crystallographica. Section E Structure Reports Online 65(Pt 2): M157
Xia, H.; Liu, Y. 2008: Di-μ-chlorido-bis-{bis-[3,5-dimethyl-pyrazol-1-yl-κN)methane]iron(II)} bis-[tetra-chloridoferrate(III). Acta Crystallographica. Section E Structure Reports Online 64(Pt 12): M1504
Wang, Y-Chun. 2012: Di-μ-chlorido-bis-{bis-[4-(adamantan-1-ylcarbamo-yl)pyridine-κN]chlorido-copper(II)} hemihydrate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 2): M147
Barceló-Oliver, M.; Terrón, A.; García-Raso, A.; Turel, I.; Morell, M. 2010: Di-μ-chlorido-bis-{chlorido[(R)/(S)-1,5-di-phenyl-3-(2-pyridyl-κN)-2-pyrazoline-κN]zinc(II)}. Acta Crystallographica. Section E Structure Reports Online 66(Pt 8): M899-M900
Hoseyni, S.Jalal.; Talei Bavil Olyai, M.Reza.; Notash, B. 2012: Di-μ-chlorido-bis-{chlorido[2,3-dimethyl-N-(pyridin-2-yl-methyl-idene)aniline-κ(2)N,N']mercury(II)}. Acta Crystallographica. Section E Structure Reports Online 68(Pt 10): M1294
Xia, D-Sheng.; Chen, W.; Tang, X-Long.; Zeng, Q-Fu. 2008: Di-μ-chlorido-bis-{chlorido[2-(2-furyl-methyl-imino-meth-yl)pyridine-κN,N']nickel(II)}. Acta Crystallographica. Section E Structure Reports Online 64(Pt 6): M836
Salehzadeh, S.; Dehghanpour, S.; Khalaj, M.; Rahimishakiba, M. 2011: Di-μ-chlorido-bis-{chlorido[4-nitro-N-(pyridin-2-yl-methyl-idene-κN)aniline-κN]mercury(II)}. Acta Crystallographica. Section E Structure Reports Online 67(Pt 3): M327
Barbul, I.; Varga, R.A.; Silvestru, C. 2011: Di-μ-chlorido-bis[chloridobis(dimethyl sulfoxide-κO)tin(II). Acta Crystallographica. Section E Structure Reports Online 67(Part 4): M486
Thomas, T.; Pugh, D.; Parkin, I.P.; Carmalt, C.J. 2011: Di-μ-chlorido-bis[dichloridobis(methylamido-κN)bis(methylamine-κN)titanium(IV). Acta Crystallographica. Section C Crystal Structure Communications 67(Part 7): M234-M236
Tang, L.; Li, Z.-X. 2008: Di-μ-chlorido-chlorido-1κCl-(μ-1-phenyl-3-phenyl-imino-but-1-enolato-1:2κO:O,N)bis-(1-phenyl-3-phenyl-imino-but-1-enolato)-1κN,O;2κN,O-dichromium(III) toluene disolvate. Acta Crystallographica. Section e Structure Reports Online 64(Part 10): M1230
Al-Sudani, A-Razak.H.; Kariuki, B.M. 2013: Di-μ-chlorido-dichlorido-bis{8-[2-(di-methyl-amino)-ethyl-amino]-quinoline}dicadmium monohydrate. Acta Crystallographica. Section E Structure Reports Online 69(Pt 9): M491-M492
Wang, H.; Zhang, D.; Zhang, L-Fang. 2008: Di-μ-chlorido-dichlorido-bis{μ-6,6'-dimethoxy-2,2'-[o-phenylenebis(nitrilomethylidyne)]diphenolato}dilead(II)dizinc(II) N,N'-dimethyl-formamide disolvate. Acta Crystallographica. Section E Structure Reports Online 64(Pt 11): M1408-M1409
Matsuura, M.; Fujihara, T.; Nagasawa, A.; Ng, S.Weng. 2012: Di-μ-chlorido-μ-(dimethyl sulfide)-bis-{dichlorido[(dimethyl selenide-κSe)(dimethyl sulfide-κS)(0.65/0.35)]niobium(III)}(Nb-Nb). Acta Crystallographica. Section E Structure Reports Online 68(Pt 9): M1166
Liu, H.-X.; Jian, F.-F.; Wang, J. 2009: Di-μ-chromato-κO:O'-bis-[bis-(phenan-throline-κN,N')cadmium(II)] dihydrate. Acta Crystallographica. Section e Structure Reports Online 65(Part 4): M392-M393
Zhang, Y.; Yuan, A.-H.; Zhou, H.; Guo, J.-X.; Liu, L. 2009: Di-μ-cyanido-1:2κC:N,2:3κN:C-hexa-cyanido-1κC,3κC-tetra-kis(1,10-phenanthroline)-1κN,N';2κN,N';3κN,N'-1,3-dicobalt(III)-2-iron(II) tetra-hydrate. Acta Crystallographica. Section e Structure Reports Online 65(Part 9): M1033-M1034
Yang, Y.; Zhou, H.; Shen, X. 2013: Di-μ-cyanido-tetra-cyanido(5,5,7,12,12,14-hexa-methyl-1,4,8,11-tetra-aza-cyclo-tetra-decane)[N-(quinolin-8-yl)quinoline-2-carboxamidato]diiron(III)nickel(II) 2.07-hydrate. Acta Crystallographica. Section E Structure Reports Online 69(Part 5): M271-M272
Fazaeli, Y.; Najafi, E.; Amini, M.M.; Khavasi, H.R. 2009: Di-μ-ethano-lato-bis-[diethano-lato(2-methyl-quinolin-8-olato)titanium(IV). Acta Crystallographica. Section e Structure Reports Online 65(Part 12): M1531
Xu, W.; Feng, L-Jing-Qian. 2012: Di-μ-glutarato-κ(4)O(1):O(5)-bis-{aqua-[5,6-diphenyl-3-(pyridin-2-yl)-1,2,4-triazine-κ(2)N(2),N(3)]copper(II)}. Acta Crystallographica. Section E Structure Reports Online 68(Pt 6): M797
Zhou, Y.-H. 2011: Di-μ-glutarato-κO:O-bis-[aqua-(1,10-phenanthroline-κN,N')copper(II). Acta Crystallographica. Section e Structure Reports Online 67(Part 4): M411
Liu, Q.; Pan, S.; Wang, D. 2009: Di-μ-hydroxido-bis-({2,2'-[propane-1,3-diylbis(nitrilo-methyl-idyne)]diphenolato}iron(III)) dimethyl-formamide disolvate. Acta Crystallographica. Section E Structure Reports Online 65(Pt 3): M305
Eshtiagh-Hosseini, H.; Alfi, N.; Mirzaei, M.; Fanwick, P.; Fanwick, P.E. 2010: Di-μ-hydroxido-bis-[aqua-(pyridine-2,6-dicarboxyl-ato)iron(III)] monohydrate. Acta Crystallographica. Section E Structure Reports Online 66(Part 11): M1450
Yang, M.; Yin, H.; Quan, L.; Cui, L.; Wang, D. 2008: Di-μ-hydroxido-bis-[aqua-trichlorido-tin(IV)] diethyl ether disolvate. Acta Crystallographica. Section E Structure Reports Online 64(Part 11): M1430
Lo, K.M.; Ng, S.W. 2009: Di-μ-hydroxido-bis-[bromidodi-p-tolyl-tin(IV). Acta Crystallographica. Section e Structure Reports Online 65(Part 7): M716
Sow, Y.; Diop, L.; Molloy, K.C.; Kociok-Köhn, G. 2012: Di-μ-hydroxido-bis-[dimeth-yl(thio-cyanato-κN)tin(IV). Acta Crystallographica. Section E Structure Reports Online 68(Part 12): M1436
Haníková, J.; Kuchár, J.; Trávníček, Z.ěk.; Cernák, J. 2012: Di-μ-hydroxido-bis-[hemiaqua-(N,N,N',N'-tetra-methyl-ethane-1,2-diamine)-copper(II)] bis-(tetra-fluoridoborate). Acta Crystallographica. Section e Structure Reports Online 68(Part 6): M784
Viljoen, J.A.; Visser, H.G.; Roodt, A. 2011: Di-μ-hydroxido-bis-[tris-(4,4,4-trifluoro-1-phenyl-acetyl-acetonato-κO,O')hafnium(IV)] dimethyl-formamide disolvate. Acta Crystallographica. Section e Structure Reports Online 67(Part 12): M1822-M1823
Viljoen, J.A.; Visser, H.G.; Roodt, A.; Steyn, M. 2009: Di-μ-hydroxido-bis[tris(1,1,1,5,5,5-hexa-fluoro-acetyl-acetonato-κO,O')hafnium(IV)] acetone solvate. Acta Crystallographica. Section e Structure Reports Online 65(Part 11): M1367-M1368
Saravanan, B.; Jayamani, A.; Sengottuvelan, N.; Chakkaravarthi, G.; Manivannan, V. 2013: Di-μ-hydroxido-κ(4) O:O-di-μ-perchlorato-κ(4) O:O'-bis-[(2,2'-bi-pyridine-κ(2) N,N')copper(II). Acta Crystallographica. Section E Structure Reports Online 69(Part 11): M600
Kazhdan, D. 2008: Di-μ-hydroxido-κO:O-μ-trifluoro-methane-sulfonato-κO:O'-bis-[(5,5'-dimethyl-2,2-bipyridine-κN,N')(η-penta-methyl-cyclo-penta-dien-yl)ytterbium(III)] tetra-phenyl-borate 5,5'-dimethyl-2,2-bipyridine. Acta Crystallographica. Section E Structure Reports Online 64(Part 2): M435
Basu Baul, T.S.; Kundu, S.; Ng, S.Weng.; Tiekink, E.R.T. 2013: Di-μ-iodido-bis-(iodido-{methyl 4-[(pyridin-2-yl-methyl-idene)amino]-benzoate-κ(2) N,N'}cadmium). Acta Crystallographica. Section E Structure Reports Online 69(Pt 11): M623-M624
Brown, S.; Crundwell, G. 2012: Di-μ-iodido-bis-[(biphenyl-2-yl)(triphenyl-phosphane-κP)palladium(II). Acta Crystallographica. Section E Structure Reports Online 68(Part 12): M1526
Schultz, M. 2007: Di-μ-iodido-bis-[(diethyl ether-κO)(η-1,3-di-tert-butyl-cyclo-penta-dien-yl)ytterbium(II). Acta Crystallographica. Section E Structure Reports Online 64(Part 1): M232
Starosta, R.ła.; Komarnicka, U.K.; Nagaj, J.; Stokowa-Sołtys, K.; Bykowska, A. 2012: Di-μ-iodido-bis-[(dimethyl 2,2'-biquinoline-4,4'-dicarboxyl-ate-κ(2)N,N')copper(I). Acta Crystallographica. Section e Structure Reports Online 68(Part 6): M756-M757
Venter, J.A.; Purcell, W.; Visser, H.G. 2009: Di-μ-iodido-bis-[acet-yl(4-methyl-2,6,7-trioxa-1-phosphabicyclo-[2.2.2]octa-ne)(N-nitroso-N-oxidoaniline-κO,O')rhodium(III). Acta Crystallographica. Section E Structure Reports Online 65(Part 12): M1528-M1529
Akkurt, M.; Karami, K.; Yalçın, S.Pınar.; Büyükgüngör, O. 2008: Di-μ-iodido-bis-{[(4-fluoro-benzoyl-methyl-ene)triphenyl-λ-phospho-rane]iodido-mercury(II)}. Acta Crystallographica. Section E Structure Reports Online 64(Pt 5): M612-M613
Volz, D.; Nieger, M.; Bräse, S. 2012: Di-μ-iodido-bis-{[(R)-(+)-2,2'-bis-(di-phenyl-phosphan-yl)-1,1'-binaphthyl-κ(2)P,P']copper(I)} 0.67-hydrate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 4): M466-M467
Omondi, B.; Meijboom, R. 2009: Di-μ-iodido-bis-{[dicyclo-hexyl(phen-yl)phosphine-κP](pyridine-κN)silver(I)}. Acta Crystallographica. Section E Structure Reports Online 65(Pt 4): M462-M463
Esmhosseini, M.; Safari, N.; Amani, V. 2010: Di-μ-iodido-bis{[hydroxy(methoxy)bis(2-pyridyl)methane-κN,O,N']iodidocadmium(II)}. Acta Crystallographica. Section E Structure Reports Online 66(Pt 11): M1434-M1435
Zheng, Z.-G.; Lin, C.-Z.; Chen, Q.-Y. 2007: Di-μ-methacrylato-bis-[diaquabis(meth-acryl-ato)europium(III)] methacrylic acid disolvate. Acta Crystallographica. Section e Structure Reports Online 64(Part 1): M178
Tarafder, M.T.H.; Reza, M.Y.; Crouse, K.A.; Chantrapromma, S.; Fun, H.-K. 2008: Di-μ-methacrylato-κO:O'-bis-[aqua-bis(1,10-phenanthroline-κN,N')copper(II)] dinitrate dihydrate. Acta Crystallographica. Section e Structure Reports Online 64(Part 7): M872-M873
Li, X.-G.; Gao, M.-M.; Ng, S.W. 2012: Di-μ-methano-lato-κ(4)O:O-bis-[bis-(3-methyl-5-phenyl-1H-pyrazole-κN(2))(nitrato-κO)copper(II). Acta Crystallographica. Section e Structure Reports Online 68(Part 4): M503
Nielson, A.J.; Shen, C.; Waters, J.M. 2013: Di-μ-methanolato-bis[(2-tert-butyl-6-methylphenolato-κO)methyl-titanium(IV). Acta Crystallographica. Section E Structure Reports Online 69(Part 10): M554-M555
García-Orduña, P.; Mena, I.; Casado, M.A.; Lahoz, F.J. 2012: Di-μ-methanolato-bis[(η4-tetrafluorobenzobarrelene)rhodium(I). Acta Crystallographica. Section C Crystal Structure Communications 68(Part 4): M113-M116
Zhang, Q.; Yin, H.; Wang, D. 2011: Di-μ-methanolato-κO:O-bis[tri-chlorido(dimethyl-formamide-κO)tin(IV). Acta Crystallographica. Section E Structure Reports Online 67(Part 2): M146
Betz, R.; Junggeburth, S.; Klüfers, P.; Mayer, P. 2009: Di-μ-methoxido-μ-oxido-bis-[triphenyl-antimony(V)] methanol disolvate. Acta Crystallographica. Section E Structure Reports Online 66(Part 1): M28
Bozkurt, N.; Dilek, N.; Caylak Delibaş, N.; Necefoğlu, H.; Hökelek, T. 2013: Di-μ-nicotinamide-κ(2) N (1):O;κ(2) O:N (1)-bis-[aqua-bis-(3-chloro-benzoato-κ(2) O,O')cadmium. Acta Crystallographica. Section E Structure Reports Online 69(Part 7): M389-M390
Necefoğlu, H.; Ozbek, F.ür.E.; Oztürk, V.; Adıgüzel, V.; Hökelek, T. 2011: Di-μ-nicotinamide-κN:O;κO:N-bis-[aqua-bis-(4-bromo-benzoato)-κO;κO,O'-manganese(II). Acta Crystallographica. Section e Structure Reports Online 67(Part 8): M1128-M1129
Hökelek, T.; Süzen, Y.; Tercan, B.ış; Tenlik, E.ç; Necefoğlu, H. 2010: Di-μ-nicotinamide-κO:N;κN:O-bis-[aqua-bis-(4-meth-oxy-benzoato-κO)copper(II). Acta Crystallographica. Section e Structure Reports Online 66(Part 7): M807-M808
Moncol, J.; Mikloš, D.ša.; Segla, P.; Koman, M. 2008: Di-μ-nicotinato-κN:O;κO:N-bis-[aqua-(ethyl-enediamine-κN,N')(nicotinato-κN)cadmium(II)] dihydrate. Acta Crystallographica. Section e Structure Reports Online 64(Part 5): M665-M666
Keng, C.T.; Lo, K.M.; Ng, S.W. 2010: Di-μ-nicotinato-κN:O;κO:N-bis-[aqua-bis-(4-bromo-benz-yl)(nicotinato-κO,O')tin(IV). Acta Crystallographica. Section e Structure Reports Online 66(Part 8): M1008
Sun, T.Ting.; Meng, L.; Shi, J.Min. 2009: Di-μ-nitrito-κO:O,O';κO,O':O-bis-{[2,6-bis-(pyrazol-1-yl-κN)pyridine-κN](nitrito-κO,O')cadmium(II)}. Acta Crystallographica. Section E Structure Reports Online 65(Pt 11): M1318
Zhu, R.-Q. 2011: Di-μ-nitrito-κO:O-bis-[bis-(1-ethyl-1H-imidazole-κN)(nitrito-κO)copper(II). Acta Crystallographica. Section e Structure Reports Online 67(Part 7): M869
Romanowski, G.; Sikorski, A.; Wojtczak, A. 2008: Di-μ-oxido-bis-({(R)-(-)-2-[1-(2-amino-propyl-imino)eth-yl]-1-naphtholato-κN,N',O}oxidovanadium(V)). Acta Crystallographica. Section E Structure Reports Online 64(Pt 7): M950-M951
Zaitsev, K.V.; Karlov, S.S.; Zaitseva, G.S.; Lermontova, E.Kh.; Churakov, A.V. 2013: Di-μ-oxido-bis-({2,2'-[ethane-1,2-diylbis(nitrilo-methanylyl-idene)]diphenolato}titanium(IV)) chloro-form disolvate. Acta Crystallographica. Section E Structure Reports Online 69(Pt 11): M626-M627
Romanowski, G.; Wera, Mł.; Sikorski, A. 2008: Di-μ-oxido-bis-({2-[(R,R)-(-)-(2-amino-cyclo-hexyl)imino-meth-yl]-4-nitro-phenolato-κN,N',O}oxidovanadium(V)) dimethyl sulfoxide disolvate. Acta Crystallographica. Section E Structure Reports Online 65(Pt 1): M25-M26
Olmstead, M.M.; Boyce, D.W.; Bria, L.E. 2011: Di-μ-oxido-bis-[(1,4,8,11-tetra-aza-cyclo-tetra-decane-κN,N',N'',N''')dimangan-ese(III,IV)] bis-(tetra-phenyl-borate) chloride acetonitrile disolvate. Acta Crystallographica. Section E Structure Reports Online 67(Part 7): M824-M825
Wang, F-Ming. 2012: Di-μ-oxido-bis-[(2-eth-oxy-6-{[2-(2-hy-droxy-ethyl-amino)-ethyl-imino]-meth-yl}phenolato-κN,N',O)oxidovanadium(V). Acta Crystallographica. Section E Structure Reports Online 68(Pt 1): M26-M27
Guo, Z.; Li, L.; Xu, T.; Li, J. 2009: Di-μ-oxido-bis-[(4-formyl-2-methoxy-phenolato-κO)oxido(1,10-phenan-throline-κN,N')vanadium(V). Acta Crystallographica. Section E Structure Reports Online 65(Part 9): M1114
Syre, R.; Frenzel, N.; Hrib, C.G.; Burte, E.P.; Jones, P.G.; Edelmann, F.T. 2013: Di-μ-oxido-bis-[bis-(diiso-propyl-aceta-midinato)-κN;κ(2) N,N'-germanium(IV). Acta Crystallographica. Section E Structure Reports Online 69(Part 12): M686-M687
Romanowski, G.; Lis, T. 2008: Di-μ-oxido-bis-{[(R,R)-(+)-1-amino-2-(3-methoxy-2-oxidobenzyl-ideneamino-κO,N)-1,2-diphenyl-ethane-κN]oxidovanadium(V)} dihydrate. Acta Crystallographica. Section E Structure Reports Online 64(Pt 7): M886-M887
Kurahashi, T.; Hada, M.; Fujii, H. 2014: Di-μ-oxo dimetal core of Mn(IV) and Ti(IV) as a linker between two chiral salen complexes leading to the stereoselective formation of different M- and P-helical structures. Inorganic Chemistry 53(2): 1070-1079
Assey, G.E.; Yisgedu, T.; Gultneh, Y.; Butcher, R.J.; Tesema, Y. 2009: Di-μ-perchlorato-bis-{μ-2-[(2-pyrid-yl)methyl-amino-meth-yl]phenolato)dicopper(II) acetonitrile disolvate. Acta Crystallographica. Section E Structure Reports Online 65(Pt 8): M1007-M1008
Meng, Q.; Cross, A.M.; May, P.S.; Sykes, A.G.; Berry, M.T. 2011: Di-μ-pivalato-κO,O':O';κO:O,O'-bis-[(methanol-κO)bis-(2,2,6,6-tetra-methylhepta-ne-3,5-dionato)praseo-dymium(III). Acta Crystallographica. Section e Structure Reports Online 67(Part 11): M1514-M1515
Yang, M.-X.; Lin, S.; Shen, H.-Y.; Chen, L.-J. 2010: Di-μ-sulfato-bis-[diaqua-(1H-imidazo[4,5-f][1,10]phenanthroline)iron(II)] dihydrate. Acta Crystallographica. Section e Structure Reports Online 66(Part 9): M1129-M1130
Zeng, W.; She, J.-H.; Wang, C.-J.; Fang, Y. 2008: Di-μ-sulfato-bis-[diaqua-(1H-imidazo[4,5-f][1,10]phenanthroline)nickel(II)] dihydrate. Acta Crystallographica. Section e Structure Reports Online 65(Part 1): M42-M43
Wu, Y.; Wang, X.; You, X. 2008: Di-μ-sulfato-bis-{[bis-(3,5-dimethyl-pyrazol-1-yl)methane]copper(II)}. Acta Crystallographica. Section E Structure Reports Online 64(Pt 10): M1242
Yang, M.-X.; Lin, S.; Chen, L.-J.; Chen, X.-H. 2010: Di-μ-sulfato-κO:O'-bis-[diaqua-(1H-imidazo[4,5-f][1,10]phenanthroline)manganese(II)] dihydrate. Acta Crystallographica. Section e Structure Reports Online 66(Part 9): M1115-M1116
Gong, Y.; Zhou, Y.; Li, J.; Wu, X.; Qin, J. 2009: Di-μ-sulfato-κO:O'-bis-[diaqua-(1H-imidazo[4,5-f][1,10]phenanthroline-κN,N)cobalt(II)] dihydrate. Acta Crystallographica. Section E Structure Reports Online 65(Part 8): M844-M845
Lin, P-Xi.; Yang, G-Bin.; An, Z. 2010: Di-μ-sulfato-κO:O'-bis-{bis-[3-(2-pyrid-yl)pyrazole]cobalt(II)}. Acta Crystallographica. Section E Structure Reports Online 66(Pt 4): M375
Haehnel, M.; Altenburger, K.; Spannenberg, A.; Arndt, P.; Rosenthal, U. 2012: Di-μ-sulfido-bis-{[rac-1,2-bis-(η(5)-4,5,6,7-tetra-hydro-inden-1-yl)ethane]-zirconium(IV)} toluene monosolvate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 11): M1425
Pagano, S.; Schnick, W. 2008: Di-μ-tert-butanolato-bis-[bis-(η-cyclo-penta-dien-yl)erbium(III). Acta Crystallographica. Section E Structure Reports Online 64(Part 3): M473
Li, X-Wen.; Qiu, Y. 2007: Di-μ-thio-cyanato-bis-({2,4-dichloro-6-[2-(diethyl-amino)ethyl-imino-meth-yl]phenolato}copper(II)). Acta Crystallographica. Section E Structure Reports Online 64(Pt 1): M218
Khumalo, N.M.; Meijboom, R.; Muller, A.; Omondi, B. 2010: Di-μ-thio-cyanato-bis-[bis-(tri-p-tolyl-phosphine)silver(I)] 0.35-hydrate. Acta Crystallographica. Section E Structure Reports Online 66(Part 4): M451-M452
Yang, L.; Zhu, C.; Li, D. 2010: Di-μ-thio-cyanato-bis-{[1,2-bis-(diiso-propyl-phosphan-yl)-1,2-dicarba-closo-dodeca-borane]silver(I)}. Acta Crystallographica. Section E Structure Reports Online 67(Pt 1): M2
Lin, H-Wei. 2008: Di-μ-thio-cyanato-κN:N-bis-({2,4-di-bromo-6-[2-(methyl-amino)ethyl-imino-meth-yl]-phenol-ato-κN,N',O}nickel(II)). Acta Crystallographica. Section E Structure Reports Online 64(Pt 2): M295
Wang, N.; Xue, R.; Li, B.; Yang, Y-Ping.; Cao, M. 2010: Di-μ-thio-cyanato-κN:N-bis-({5-meth-oxy-2-[3-(methyl-amino)propyl-imino-meth-yl]phenolato-κO,N,N'}copper(II)). Acta Crystallographica. Section E Structure Reports Online 66(Pt 5): M601-M602
Suleiman Gwaram, N.; Ikmal Hisham, N.Azimah.; Khaledi, H.; Mohd Ali, H. 2011: Di-μ-thio-cyanato-κN:S;κS:N-bis-({2-morpholino-N-[1-(2-pyrid-yl)ethyl-idene]ethanamine-κN,N',N''}(thio-cyanato-κN)cadmium). Acta Crystallographica. Section E Structure Reports Online 67(Pt 2): M251
A Shaker, S.; Khaledi, H.; Mohd Ali, H. 2010: Di-μ-thio-cyanato-κN:S;κS:N-bis-[bis-(2-methyl-1H-benzimidazole-κN)(thio-cyanato-κN)cadmium(II). Acta Crystallographica. Section E Structure Reports Online 66(Part 11): M1464
Wattanakanjana, Y.; Pakawatchai, C.; Nimthong, R. 2013: Di-μ-thio-semicarbazide-κ(4)S:S-bis-[chlori-dobis(triphenyl-phosphane-κP)silver(I). Acta Crystallographica. Section E Structure Reports Online 69(Part 2): M83-M84
Jia, L.; Ma, S.-X.; Li, D.-C. 2008: Di-μ-thio-semicarbazide-κS:S-bis-[bis-(thio-semicarbazide-κS)copper(I)] diiodide. Acta Crystallographica. Section e Structure Reports Online 64(Part 6): M820
Zhang, K.; Sato, O. 2014: Di-μ-tricyanido-tetra-cyanidobis[hydro-tris-(pyrazoylborato)]tetra-methanol-diiron(III)iron(II) di-methanol disolvate. Acta Crystallographica. Section E Structure Reports Online 70(Part 2): M56
Merola, J.S.; Morris, D.; De Weerd, N. 2013: Di-μ2-chlorido-bis-[chlorido(η(5)-2,3,4,5-tetra-methyl-1-propyl-cyclo-penta-dien-yl)iridium(III). Acta Crystallographica. Section E Structure Reports Online 69(Part 3): M176
Liu, J.-J.; Liao, J.-Z.; Li, Z.-Y.; Wang, Y.; Huang, C.-C. 2013: Di-μ2-chlorido-dichloridobis(dimethylformamide)tetrakis[μ3-1-(2-oxidobenzoyl)-2-(2-oxo-2-phenylethanethioyl)hydrazine-1,2-diido]octacopper(II) dimethylformamide disolvate. Acta Crystallographica. Section C Crystal Structure Communications 69(Part 6): 613-615
Najafi, E.; Amini, M.M.; Ng, S.W. 2012: Di-μ2-ethano-lato-octa-methyl-bis-(μ-4-methyl-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazol-1-ido-κ(2) N (1):N (2))di-μ3-oxido-tetra-tin(IV). Acta Crystallographica. Section e Structure Reports Online 68(Part 12): M1545
Najafi, E.; Amini, M.M.; Ng, S.W. 2012: Di-μ2-isopropano-lato-octa-methyl-bis-(μ-4-methyl-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazol-1-ido-κ(2) N (1):N (2))di-μ3-oxido-tetra-tin(IV). Acta Crystallographica. Section e Structure Reports Online 68(Part 12): M1546
Ng, S.Weng. 2012: Di-μ3-acetato-bis-{μ-6,6'-dieth-oxy-2,2'-[propane-1,2-diylbis(nitrilo-methanylyl-idene)]diphenolato}dicadmiumdisodium ethanol 0.67-solvate. Acta Crystallographica. Section E Structure Reports Online 68(Pt 12): M1548-M1549
Gao, S.; Fan, J.; Sun, S.; Song, F.; Peng, X.; Duan, Q.; Jiang, D.; Liang, Q. 2012: Di/mono-nuclear iron(I)/(II) complexes as functional models for the 2Fe2S subunit and distal Fe moiety of the active site of [FeFe] hydrogenases: protonations, molecular structures and electrochemical properties. Dalton Transactions 41(39): 12064-12074
Rivero-Müller, A.; Jonas, K.C.; Hanyaloglu, A.C.; Huhtaniemi, I. 2013: Di/oligomerization of GPCRs-mechanisms and functional significance. Progress in Molecular Biology and Translational Science 117: 163-185
Heideman, W.H.; Nierkens, V.; Stronks, K.; Middelkoop, B.J.C.; Twisk, J.W.R.; Verhoeff, A.P.; de Wit, M.; Snoek, F.J. 2011: DiAlert: a lifestyle education programme aimed at people with a positive family history of type 2 diabetes and overweight, study protocol of a randomised controlled trial. Bmc Public Health 11: 751
Heideman, W.H.; de Wit, M.; Middelkoop, B.J.C.; Nierkens, V.; Stronks, K.; Verhoeff, A.P.; Snoek, F.J. 2012: DiAlert: a prevention program for overweight first degree relatives of type 2 diabetes patients: results of a pilot study to test feasibility and acceptability. Trials 13: 178
Keith-Hynes, P.; Guerlain, S.; Mize, B.; Hughes-Karvetski, C.; Khan, M.; McElwee-Malloy, M.; Kovatchev, B.P. 2013: DiAs user interface: a patient-centric interface for mobile artificial pancreas systems. Journal of Diabetes Science and Technology 7(6): 1416-1426
Place, J.ér.ôm.; Robert, A.; Ben Brahim, N.; Keith-Hynes, P.; Farret, A.; Pelletier, M.-J.ée.; Buckingham, B.; Breton, M.; Kovatchev, B.; Renard, E. 2013: DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials. Journal of Diabetes Science and Technology 7(6): 1427-1435
Scornik, F.S.; Bucciero, R.S.; Wu, Y.; Selga, E.; Bosch Calero, C.; Brugada, R.; Pérez, G.J. 2013: DiBAC₄(3) hits a "sweet spot" for the activation of arterial large-conductance Ca²⁺-activated potassium channels independently of the β₁-subunit. American Journal of Physiology. Heart and Circulatory Physiology 304(11): H1471-H1482
Babadi, B.; McKinney, S.M.; Tarokh, V.; Ellenbogen, J.M. 2012: DiBa: a data-driven Bayesian algorithm for sleep spindle detection. IEEE Transactions on Bio-Medical Engineering 59(2): 483-493
Sevrain, C.M.; Haelters, J.-P.; Chantôme, A.él.; Couthon-Gourvès, H.él.èn.; Gueguinou, M.; Potier-Cartereau, M.; Vandier, C.; Jaffrès, P.-A. 2013: DiGalactosyl-Glycero-Ether Lipid: synthetic approaches and evaluation as SK3 channel inhibitor. Organic and Biomolecular Chemistry 11(27): 4479-4487
Zammit, A.; Grech Marguerat, D.; Psaila, J.; Attard, A. 2013: DiGeorge Syndrome Presenting as Hypocalcaemia-Induced Seizures in Adulthood. Case Reports in Medicine 2013: 923129
Fomin, A.B.F.; Pastorino, A.C.; Kim, C.A.; Pereira, C.A.; Carneiro-Sampaio, M.; Abe-Jacob, C.M. 2010: DiGeorge Syndrome: a not so rare disease. Clinics 65(9): 865-869
Rope, A.F.; Cragun, D.L.; Saal, H.M.; Hopkin, R.J. 2009: DiGeorge anomaly in the absence of chromosome 22q11.2 deletion. Journal of Pediatrics 155(4): 560-565
Barr, I.; Smith, A.T.; Senturia, R.; Chen, Y.; Scheidemantle, B.D.; Burstyn, J.N.; Guo, F. 2011: DiGeorge critical region 8 (DGCR8) is a double-cysteine-ligated heme protein. Journal of Biological Chemistry 286(19): 16716-16725
Garcia, P.; Anjos, R.; Abecassis, M.; Santos, Jé.A.Oliveira.; Martins, F.Maymone. 2009: DiGeorge syndrome and vascular ring. An unusual association with multidisciplinary approach. Revista portuguesa de cirurgia cardio-toracica e vascular: orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular 16(3): 129-132
Chen, Z.; Wu, J.; Yang, C.; Fan, P.; Balazs, L.; Jiao, Y.; Lu, M.; Gu, W.; Li, C.; Pfeffer, L.M.; Tigyi, G.; Yue, J. 2012: DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in mice. Journal of Biological Chemistry 287(23): 19018-19028
Choudhry, P.; Trede, N.S. 2013: DiGeorge syndrome gene tbx1 functions through wnt11r to regulate heart looping and differentiation. Plos one 8(3): E58145
Luo, K.-J.; Chen, P.-Y.; Li, W. 2014: DiGeorge syndrome in a neonate. Zhongguo Dang Dai Er Ke Za Zhi 16(9): 949-951
Johnston, P.C.; Donnelly, D.E.; Donnelly, D.K.; Morrison, P.J.; Hunter, S.J. 2008: DiGeorge syndrome presenting as late onset hypocalcaemia in adulthood. Ulster Medical Journal 77(3): 201-202
Sainz de Los Terreros, A.; Cecilio, A. 2011: DiGeorge syndrome with mild episodic hypocalcemia. Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia y Nutricion 58(2): 92-94
Yutzey, K.E. 2010: DiGeorge syndrome, Tbx1, and retinoic acid signaling come full circle. Circulation Research 106(4): 630-632
Popović-Deušić, S.; Lečić-Toševski, Dšica.; Pejović-Milovančić, M.; Draganić-Gajić, S.; Aleksić-Hil, O.; Radosavljev-Kirćanski, J. 2011: DiGeorge syndrome: a case report. Srpski Arhiv Za Celokupno Lekarstvo 139(9-10): 681-684
Nikitina, N.; Bronner-Fraser, M.; Sauka-Spengler, T. 2009: Dii cell labeling in lamprey embryos. Cold Spring Harbor Protocols 1: Pdb.Prot 5124
Froelich, K.; Steussloff, G.; Schmidt, K.; Ramos Tirado, M.; Technau, A.; Scherzed, A.; Hackenberg, S.; Radeloff, A.; Hagen, R.; Kleinsasser, N. 2013: Dii labeling of human adipose-derived stem cells: evaluation of DNA damage, toxicity and functional impairment. Cells Tissues Organs 197(5): 384-398
Lee, B.-C.; Jhang, S.-U.; Choi, J.-H.; Lee, S.-Y.; Ryu, P.-D.; Soh, K.-S. 2009: Dii staining of fine branches of Bonghan ducts on surface of rat abdominal organs. Journal of Acupuncture and Meridian Studies 2(4): 301-305
Schmidt, H.; Rathjen, F.G. 2011: DiI-labeling of DRG neurons to study axonal branching in a whole mount preparation of mouse embryonic spinal cord. Journal of Visualized Experiments: Jove 2011(58)
Liu, Y.; Tennant, D.A.; Zhu, Z.; Heath, J.K.; Yao, X.; He, S. 2014: DiME: a scalable disease module identification algorithm with application to glioma progression. Plos one 9(2): E86693
Walter, V.; Nobel, A.B.; Wright, F.A. 2011: DiNAMIC: a method to identify recurrent DNA copy number aberrations in tumors. Bioinformatics 27(5): 678-685
Deshpande, K.; Ganz, A. 2009: DiNAR: health monitoring of IT systems in emergency response. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 1699-1702
Seabold, G.K.; Daunais, J.B.; Rau, A.; Grant, K.A.; Alvarez, V.A. 2010: DiOLISTIC labeling of neurons from rodent and non-human primate brain slices. Journal of Visualized Experiments: Jove 2010(41)
Staffend, N.A.; Meisel, R.L. 2011: DiOlistic Labeling of Neurons in Tissue Slices: a Qualitative and Quantitative Analysis of Methodological Variations. Frontiers in Neuroanatomy 5: 14
Staffend, N.A.; Meisel, R.L. 2011: DiOlistic labeling in fixed brain slices: phenotype, morphology, and dendritic spines. Current Protocols in Neuroscience Chapter 2: Unit 2.13
Sherazee, N.; Alvarez, V.A. 2013: DiOlistics: delivery of fluorescent dyes into cells. Methods in Molecular Biology 940: 391-400
Li, H.; Buschman, L.L.; Huang, F.; Zhu, K.Y.; Bonning, B.; Oppert, B. 2007: DiPel-selected Ostrinia nubilalis larvae are not resistant to transgenic corn expressing Bacillus thuringiensis Cry1Ab. Journal of Economic Entomology 100(6): 1862-1870
Friedel, M.; Nikolajewa, S.; Sühnel, J.ür.; Wilhelm, T. 2009: DiProDB: a database for dinucleotide properties. Nucleic Acids Research 37(Database Issue): D37-D40
Friedel, M.; Nikolajewa, S.; Sühnel, J.ür.; Wilhelm, T. 2009: DiProGB: the dinucleotide properties genome browser. Bioinformatics 25(19): 2603-2604
Ruan, J.; Song, H.; Li, C.; Bao, C.; Fu, H.; Wang, K.; Ni, J.; Cui, D. 2012: DiR-labeled Embryonic Stem Cells for Targeted Imaging of in vivo Gastric Cancer Cells. Theranostics 2(6): 618-628
Gotea, V.; Ovcharenko, I. 2008: DiRE: identifying distant regulatory elements of co-expressed genes. Nucleic Acids Research 36(Web Server Issue): W133-W139
Park, J.-y.; Ike, M.; Arakane, M.; Shiroma, R.; Li, Y.; Arai-Sanoh, Y.; Kondo, M.; Tokuyasu, K. 2011: DiSC (direct saccharification of culms) process for bioethanol production from rice straw. Bioresource Technology 102(11): 6502-6507
Wójcikowski, M.; Zielenkiewicz, P.; Siedlecki, P.ł 2014: DiSCuS: an open platform for (not only) virtual screening results management. Journal of Chemical Information and Modeling 54(1): 347-354
Kovacheva, V.N.; Khan, A.M.; Khan, M.; Epstein, D.B.A.; Rajpoot, N.M. 2014: DiSWOP: a novel measure for cell-level protein network analysis in localized proteomics image data. Bioinformatics 30(3): 420-427
Ghosh, T.Shankar.; Monzoorul Haque, M.; Mande, S.S. 2010: DiScRIBinATE: a rapid method for accurate taxonomic classification of metagenomic sequences. Bmc Bioinformatics 11 Suppl. 7: S14
Cocherel, N.; Poriel, C.; Vignau, L.; Bergamini, J.-F.ço.; Rault-Berthelot, J.ël. 2010: DiSpiroXanthene-IndenoFluorene: a new blue emitter for nondoped organic light emitting diode applications. Organic Letters 12(3): 452-455
Greenhill, L.M. 2009: DiVersity Matters: a review of the diversity initiative of the Association of American Veterinary Medical Colleges. Journal of veterinary medical education 36(4): 359-362
Wyse, M.M.; Lei, J.; Nestor-Kalinoski, A.L.; Eisenmann, K.M. 2012: Dia-interacting protein (DIP) imposes migratory plasticity in mDia2-dependent tumor cells in three-dimensional matrices. Plos one 7(9): E45085
Ray, S.C.; Sahu, D.R.; Papakonstantinou, P. 2011: Dia-magnetic to ferro-magnetic behavioral change of Fe-catalysts based nitrogenated carbon nanotubes (NCNTs) by the process of chlorination/oxidation. Journal of Nanoscience and Nanotechnology 11(9): 8269-8273
Andress, E.J.; Holic, R.; Edelmann, M.J.; Kessler, B.M.; Yu, V.P.C.C. 2011: Dia2 controls transcription by mediating assembly of the RSC complex. Plos one 6(6): E21172
Keyamura, K.; Abe, Y.; Higashi, M.; Ueda, T.; Katayama, T. 2009: DiaA dynamics are coupled with changes in initial origin complexes leading to helicase loading. Journal of Biological Chemistry 284(37): 25038-25050
Zawilak-Pawlik, A.; Donczew, R.ł; Szafrański, S.; Mackiewicz, P.ł; Terradot, L.; Zakrzewska-Czerwińska, J. 2011: DiaA/HobA and DnaA: a pair of proteins co-evolved to cooperate during bacterial orisome assembly. Journal of Molecular Biology 408(2): 238-251
Semjonow, A. 2007: DiaPat test for prostate cancer diagnosis. Der Urologe. Ausg. a 46(10): 1428
Oberpenning, F.; von Knobloch, R.; Sprute, W.; Roth, S.; Rathert, M.; Bierer, S.; Gerss, J.; Semjonow, A. 2008: DiaPat urine test for prostate cancer. Predictive value for results of transrectal ultrasound-guided prostate biopsies. Der Urologe. Ausg. a 47(6): 735-739
Tuccinardi, D.; Fioriti, E.; Manfrini, S.; D'Amico, E.; Pozzilli, P. 2011: DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes. Expert Opinion on Biological Therapy 11(9): 1233-1240
Schloot, N.C.; Cohen, I.R. 2013: DiaPep277® and immune intervention for treatment of type 1 diabetes. Clinical Immunology 149(3): 307-316
Aminian, A.; Brethauer, S.A.; Kashyap, S.R.; Kirwan, J.P.; Schauer, P.R. 2014: DiaRem score: external validation. LANCET. Diabetes and Endocrinology 2(1): 12-13
Kenngott, H.G.; Clemens, G.; Gondan, M.; Senft, J.; Diener, M.K.; Rudofsky, G.; Nawroth, P.P.; Büchler, M.W.; Fischer, L.; Müller-Stich, B.P. 2013: DiaSurg 2 trial--surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial--DRKS00004550. Trials 14: 183
Reddy, K.Srinivas.; Reddy, R.Sunil.Kumar.; Sudheer, A.; Reddy, R.Vamshidhar.; Rao, N.Venugopal.; Reddy, P.Lakshmipathy. 2013: DiaTreat: a new method of communication for better diagnosis and treatment of dental problems. Journal of Contemporary Dental Practice 14(1): 158-161
Invernizzi, G. 2013: Diab'à'table, a patient education program dedicated to eating behaviors. Soins; la Revue de Reference Infirmiere 2013(773): 19-21
Alguire, E.; Subotnik, J.E. 2011: Diabatic couplings for charge recombination via Boys localization and spin-flip configuration interaction singles. Journal of Chemical Physics 135(4): 044114
Hoyer, C.E.; Xu, X.; Ma, D.; Gagliardi, L.; Truhlar, D.G. 2014: Diabatization based on the dipole and quadrupole: the DQ method. Journal of Chemical Physics 141(11): 114104
Carral San Laureano, F.; Ayala Ortega, Mía.del.Carmen.; Jiménez Millán, A.Isabel.; Piñero Zaldivar, A.; García Calzado, Cón.; Prieto Ferrón, M.; Silva Rodríguez, J.José. 2013: DiabeTIC website: a pilot study of satisfaction and impact on metabolic control. Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia y Nutricion 60(8): 441-446
Galli-Tsinopoulou, A.; Grammatikopoulou, M.G.; Stylianou, C.; Emmanouilidou, E.; Kokka, P. 2010: Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese. Journal of Endocrinological Investigation 33(8): 549-553
Kalra, S. 2013: Diabesity. Jpma. Journal of the Pakistan Medical Association 63(4): 532-534
Stoclet, J.-C. 2013: Diabesity and cardiovascular diseases: Novel mediators and novel targets. Annales Pharmaceutiques Francaises 71(1): 4-6
Anjum, Q. 2011: Diabesity--a future pandemic. Jpma. Journal of the Pakistan Medical Association 61(4): 321
Farag, Y.M.K.; Gaballa, M.R. 2011: Diabesity: an overview of a rising epidemic. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 26(1): 28-35
Kral, J.G. 2014: Diabesity: palliating, curing or preventing the dysmetabolic diathesis. Maturitas 77(3): 243-248
Chauhan, H.K.C. 2012: Diabesity: the 'Achilles Heel' of our modernized society. Revista da Associacao Medica Brasileira 58(4): 399
Colagiuri, S. 2010: Diabesity: therapeutic options. Diabetes Obesity and Metabolism 12(6): 463-473
Mathieu, M.-E.; Brochu, M.; Béliveau, L. 2008: DiabetAction: changes in physical activity practice, fitness, and metabolic syndrome in type 2 diabetic and at-risk individuals. Clinical Journal of Sport Medicine: Official Journal of the Canadian Academy of Sport Medicine 18(1): 70-75
Joslin, E.P. 1948: Diabetes. New England Journal of Medicine 238(14): 471-476
Joslin, E.P. 1948: Diabetes. New England Journal of Medicine 238(13): 437
Lomberk, G. 2009: Diabetes. Pancreatology: Official Journal of the International Association of Pancreatology . 9(3): 200-202
Stockhammer, F.; Misch, M.; Helms, H.-J.; Lengler, U.; Prall, F.; von Deimling, A.; Hartmann, C. 2012: IDH1/2 mutations in WHO grade Ii astrocytomas associated with localization and seizure as the initial symptom. Seizure 21(3): 194-197
Anonymous 2014: Diabetes. Nursing Standard: 1987) 28(22): 19
Taylor, R. 2014: Diabetes. Nursing Standard: 1987) 29(3): 61
Ali, M.K.; Narayan, K.M.V.; Tandon, N. 2010: Diabetes and coronary heart disease: current perspectives. Indian Journal of Medical Research 132: 584-597
D'Arrigo, T. 2007: Diabetes and depression. a twin threat to women's hearts. Research profile. Julie Ann Wagner, PhD. Diabetes Forecast 60(6): 59-60
Young, F.; Critchley, J.; Unwin, N. 2009: Diabetes and tuberculosis: a dangerous liaison and no white tiger. Indian Journal of Medical Research 130(1): 1-4
Ruder, K. 2007: Diabetes & your \$. Here's how to control the costs of prescriptions and supplies. Diabetes Forecast 60(4): 44-47
Saunders, M.; Schattner, P.; Mathews, M. 2008: Diabetes 'cycles of care' in general practice - do government incentives help?. Australian Family Physician 37(9): 781-784
Hoffmann, F.; Icks, A. 2012: Diabetes 'epidemic' in Germany? a critical look at health insurance data sources. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 120(7): 410-415
Maugh, T.H. 1975: Diabetes (II): Model Systems Indicate Viruses a Cause. Science 188(4187): 436-438
Maugh, T.H. 1975: Diabetes (III): new Hormones Promise more Effective Therapy. Science 188(4191): 920-923
Beckles, G.L.; Zhu, J.; Moonesinghe, R. 2011: Diabetes - United States, 2004 and 2008. Mmwr Suppls 60(1): 90-93
Beckles, G.L.; Chou, C.-F. 2013: Diabetes - United States, 2006 and 2010. Mmwr Suppls 62(3): 99-104
Gebel, E. 2009: Diabetes 101. Gastroparesis. Feeling full. This nerve disorder can leave your stomach out of sync. Diabetes Forecast 62(10): 39-40
Ganapathy, P.S.; Roon, P.; Moister, T.K.V.E.; Mysona, B.; Smith, S.B. 2009: Diabetes Accelerates Retinal Neuronal Cell Death in a Mouse Model of Endogenous Hyperhomocysteinemia. Ophthalmology and Eye Diseases 1: 3-11
Joslin, E.P.; Lahey, F.H. 1934: Diabetes and Hyperthyroidism. Annals of Surgery 100(4): 629-637
Nixon, J.A. 1924: Diabetes and Insulin. British Medical Journal 1(3289): 53-55
Tew, W.P. 1947: Diabetes and Maternity. Canadian Medical Association Journal 57(5): 441-445
Anonymous 1943: Diabetes and the Eye. British journal of ophthalmology 27(11): 509-513
Schlosser, M.; Mueller, P.W.; Achenbach, P.; Lampasona, V.; Bingley, P.J. 2011: Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2β. Diabetes Care 34(11): 2410-2412
Schlosser, M.; Mueller, P.W.; Törn, C.; Bonifacio, E.; Bingley, P.J. 2010: Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia 53(12): 2611-2620
Keith, A. 1930: An Oration on THE INEXORABILITY OF THE LAW OF EVOLUTION AS MANIFESTED IN MODERN MEDICINE. British Medical Journal 1(3619): 893-895
McCreery, A.H. 1917: Diabetes Associated with Haemochromatosis. Canadian Medical Association Journal 7(6): 481-502
Lou, Q.; Chen, Y.; Guo, X.; Yuan, L.; Chen, T.; Wang, C.; Shen, L.; Sun, Z.; Zhao, F.; Dai, X.; Huang, J.; Yang, H. 2014: Diabetes Attitude Scale: validation in type-2 diabetes patients in multiple centers in China. Plos one 9(5): E96473
Peyrot, M.; Burns, K.Kovacs.; Davies, M.; Forbes, A.; Hermanns, N.; Holt, R.; Kalra, S.; Nicolucci, A.; Pouwer, F.; Wens, J.; Willaing, I.; Skovlund, Søren.E. 2013: Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Research and Clinical Practice 99(2): 174-184
Kovacs Burns, K.; Nicolucci, A.; Holt, R.I.G.; Willaing, I.; Hermanns, N.; Kalra, S.; Wens, J.; Pouwer, F.; Skovlund, S.E.; Peyrot, M.; Malek, R.; Wens, J.; Salles, Jão.Eduardo.; Burns, K.Kovacs.; Vallis, M.; Guo, X.; Willaing, I.; Skovlund, Søren.Eik.; Reach, Gérard.; Hermanns, N.; Kulzer, B.; Kalra, S.; Nicolucci, A.; Comaschi, M.; Ishii, H.; Escalante, M.; Pouwer, F.; Kokoszka, A.; Mayorov, A.; Torre, E.Menéndez.; Tarkun, I.; Davies, M.; Holt, R.; Forbes, A.; Munro, N.; Peyrot, M. 2013: Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking indicators for family members living with people with diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 30(7): 778-788
Nicolucci, A.; Kovacs Burns, K.; Holt, R.I.G.; Comaschi, M.; Hermanns, N.; Ishii, H.; Kokoszka, A.; Pouwer, F.; Skovlund, S.E.; Stuckey, H.; Tarkun, I.; Vallis, M.; Wens, J.; Peyrot, M.; Malek, R.; Wens, J.; Salles, Jão.Eduardo.; Burns, K.Kovacs.; Vallis, M.; Guo, X.; Willaing, I.; Skovlund, Søren.Eik.; Reach, Gérard.; Hermanns, N.; Kulzer, B.; Kalra, S.; Nicolucci, A.; Comaschi, M.; Ishii, H.; Escalante, M.; Pouwer, F.; Kokoszka, A.; Mayorov, A.; Torre, E.Menéndez.; Tarkun, I.; Davies, M.; Holt, R.; Forbes, A.; Munro, N.; Peyrot, M. 2013: Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 30(7): 767-777
Ludvik, B.; Schernthaner, G. 2012: Diabetes Care Austria 2009: registry for type 2 diabetic patients in general practitioners' ordinations in Austria. Wiener Klinische Wochenschrift 124(3-4): 69-77
Cleveringa, F.G.W.; Minkman, M.H.; Gorter, K.J.; van den Donk, M.; Rutten, G.E.H.M. 2010: Diabetes Care Protocol: effects on patient-important outcomes. a cluster randomized, non-inferiority trial in primary care. Diabetic Medicine: a Journal of the British Diabetic Association 27(4): 442-450
Alyaarubi, S. 2011: Diabetes Care in Oman: Obstacles and solutions. Sultan Qaboos University Medical Journal 11(3): 343-348
Anonymous 2014: Diabetes Care. Introduction. Diabetes Care 37 Suppl. 1: S2-S3
Cefalu, W.T. 2013: Diabetes Care: "state of the union". Diabetes Care 36(1): 1-3
Liebson, P.R. 2008: Diabetes Control and Cardiovascular Risk: ACCORD, ADVANCE, AVOID, and SANDS. Preventive cardiology 11(4): 230-236
Pandey, D.; Aiyer, H.Malini.; Pandey, R. 2012: Diabetes Cured by Pancreaticoduodenectomy: A Case Report of Glucagonoma Masquerading as Carcinoma of the Head of Pancreas. Journal of Gastrointestinal Cancer 43 Suppl. 1: S114-S116
Bendkowski, B. 1959: Boils in Allergic Patients. Journal of the College of General Practitioners and Research Newsletter. College of General Practitioners 2(2): 182-189
Oates, T.W.; Huynh-Ba, G. 2012: Diabetes Effects on Dental Implant Survival. Forum Implantologicum 8(2): 7-14
Chen, M.-F.; Wang, R.-H.; Cheng, C.-P.; Chin, C.-C.; Stocker, J.; Tang, S.-M.; Chen, S.-W. 2011: Diabetes Empowerment Process Scale: development and psychometric testing of the Chinese version. Journal of Advanced Nursing 67(1): 204-214
Neithercott, T. 2012: Diabetes Forecast 2012 consumer guide. Diabetes Forecast 65(1): 27-30
Patel, J.V.; Hughes, E.A.; Lip, G.Y.H.; Gill, P.S. 2011: Diabetes Health, Residence and Metabolism in Asians: the DHRMA study, research into foods from the Indian subcontinent - a blinded, randomised, placebo controlled trial. Bmc Cardiovascular Disorders 11: 70
Davis, T.C.; Seligman, H.K.; Dewalt, D.A.; Platt, D.J.; Reynolds, C.; Timm, D.F.; Arnold, C.L. 2012: Diabetes Implementation of a Self-management Program in Resource Poor and Rural Community Clinics. Journal of Primary Care and Community Health 3(4): 239-242
Smith, R.P. 1927: Diabetes in a Child Three Years of Age. Canadian Medical Association journal 17(2): 214-216
Lowrie, M.I. 1954: Diabetes in An Aged Dog. Canadian Journal of Comparative Medicine and Veterinary Science 18(11): 414-415
Beattie, W.A. 1917: Diabetes in Pregnancy, with Report of Cases. California State Journal of Medicine 15(1): 11-13
Graham, E.A. 1917: Diabetes Insipidus as a Sequel to a Gunshot Wound of the Head. Annals of Surgery 66(5): 529-531
Patrick, A. 1931: Diabetes Insipidus following Fractured Skull. British Medical Journal 2(3693): 689-691
Biggart, J.H. 1938: Diabetes Insipidus the Role of the Anterior Hypophysis. Ulster Medical Journal 7(2): 115-119
Court, D.; Taylor, S.A. 1939: Diabetes Insipidus Treated by slowly acting Pituitary Emulsion. Proceedings of the Royal Society of Medicine 32(10): 1203-1206
Al Salloom, A.A.; Almalki, S.T.; Almana, H.; Burdelski, M. 2013: Diabetes Insipidus and Sclerosing Cholangitis in a child may be a clue to the diagnosis of Langerhans' Cell Histiocytosis: A Case Report. International Journal of Health Sciences 7(2): 248-251
Ellis, R.W. 1933: Diabetes Insipidus and ? Anterior Pituitary Lobe Deficiency. Proceedings of the Royal Society of Medicine 26(3): 282-284
Whipham, T.R. 1915: Diabetes Insipidus with Infantilism. Proceedings of the Royal Society of Medicine 8(Sect Study Dis Child): 10
Sequeira, J.H. 1914: Diabetes Insipidus with Papular and Nodular Xanthomata. Proceedings of the Royal Society of Medicine 7(Dermatol Sect): 262
McHugo, J.; Harden, A. 2011: Diabetes Insipidus. Navigating troubled waters. Advance for Nps and Pas 2(4): 20-23; Quiz 24
Kirtland, K.A.; Burrows, N.R.; Geiss, L.S. 2014: Diabetes Interactive Atlas. Preventing Chronic Disease 11: 130300
Speight, J.; Browne, J.L.; Holmes-Truscott, E.; Hendrieckx, C.; Pouwer, F. 2012: Diabetes MILES--Australia (management and impact for long-term empowerment and success): methods and sample characteristics of a national survey of the psychological aspects of living with type 1 or type 2 diabetes in Australian adults. Bmc Public Health 12: 120
Nefs, G.; Bot, M.; Browne, J.L.; Speight, J.; Pouwer, Fçois. 2012: Diabetes MILES--The Netherlands: rationale, design and sample characteristics of a national survey examining the psychosocial aspects of living with diabetes in Dutch adults. Bmc Public Health 12: 925
Dionisio, R.; Giardini, A.; De Cata, P.; Pirali, B.; Rossi, S.; Negri, E.M.; Ferrari, P.; Preti, P. 2015: Diabetes Management in End of Life: A Preliminary Report Stemming From Clinical Experience. American Journal of Hospice and Palliative Care 32(6): 588-593
Krass, I.; Mitchell, B.; Song, Y.J.C.; Stewart, K.; Peterson, G.; Hughes, J.; Smith, L.; White, L.; Armour, C. 2011: Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 28(8): 987-993
Chang, K. 2010: Diabetes Medication Choice cards improve patient knowledge and involvement in decision-making, but do not improve medication adherence or glycaemic control. Evidence-Based Nursing 13(1): 25-26
Anderson, R.T.; Girman, C.J.; Pawaskar, M.D.; Camacho, F.T.; Calles, J.; Kelly, W.S.; DeMuro, C.; Balkrishnan, R. 2009: Diabetes Medication Satisfaction Tool: a focus on treatment regimens. Diabetes Care 32(1): 51-53
Jamieson, H.C. 1927: Diabetes Mellitus and Myxoedema. Canadian Medical Association Journal 17(1): 88-89
Nix, N.W. 1943: Diabetes Mellitus Associated with Addison's Disease. Canadian Medical Association Journal 49(3): 189-191
Clark, E. 1956: Diabetes Mellitus in a Six year Old Spayed Wire Haired Terrier. Canadian Journal of Comparative Medicine and Veterinary Science 20(2): 51-52
Brookfield, R.W.; Corbett, H.V. 1934: Diabetes Mellitus in Association with Degeneration of the Suprarenal Glands. British Medical Journal 1(3814): 231-246.2
Rapaport, H. 1927: Diabetes Mellitus with Myelogenous Leukemia and Miliary Tuberculosis: Case Report. California and Western Medicine 27(6): 802-803
Acevedo, A.; Diaz, Y.; Perez, C.M.; Garau, M.; Baron, J.; Cruz-Correa, M. 2012: Diabetes Mellitus and Colorectal Neoplasia. Journal of Cancer Therapy 3(6a): 859-865
Anonymous 1961: Diabetes Mellitus and Hormone Imbalance. British Medical Journal 2(5265): 1484-1485
Walker, A. 1928: Diabetes Mellitus and Pregnancy. Proceedings of the Royal Society of Medicine 21(3): 377-385
Huppertz, E.; Pieper, L.; Klotsche, J.; Stridde, E.; Pittrow, D.; Böhler, S.; Lehnert, H. 2009: Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 117(1): 6-14
Bird, J.D. 1960: Antibiotics in General Practice. Journal of the College of General Practitioners 3(4): 501
Lindsay, L.M. 1917: Diabetes Mellitus in a Child of Three. Canadian Medical Association Journal 7(2): 133-135
Ooi, C.G.; Haizee, H.N.; Kando, O.V.; Lua, G.W.; Philip, H.; Chan, S.P.; Ismail, I.S.; Rokiah, P.; Zaini, A.; Hew, F.L. 2002: Diabetes Mellitus in a Malaysian Teaching Hospital: Prevalence of Diabetes Mellitus and Frequency of Testing for Hypercholesterolaemia, Proteinuria and HbAlc. Medical Journal of Malaysia 57(2): 195-200
Payne, W.W. 1936: Diabetes Mellitus with an unusually Low Renal Threshold for Sugar. Proceedings of the Royal Society of Medicine 29(10): 1216
Stessman, J.; Jacobs, J.M. 2014: Diabetes Mellitus, Physical Activity, and Longevity Between the Ages of 70 and 90. Journal of the American Geriatrics Society 2014
Dib, S.A.; Tschiedel, B.; Nery, M. 2008: Diabetes Mellitus, Type 1 : from research to clinic. Arquivos Brasileiros de Endocrinologia e Metabologia 52(2): 143-145
Mosenthal, H.O. 1933: Diabetes Mellitus-Problems of Present day Treatment. Bulletin of the new York Academy of Medicine 9(9): 505-522
Khan, N.; Gomathi, K.G.; Shehnaz, S.Ilyas.; Muttappallymyalil, J. 2012: Diabetes Mellitus-Related Knowledge among University Students in Ajman, United Arab Emirates. Sultan Qaboos University Medical Journal 12(3): 306-314
Breithaupt, D.J.; Leckie, R.B. 1961: Diabetes Mellitus: a Study of the Practicability of Life Insurance. Canadian Medical Association Journal 85(6): 299-302
Awah, P.K.; Unwin, N.C.; Phillimore, P.R. 2009: Diabetes Mellitus: Indigenous naming, indigenous diagnosis and self-management in an African setting: the example from Cameroon. Bmc Endocrine Disorders 9: 5
de Oliveira, N.Ferreira.; Souza, M.Conceição.Bernardo.de.Mello.E.; Zanetti, M.Lúcia.; dos Santos, M.Antônio. 2011: Diabetes Mellitus: challenges related to self-care addressed in a Psychological Support Group. Revista Brasileira de Enfermagem 64(2): 301-307
Weng, J.; Pozzilli, P. 2014: Diabetes Metabolism: Research and Reviews--Chinese Diabetes Society special issue: a small but encouraging step toward the successful control of diabetes in China. Diabetes/metabolism research and reviews 30(6): 445-446
Liebreich, T.; Plotnikoff, R.C.; Courneya, K.S.; Boulé, N. 2009: Diabetes NetPLAY: A physical activity website and linked email counselling randomized intervention for individuals with type 2 diabetes. International Journal of Behavioral Nutrition and Physical Activity 6: 18
Kozak, B.M.; Tjota, M.Y.; Close, K.L. 2010: Diabetes News. Journal of Diabetes 2010
Regier, E.E.; Close, K.L. 2014: Diabetes News. Journal of Diabetes 2014
Venditti, E.M.; Kramer, M.Kaye. 2013: Diabetes Prevention Program community outreach: perspectives on lifestyle training and translation. American Journal of Preventive Medicine 44(4 Suppl. 4): S339-S345
Heikes, K.E.; Eddy, D.M.; Arondekar, B.; Schlessinger, L. 2008: Diabetes Risk Calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes. Diabetes Care 31(5): 1040-1045
Hivert, M.-F.; Warner, A.S.; Shrader, P.; Grant, R.W.; Meigs, J.B. 2009: Diabetes Risk Perception and Intention to Adopt Healthy Lifest yles Among Primary Care Patients. Diabetes Care 32(10): 1820-1822
Kiblinger, L.; Braza, N.L. 2007: Diabetes Risk/Improvement Scale. Diabetes Educator 33(4): 628; 630 632 Passim
Colvin, C.W.; Ashraf, A.P.; Griffin, R.L.; Diaz, B.T.; Yannam, G.R.; Johnson, J.E.; Lucas, A.P.; Propst, M.; Harmon, C.M. 2015: Diabetes Status and Race are Associated with Cardiovascular Risk Markers in Obese Adolescents. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 21(2): 165-173
Butterfield, W.J. 1964: Diabetes Survey in Bedford 1962. Proceedings of the Royal Society of Medicine 57(3): 196-200
Crombie, D.L. 1957: Diabetes Surveys. Research Newsletter. College of General Practitioners 1957(17): 319-321
Fera, T.; Bluml, B.M.; Ellis, W.M. 2009: Diabetes Ten City Challenge: final economic and clinical results. Journal of the American Pharmacists Association: Japha 49(3): 383-391
Pavy, F.W. 1869: Diabetes Treated with Carbonate of Ammonia, Administered Largely. British Medical Journal 1(443): 590
Kirby, T. 2013: Diabetes UK Professional Meeting. Lancet. Diabetes and Endocrinology 1 Suppl. 1: S21
Ansari, L. 2013: Diabetes UK defends its type 2 diabetes awareness campaign. Bmj 347: F7025
Dyson, P.A.; Kelly, T.; Deakin, T.; Duncan, A.; Frost, G.; Harrison, Z.; Khatri, D.; Kunka, D.; McArdle, P.; Mellor, D.; Oliver, L.; Worth, J. 2011: Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 28(11): 1282-1288
Young, B. 2013: Diabetes UK replies to Dr Aseem Malhotra. Bmj 346: F3999
Ansari, L. 2014: Diabetes UK responds to comments by Asimakopoulou and colleagues. Bmj 348: G1152
Castell, C. 2007: Diabetes World Day, November 14. Revista de Enfermeria 30(10): 5
Anonymous 1924: Diabetes a Century Ago. Canadian Medical Association Journal 14(5): 432-433
Tai, W.; Shi, E.; Yan, L.; Jiang, X.; Ma, H.; Ai, C. 2012: Diabetes abolishes the cardioprotection induced by sevoflurane postconditioning in the rat heart in vivo: roles of glycogen synthase kinase-3β and its upstream pathways. Journal of Surgical Research 178(1): 96-104
Mascarenhas-Melo, F.; Marado, D.; Palavra, F.; Sereno, J.é; Coelho, Ál.; Pinto, R.; Teixeira-Lemos, E.; Teixeira, F.; Reis, F.áv. 2013: Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovascular Diabetology 12: 61
Ha, Y.; Saul, A.; Tawfik, A.; Zorrilla, E.P.; Ganapathy, V.; Smith, S.B. 2012: Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1. Molecular Vision 18: 2860-2870
Caquard, M.èn.; Ferret-Bernard, S.ép.; Haurogné, K.; Ouary, M.èl.; Allard, M.; Jégou, D.; Bach, J.-M.; Lieubeau, B. 2010: Diabetes acceleration by cyclophosphamide in the non-obese diabetic mouse is associated with differentiation of immunosuppressive monocytes into immunostimulatory cells. Immunology Letters 129(2): 85-93
Fritschka, E. 2013: Diabetes acts as BNP booster. MMW Fortschritte der Medizin 155(16): 31
Isola, M.; Lantini, M.; Solinas, P.; Diana, M.; Isola, R.; Loy, F.; Cossu, M. 2011: Diabetes affects statherin expression in human labial glands. Oral Diseases 17(7): 685-689
Morgado, C.; Pinto-Ribeiro, F.; Tavares, I. 2008: Diabetes affects the expression of GABA and potassium chloride cotransporter in the spinal cord: a study in streptozotocin diabetic rats. Neuroscience Letters 438(1): 102-106
Ibrahim, H.N.; Kukla, A.; Cordner, G.; Bailey, R.; Gillingham, K.; Matas, A.J. 2010: Diabetes after kidney donation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(2): 331-337
Durrbach, A. 2006: Diabetes after transplantation. Nephrologie and Therapeutique 2(Suppl 3): S197-S199
Pavlakis, M.; Goldfarb-Rumyantzev, A.S. 2008: Diabetes after transplantation and sirolimus: what's the connection?. Journal of the American Society of Nephrology: Jasn 19(7): 1255-1256
Muresanu, D.F.; Sharma, A.; Sharma, H.S. 2010: Diabetes aggravates heat stress-induced blood-brain barrier breakdown, reduction in cerebral blood flow, edema formation, and brain pathology: possible neuroprotection with growth hormone. Annals of the new York Academy of Sciences 1199: 15-26
Sharma, H.Shanker.; Patnaik, R.; Sharma, A. 2010: Diabetes aggravates nanoparticles induced breakdown of the blood-brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. Journal of Nanoscience and Nanotechnology 10(12): 7931-7945
Pacios, S.; Kang, J.; Galicia, J.; Gluck, K.; Patel, H.; Ovaydi-Mandel, A.; Petrov, S.; Alawi, F.; Graves, D.T. 2012: Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 26(4): 1423-1430
Rosenthal, M. 2010: Diabetes alert dogs. Diabetes Self-Management 27(4): 23-26
Baptista, F.I.; Pinto, M.J.; Elvas, F.; Almeida, R.D.; Ambrósio, A.ón.F. 2013: Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus. Plos one 8(6): E65515
Di Marco, E.; Gray, S.P.; Jandeleit-Dahm, K. 2013: Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature. Frontiers in Endocrinology 4: 68
Burul-Bozkurt, N.; Pekiner, C.; Kelicen, P. 2010: Diabetes alters aromatase enzyme levels in gonadal tissues of rats. Naunyn-Schmiedeberg's Archives of Pharmacology 382(1): 33-41
Burul-Bozkurt, N.; Pekiner, C.; Kelicen, P. 2010: Diabetes alters aromatase enzyme levels in sciatic nerve and hippocampus tissues of rats. Cellular and Molecular Neurobiology 30(3): 445-451
Crespo, M.J.; Marrero, M.; Cruz, N.; Quidgley, J.; Creagh, O.; Torres, H.; Rivera, K. 2011: Diabetes alters cardiovascular responses to anaesthetic induction agents in STZ-diabetic rats. Diabetes and Vascular Disease Research 8(4): 299-302
Katta, A.; Preston, D.L.; Karkala, S.K.; Asano, S.; Meduru, S.; Mupparaju, S.P.; Yokochi, E.; Rice, K.M.; Desai, D.H.; Blough, E.R. 2008: Diabetes alters contraction-induced mitogen activated protein kinase activation in the rat soleus and plantaris. Experimental Diabetes Research 2008: 738101
Oviedo-Socarrás, T.; Vasconcelos, A.C.; Barbosa, I.X.; Pereira, N.B.; Campos, P.P.; Andrade, S.P. 2014: Diabetes alters inflammation, angiogenesis, and fibrogenesis in intraperitoneal implants in rats. Microvascular Research 93: 23-29
Sheikh, A.Q.; Hurley, J.R.; Huang, W.; Taghian, T.; Kogan, A.; Cho, H.; Wang, Y.; Narmoneva, D.A. 2012: Diabetes alters intracellular calcium transients in cardiac endothelial cells. Plos one 7(5): E36840
Connizzo, B.K.; Bhatt, P.R.; Liechty, K.W.; Soslowsky, L.J. 2014: Diabetes alters mechanical properties and collagen fiber re-alignment in multiple mouse tendons. Annals of Biomedical Engineering 42(9): 1880-1888
Tu, H.; Zhang, L.; Tran, T.P.; Muelleman, R.L.; Li, Y.L. 2010: Diabetes alters protein expression of hyperpolarization-activated cyclic nucleotide-gated channel subunits in rat nodose ganglion cells. Neuroscience 165(1): 39-52
Xu, R.; Yang, R.; Hu, H.; Xi, Q.; Wan, H.; Wu, Y. 2013: Diabetes alters the expression of partial vasoactivators in cerebral vascular disease susceptible regions of the diabetic rat. Diabetology and Metabolic Syndrome 5(1): 63
Zakaria, R.; Rajikin, M.H.; Yaacob, N.S.; Nor, N.M. 2007: Diabetes alters the mRNA expression of insulin-like growth factors and their receptors in the mouse fallopian tube and uterus during the preimplantation stages. Reproductive Biology 7(1): 41-53
Letonturier, P. 2008: Diabetes always hits the heart. Presse Medicale 37(9): 1351-1353
Reichard, A.; Stolzle, H. 2011: Diabetes among adults with cognitive limitations compared to individuals with no cognitive disabilities. Intellectual and Developmental Disabilities 49(3): 141-154
Chuang, S.-Y.; Hsu, P.-F.; Sung, S.-H.; Chou, P.; Chen, C.-H. 2010: Diabetes and 15-year cardiovascular mortality in a Chinese population: Differential impact of hypertension and metabolic syndrome. Journal of the Chinese Medical Association: Jcma 73(5): 234-240
Sima, A.A.F.; Li, Z.-G. 2006: Diabetes and Alzheimer's disease - is there a connection?. Review of Diabetic Studies: Rds 3(4): 161-168
Livingstone, J.L. 1936: Diabetes and Bilateral Pulmonary Tuberculosis treated by Artificial Pneumothorax and Phrenic Evulsion. Proceedings of the Royal Society of Medicine 29(10): 1226
Schernthaner, G. 2010: Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. Wiener Medizinische Wochenschrift 160(1-2): 8-19
Qazi, M.U.; Malik, S. 2013: Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study. Global Heart 8(1): 43-48
Anonymous 1949: Diabetes and Gout. British Medical Journal 2(4629): 692
Ammary-Risch, N.J.; Aguilar, M.; Goodman, L.Saunders.; Quiroz, L. 2012: Diabetes and Healthy Eyes Toolkit: a community health worker program to prevent vision loss and blindness among people with diabetes. Family and Community Health 35(2): 103-110
Diouf, A.; Cournil, A.; Ba-Fall, K.; Ngom-Guèye, N.èy.F.; Eymard-Duvernay, S.; Ndiaye, I.; Batista, G.; Guèye, P.M.é; Bâ, P.S.; Taverne, B.; Delaporte, E.; Sow, P.S. 2012: Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors. Isrn Aids 2012: 621565
Anonymous 1950: Diabetes and Insulin. British Medical Journal 1(4662): 1122
Barlow, K.E. 1939: Diabetes and Kidney Failure. British Medical Journal 2(4110): 765-767
Khithani, A. 2009: Diabetes and PET Scans: only Part of a Bigger Problem. Gastrointestinal Cancer Research: Gcr 3(4): 165-166